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The vertebrate immune system detects and eliminates a wide spectrum of pathogens 
including viruses, bacteria and parasites to protect against infection. In mammals, such 
as humans, the immune system contains three lines of defense against invading patho-
gens: 1) physical and chemical barriers formed by the skin and mucous membranes,1, 2 
2) immune cells and molecules that promote innate responses3 and 3) adaptive responses 
mediated by B and T lymphocytes. All immune cells originate from hematopoietic stem 
cells (HSC) that reside in the bone marrow (BM). During hematopoiesis, HSC-derived 
progenitor cells are progressively restricted into distinct cell lineages controlled by spe-
cific transcription programs (Figure 1).4 Innate immune cells are crucial for fast host 
responses. They recognize general foreign structures and eliminate pathogens through 
phagocytosis (granulocytes and macrophages) or cytotoxicity (natural killer cells).3 B and 
T lymphocyte responses take more time. They bind to pathogens with highly specific 
antigen receptors. The few cells that specifically recognize the pathogens proliferate to 
enhance the response, thereby adapting the antigen receptor affinity to improve the rec-
ognition of pathogens. This improved response is subsequently maintained in the form 
of immunological memory, i.e. long-lived memory B and T cells that provide a faster 
response to the same pathogen during next encounter. 
The capability of B and T lymphocytes to recognize the enormous diversity of patho-
gens is underlined by the unique antigen-specific receptors generated during early stages 
of B and T-cell development. The antigen receptors are encoded by immunoglobulin (Ig) 
and T-cell receptor (TR) loci that contain various coding elements. Random assembly 
of these elements provides the broad and diverse repertoire of antigen-specific recep-
tors. The assembly occurs via somatic V(D)J recombination and requires a tight control. 
Alterations at any step of these processes may lead to formation of different or abnormal 
antigen-receptor repertoire. 
This thesis is focused on the mechanisms underlying the stage-specific regulation of 
V(D)J recombination and the generation of a diverse antigen-receptor repertoire during 
precursor-B-cell development. 
B-CELL DEVELOPMENT IN BONE MARROW
B cells create the humoral part of the adaptive response and contribute to the clear-
ance of pathogens through production of immunoglobulins (Ig). Ig can be secreted as 
soluble molecules (antibodies) or expressed on the B-cell surface as B-cell antigen recep-
tors (BCR). The ultimate goal of precursor-B-cell differentiation in bone marrow (BM) is 
to generate a unique BCR, whereby all B cells together provide an enormous Ig repertoire 
diversity.
11
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Figure 1. Schematic representation of hematopoiesis. Hematopoiesis occurs in bone marrow and occurs 
throughout the life. Long-lived and self-renewing hematopoietic stem cells (HSC) give rise to a number of 
different progenitor stages that become progressively restricted towards a specific cell lineage.4 The dotted 
arrows represent an alternative model of hematopoiesis which postulate existence of LMPP giving rise to CLP 
and GMP, and direct formation of MEP from MPP.5 MPP, multipotent progenitor; LMPP, lymphoid-primed 
multipotent progenitor; CLP, common lymphoid progenitor; CMP, common myeloid progenitor; GMP, gran-
ulocyte/monocyte progenitor; MEP, megakaryocyte/erythrocyte progenitor; NK, natural killer. The Figure was 
adapted from Bryder et al., 2006, Am J Pathol.4
B-cell commitment
After birth, B cells are continuously generated throughout life from hematopoietic 
stem cells (HSC) that reside in BM and are long-lived with self-renewing capacity. In 
mouse models, it has been established that B-cell precursors differentiate through several 
consecutive stages controlled by a tight balance between various transcription factors 
(Figures 1 and 2).6, 7 First, HSC give rise to multilineage progenitors. Subsequently, the 
expression of PU.1, Ikaros and growth factor receptor FLT3 restrict the multilineage 
progenitors to either the lymphoid or myeloid lineage. High levels of Ikaros and low 
levels of PU.1 direct the cells to lymphoid lineage, while high PU.1 expression induces 
myeloid cell fate. Next, common lymphoid progenitors induce expression of IL-7R which 
antagonizes myeloid development and supports lymphoid development.8-11 Subsequently, 
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upregulation of E2A further blocks the myeloid cell fate and promotes formation of 
lymphoid progenitors that can differentiate into B cells, T cells or NK cells (Figure 2).7, 
12 E2A is one of the most important transcription factors in developing B cells. It belongs 
to the basic helix-loop-helix (bHLH) family of transcription factors and exists in two 
splice variants: E12 and E47. Similar to the other bHLH proteins, E2-2 and HEB, E2A 
can bind specific DNA sequences, E-boxes, as homo- or heterodimers.13, 14 B cells mainly 
express E47 homodimers.15 Inhibition of E2A by ID2 protein at this stage of develop-
ment may recruit the cells to the NK lineage.16-18 
Next, PU.1, E2A and FOXO1 further upregulate expression of EBF transcription 
factor. EBF specifies the B-cell fate and directs differentiation of lymphoid progenitors 
into pre-pro-B cells.19-22 These cells are not yet fully committed to the B-cell lineage and 
show a high degree of T-cell lineage plasticity.12 Notch signaling may still skew the pre-
pro-B-cell development into T-cell lineage.23 Finally, E2A, EBF and FOXO1 promote 
expression of multiple B-cell specific factors, including the most crucial Pax5. Pax5 
ensures irreversible commitment of pre-pro-B cells to pro-B cells through upregulation of 
EBF and downregulation of Notch signaling and ID2. Moreover, Pax5 directs expression 
of B-cell specific molecules such as CD19.21, 22, 24 Pax5 and EBF transcription factors are 
expressed only in B-lineage cells and have the ability to silence non–B-cell genes and to 
activate B-cell genes. This gives the B-cell program its tight coherence and provides full 
commitment (Figure 2).25, 26
Figure 2. Hematopoietic stem cells (HSC) commitment to the B-cell lineage. HSC in bone marrow give rise 
to multilineage progenitors able to differentiate into all blood cells. Restriction, specification and commitment 
to each blood cell lineage depends on a tight balance between various transcription factors. High levels of Ikaros 
and low levels of PU.1 restricts the multilineage progenitors into lymphoid progenitors, which further upon 
induction of IL-7R signaling, E2A, FOXO1 and RAG1 are specified to the B-cell lineage. ID2 and Notch-1 
proteins may still re-direct the cell plasticity into NK-cell and T-cell fate. Upon expression of EBF the pre-pro-B 
cells differentiate into pro-B cells and finally Pax5 ensures full commitment to the B-cell lineage. Arrows indi-
cate positive interactions and ┴ indicates repression. The Figure was adapted from Nutt et al., 2007, Immunity7 
and Berkowska et al., 2011, Ann NY Acad Sci.27
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B-cell differentiation and ordered immunoglobulin gene rearrangements
B-cell differentiation in BM takes place in 5 consecutive differentiation stages (Figure 
3A).4, 28-33 This differentiation is similar between man and mice and ensures the gener-
ation of unique Ig molecules composed of two Ig heavy chains (IgH) and two Ig light 
chains (Igκ or Igλ) encoded by rearranged Ig loci. In lymphoid progenitor cell Ig loci 
lack a functional first coding exon and instead they contain multiple coding elements. 
The first functional coding exon is generated through somatic rearrangement of these 
elements during B-cell differentiation process (Figure 3B),34, 35 which is paralleled by an 
ordered upregulation and downregulation of lineage-specific markers (Figure 3C).36, 37 
Two common precursors-B cell nomenclature system by Osmond28, 38 (adapted for mice) 
and by Melchers and Rolink39 (adapted for man) distinguish the B-cell developmental 
stages based on the Ig gene rearrangement processes and expression of specific markers.
Figure 3. B-cell differentiation in bone marrow. (A) Precursor-B cells differentiate in bone marrow through 5 
distances stages. (B) During the differentiation, precursor-B cells rearrange Ig genes to finally create functional 
and diverse B-cell receptors expressed on mature cells migrating out of bone marrow. (C) The distinct stages of 
differentiation can be distinguished through surface and intracellular expression of several markers. The nomen-
clature of B-cell-differentiation stages and usage of expression marker varies between mouse and human. Two 
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commonly used precursor-B cell nomenclature systems are these by Osmond28, 38 and by Melchers and Rolink.39 
The Figure was adapted from Hardy et al., 2001, Annu Rev Immunol37 and van Zelm et al., 2005, J Immunol.36
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Figure 4. IGH gene rearrangement and immunoglobulin structure. (A) VDJ recombination in IGH 
locus initiates through Dh to Jh rearrangement and proceeds with coupling of Vh gene to the DJh joint. 
Subsequently, the VDJh exon is transcribed and spliced to the IGHM exon followed by translation to Igµ 
protein. Similar recombination events within IGL loci lead to formation of functional IgL protein. Finally, IgH 
and IgL chains are paired into complete Ig (BCR) which is expressed on the B-cell membrane with CD79a 
and CD79b proteins (B, left panel). (B, right panel) The IgH variable domain is composed of 4 framework 
regions (FR) separated by 3 complementary determining regions (CDR) forming loops responsible for antigen 
binding. The Figure was adapted from thesis of Prof. dr. J.J.M. van Dongen, from thesis of Dr. M.C. van Zelm 
and from thesis of Dr. M.A. Berkowska. 
Ig gene rearrangements occur in a stepwise manner, i.e. Ig heavy chain locus (IGH) is 
rearranged before Ig light chain loci (IGK or IGL). IGH assembly begins with Dh to Jh 
rearrangement initiated in pro-B cells (mouse: pre-pro-B cells). This is followed in pre-BI 
cells (mouse: pre-B cells) with genomic coupling of one of the Vh genes to the already 
formed incomplete Dh-Jh joint to generate a complete Vh-DJh rearrangement (Figures 
3A-B and 4A).32, 36, 40 Dh-Jh rearrangements occur generally on both IGH alleles31, 41 and 
15
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are not exclusive for B cells, as up to 48% of common lymphoid progenitors carry these 
Dh-Jh rearrangements.12 The Vh-DJh rearrangements, however, are specific for B cells 
and are initially induced only on one allele. The second IGH allele is poised for rearrange-
ment only if the first rearrangement was unsuccessful. If the rearrangement attempt was 
successful on one allele, the second non-rearranging allele undergoes allelic exclusion. 
Subsequently, the rearranged genes are transcribed, spliced and translated into IgH pro-
tein (Figure 4B). Because V and J genes can be read only in one reading frame and stop 
codons can be introduced in the coding joints, only less than one-third of rearrangements 
leads to a functional protein. 
Following the successful assembly of IgH, Ig light chain gene rearrangements are 
induced in pre-BII small cells (mouse: pre-B small cells) (Figure 3A-B). Still, a minor 
fraction of B cells rearranges Ig light chain loci before formation of productive IgH.42 
Because the Ig light chain loci do not contain D genes, the Ig light chain gene rear-
rangements occur through joining of one of the V with one of the J genes. The V-J 
rearrangements are first induced on one IGK allele and only if both IGK alleles render 
a non-functional rearrangement, the IGL alleles will be recombined. In addition, the 
presence of many V and J genes and only single step of rearrangement allows for multiple 
attempts on the same allele, known as receptor editing: if a non-functional rearrangement 
is formed, an upstream V and a downstream J gene can rearrange and thereby removes the 
preexisting V-J rearrangement from the genome. 
IL-7R and pre-B-cell receptor signaling
IL-7R and pre-BCR signaling are key mediators of the order in Ig gene rearrange-
ments. In pro-B cells, the IL-7R signaling opens the IGH locus for rearrangements by 
facilitating the locus contraction.43 The IL-7R signaling also modifies the histone code 
through activation of STAT5. In pro-B cells, STAT5 regulates germline transcription 
and histone acetylation of the distal Vh region,44 whereas within the IGK locus, IL-7R 
signaling recruits STAT5 tetramers to iEκ which further induces Ezh2 methyltransfer-
ase and thereby silences the IGK locus through H3K27me3 modifications.45  In pre-B 
cells, the primary function of IL-7R is to maintain and expand the cells (Figure 5). 
IL-7R activates STAT546-48 which further induces transcription of cell-cycle checkpoint 
protein cyclin D349, 50 and anti-apoptotic factors such as BCL2, BCLXL and MCL1.51-53 
Complementary signaling through the phosphoinositide 3‑kinase (PI3K)–AKT pathway 
represses FOXO1, an inducer of RAG1 and RAG2 gene transcription.54, 55 
By contrast, the pre-BCR inhibits proliferation and induces Ig light chain gene rear-
rangement (Figure 5).33, 56-58 The pre-BCR is formed after functional VDJh rearrange-
ment through assembly of the Igµ with the surrogate light chain molecules VpreB and 
I. General Introduction
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λ14.1. Aggregation of the pre-BCR and auto-crosslinking of the surrogate light chains is 
sufficient to induce the signaling which is mediated by basic amino acids in the non-im-
munoglobulin tail of λ14.1.59-61 Upon pre-BCR cross-linking, the protein-tyrosine kinase 
LYN phosphorylates immunoreceptor tyrosine-based activation motifs (ITAMs) in 
CD79a and CD79b. Recruitment of LYN and activation of BLNK promotes the RAS–
RAF-MEK-ERK pathway,62, 63 which represses cyclin D3 and ID3, while induces E2A.64 
Increasing levels of free nuclear E2A together with IRF4, downstream of BLNK, coor-
dinately enhance Ig light chain gene accessibility and rearrangements.65 Allelic exclusion 
of the second non-rearranged IGH allele is established via SYK and PLCγ signaling.66, 67 
Figure 5. IL-7R and pre-B-cell receptor signaling. IL-7R and pre-BCR provide distinct downstream signaling 
pathways which ensure that proliferation and immunoglobulin recombination are mutually exclusive. Signaling 
through IL-7R activates STAT5 and PI3K-AKT pathway which induce cell proliferation and survival, while 
repress Ig light chain gene rearrangements. Pre-BCR signaling by contrast via SYK and BLNK activates RAS-
ERK pathway thereby attenuating cell cycling and promoting Ig light chain gene rearrangements. Downstream 
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signaling of pre-BCR via PLCγ2 and SYK ensures allelic exclusion of the second non-rearranged IGH allele. 
The Figure was adapted from Clark et al., 2014, Nat Rev Immunol57 and Rickert, 2013, Nat Rev Immunol.58
Preferential coupling of the PI3K pathway to the IL‑7R, and not to the pre-BCR, 
ensures that each receptor has opposing and antagonistic functions.68 Thus, in the pres-
ence of IL-7, the pre-BCR cannot fully act. After a pre-B cell has attenuated or escaped 
IL-7R signaling, likely through Ikaros,69, 70 the SYK–BLNK represses PI3K-AKT which 
augments FOXO1 activity and commits to the Ig light chain gene rearrangements 
(Figure 5).54, 55
Early B-cell tolerance checkpoints
Upon successful rearrangement of an Ig light chain gene, at the immature-B cell stage 
complete Ig molecules are formed which are composed of two IgH and two IgL chains 
(Figure 4B, left panel). Each Ig chain contains a variable domain that determines the 
antigen-specificity and a constant domain, which is responsible for the Ig functionality. 
The Ig variable domain is composed of 4 conserved framework regions (FR) interspersed 
by 3 complementary determining regions (CDR) (Figure 4B, right panel). The FRs 
form a solid Ig structure, while the 3 diverse CDRs create loops recognizing pathogens. 
CDR3 is the most polymorphic because it is encoded by the junction between rearranged 
V, (D) and J genes and thereby crucial for antigen binding specificity.
Upon generation of a BCR, developing B cells expressing the receptors at the imma-
ture-B cell stage are selected for recognition of antigens followed by negative selection 
for self-reactivity. Approximately 75% of Ig generated in BM is autoreactive and approx-
imately 55% is polyreactive.71 To ensure proper immune tolerance, negative selection 
allows to remove these receptors from the repertoire via apoptosis, anergy or receptor 
editing.72-75 Removal of the autoreactive and polyreactive Ig first occurs at the imma-
ture-B cells stage (Figure 6).71, 76 During differentiation from early immature-B-cell to 
immature-B-cell in BM, central tolerance mechanisms reduce both the autoreactive and 
polyreactive Ig repertoire to ~45% and less than 10%, respectively. In addition, there 
is a peripheral tolerance checkpoint after migration of the B cells out of the BM which 
further reduces autoreactive Ig repertoire to ~20%.71, 76 
THE V(D)J RECOMBINATION PROCESS
The Ig heavy chain and Ig light chain loci contain multiple variable (V), diverse (D) 
and joining (J) coding elements which must be assembled to create the functional first 
coding exon. During generation of Ig, only one V, one D and one J genes are randomly 
I. General Introduction
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Figure 6. Early B-cell tolerance checkpoints. Immunoglobulins created in bone marrow are counterselected 
for autoreactivity and polyreactivity at two tolerance checkpoints. First, central B-cell tolerance in bone marrow 
reduces the ~75% autoreactive and ~55% polyreactive receptors to ~45% and less than 10%, respectively. 
Subsequently, during the cell transition from bone marrow to periphery, peripheral B-cell tolerance checkpoint 
further removes autoreactive immunoglobulin to ~20% present in naive mature B-cell repertoire. The Figure 
was adapted from Wardemann et al., 2003, Science71 and Meffre, 2011, Ann NY Acad Sci.76    
Molecular mechanism of V(D)J recombination 
The V(D)J recombination starts with induction of double stranded DNA breaks 
(DSBs) by the heterodimeric complex of recombinase activating gene protein products 
RAG1 and RAG2 (Figure 7). RAG proteins specifically recognize recombination signal 
sequences (RSS) flanking all Ig genes. RSS are composed of conserved heptamer and 
nonamer sequences separated by a less conserved spacer region of 12 or 23 base pairs 
(bp).78-80 Rearrangements always occur between Ig genes flanked by a 12-bp RSS and a 
23-bp RSS, commonly referred to as 12-23 rule.79
The RAG complex brings together the two genes poised for rearrangement and intro-
duces single stranded DNA breaks at the border of each gene and its flanking RSS.81-83 
Next, DNA hairpins are created at the site of the gene breaks (coding ends) and blunt 
ends are created at the side of RSS (signal ends). Before ligation of the two coding ends 
by the non-homologous end joining pathway (NHEJ), the MRN complex consisting of 
NBS, MRE11 and RAD50 proteins tethers the DNA ends to ensure they remain in close 
proximity.84, 85 In addition, the MRN complex activates the ataxia-telangiectasia-mutated 
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chosen and rearranged in a process of somatic V(D)J recombination.35, 77 V(D)J recombi-
nation mechanism is the same for all Ig loci and occurs in a stepwise manner. 
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protein (ATM), which results in cell cycle arrest, activation of DNA repair pathways 
and initiation of apoptosis in cells that fail to repair.86-89 The DNA repair is initiated 
by loading of Ku70 and Ku80 proteins onto the break and recruitment of the catalytic 
subunit of DNA-dependent protein kinase (DNA-PKcs) and Artemis.90, 91 DNA-PKcs 
stabilizes the protein-DNA complex, protects against exonuclease activity and stimulates 
juxtaposition of DNA ends.92 Subsequently, Artemis opens the hairpins within coding 
ends preferentially at the tip or 1-2 bp 5’ of the tip.93, 94 If the hairpins are opened 5’ of the 
tip, complementary nucleotides can be added to generate blunt ends which results in for-
mation of palindromic (P-) nucleotides. Nucleotides can be also deleted by exonucleases 
or non-template (N-) nucleotides can be added by terminal deoxynucleotidyl transferase 
protein (TdT).95-97 Finally, the DNA coding ends are ligated by a protein complex includ-
ing XRCC4, DNA ligase IV and XLF.98-100 The signal ends at the side of RSS are joined 
by the NHEJ and remain in the cell as a circular excision product.  
V J
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Figure 7. Molecular mechanism of V(D)J recombination. The RAG protein complex cleaves the double 
stranded DNA at the border of two immunoglobulin genes poised for rearrangement and flanking recombina-
tion signal sequences. This results in coding ends and signal ends formation. The signal ends are directly ligated 
by the non-homologous end joining pathway (NHEJ) and the coding ends with hairpins are tethered in close 
proximity by MRN complex (NBN, MRE11, Rad50). Subsequently, Ku70, Ku80, DNA-PKcs and Artemis 
are loaded onto the coding ends and Artemis cleaves the hairpins. The opened ends are further processed by 
endonucleases and TdT which incorporates the non-template N-nucleotides. Finally, the two coding ends are 
sealed into the coding joint by complex of DNA ligase IV, XRCC4 and XLF. The Figure was adapted from van 
der Burg et al., 2009, Curr Opin Allergy Clin Immunol101 and Berkowska et al., 2011, Ann NY Acad Sci.27  
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Organization of immunoglobulin loci
The stepwise manner of Ig gene rearrangements is controlled by various regulatory 
elements present within Ig loci (Figure 8).102-105 Each V gene contains individual pro-
moter located upstream of the gene, while D and J gene clusters contain one common 
promotor for the cluster. Furthermore, each Ig locus contains intron enhancer located 
between J and C genes and enhancer at the 3’ end of the locus. Presence of few additional 
regulatory elements were recently shown within murine IGH locus, i.e. Pax5-activated 
intergenic elements (PAIR) interspersed in the distal Vh region,106 intergenic control 
region (IGCR1) located between V and D genes107 and CTCF-binding elements (CBE) 
at the 3’ end of the locus. Within murine IGK, additional silencer in the intervening 
sequence (SiS) located between V and J genes was also recently described (Figure 8).108
Figure 8. Organization of immunoglobulin loci. (A) Murine and (B) human immunoglobulin loci posi-
tioned at different chromosomes show similar organization although differ in size. They are composed of 
multiple variable (V), diverse (D), joining (J) and constant (C) genes and contain a spectrum of regulatory 
elements. Intronic enhancers (iE) and enhancers located at the 3’ end of the locus were described in all loci. 
Additionally, within murine IGH locus Pax5-activated intergenic elements (PAIR) and intergenic control 
region (IGCR1) were recently found, while silencer in the intervening sequence (SiS) was detected within 
murine IGK. Each C gene of the IGH is preceded by a switch region. Rearrangement within the IGK between 
the IRS (mouse) or intronRSS (human) and the RS (mouse) and Kde (human) elements can make the IGK 
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allele nonfunctional by deleting the Cκ exons and the enhancers. CBE, CTCF-binding element, Ψε-pseudo 
epsilon gene; Ψγ-pseudo gamma gene; Ψλ-pseudo lambda gene.
TRANSCRIPTIONAL AND EPIGENETIC REGULATION OF IG GENE 
REARRANGEMENTS
The formation of Ig during B-cell differentiation is tightly regulated. V(D)J recom-
bination occurs in a stepwise manner where IGH rearranges prior IGK and IGL, and 
Dh-Jh joints are formed before Vh-Dh assembly. Moreover, IGK rearranges before IGL 
and functional Ig rearrangements never occur on both Ig alleles. The tight control is par-
tially provided by presence of RSS only within antigen receptor loci and RAG expression 
only in lymphoid cells. Although the V(D)J recombination machinery is common for 
lymphoid cells, complete TCRβ rearrangements never occur in B cells and complete IGH 
gene rearrangements are absent or very rare in T cells. Thus, the lineage and developmen-
tally restricted manner of V(D)J recombination must be further controlled. The second 
degree of control is provided by transcriptional regulation. B and T lymphocyte express 
distinct transcription factors which recognize specific binding sites within promoters and 
enhancers of antigen receptor loci. 
P V P PD J Ei Sμ Cμ 3’E
P V P PD J Ei Sμ Cμ 3’E
promoterpromoter promoter enhancer enhancer
P V P DJ Ei Sμ Cμ 3’E
promoter - binding proteins enhancer - binding proteins
germ-line transcription
germ-line transcription
P V D J Ei Sμ Cμ 3’E
Igμ transcription
Germline DNA: Ig chromatin closed
B-cell specific proteins bind to Ig enhnacer and promoter: chromatin opens
pro-B cells with D-J joint in DNA
pre-B cells with V-DJ joint in DNA
Figure 9. Transcriptional regulation of immunoglobulin loci accessibility. IGH locus becomes progressively 
accessible for transcriptional machinery. Prior to rearrangement, chromatin opens within enhancers and promoters 
of diversity (D) and joining (J) genes which enables binding of B-cell specific transcription factors. Occupancy of 
promoters and enhancers by transcription factors initiates germ-line transcription and induces Dh-Jh rearrange-
ment. After DJh joint formation, promoters of variable (V) genes become accessible for transcriptional machin-
ery which promotes Vh-DJh rearrangement. The Figure was adapted from Corcoran, 2010, Semin Immunol.110 
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The binding sites, however, become accessible for transcription factors only at specific 
stages during development. It is thought that the ordered accessibility of Ig loci is con-
trolled by epigenetic processes such as DNA and chromatin modifications, locus contrac-
tion and nuclear positioning.29, 77, 109  
Transcriptional regulation of immunoglobulin loci accessibility 
The ordered accessibility of Ig genes for V(D)J recombination is underlined by tran-
scriptional control (Figure 9). Alt & Yancopoulos formulated the accessibility hypothesis 
which proposed that the germ-line transcription over unrearranged IGH and IGL loci 
regulated the stepwise V(D)J recombination.31 In non-rearranging B cells, the chromatin 
enclosing Ig loci is not accessible for the transcription machinery. Prior to rearrangement, 
the chromatin opens progressively within Ig promoters and enhancers to enable binding 
of  B-cell specific transcription factors. Occupancy of promoters and enhancers by tran-
scription factors initiates germ-line transcription and induces rearrangement.110 Within 
the IGH locus, chromatin is first opened at the Dh-Jh region, and only after Dh-Jh 
rearrangement, the Vh region becomes accessible (Figure 9).111, 112 Within the IGK locus, 
germline transcription is induced after pre-BCR signaling.113   
Figure 10. DNA organization in the eukaryotic cell nucleus. DNA is tightly packed in the small volume of 
nucleus to fit its mass. 146 base pairs of double stranded DNA helix are wrapped around a protein octamer 
composed of 2 copies of 4 histone molecules: H2A, H2B, H3 and H4. The DNA with histones create the basic 
nucleus
chromosome
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chromatin unit, the nucleosome. Subsequently, the nucleosomes are packed into 10 nm and 30 nm chromatin 
fiber structures. During mitosis, additional DNA compaction takes place and the 30 nm chromatin fiber is 
further folded into chromosomes. This Figure was adapted from thesis of Dr. R. Stadhouders.
The histone code determines chromatin accessibility
Ig loci are present in every cell of multicellular organisms such as vertebrates, however, 
they are transcribed only in B cells, thus their expression is tightly regulated. To fit the 
small volume of the cell nucleus, around 2 meter-long DNA molecule is tightly packed 
(Figure 10). A stretch of 146 base pairs of double-stranded DNA helix is wrapped around 
a histone protein octamer (two copies of the four core histones: H2A, H2B, H3, H4) 
creating nucleosome, which forms the basic unit of chromatin. Further nucleosomes are 
compacted into 10 nm and 30 nm chromatin fibers which subsequently are folded into 
chromosomes in proliferating cells.114, 115 
When the DNA is tightly wrapped around histones and the nucleosome density is 
high, chromatin is difficult to access for the transcriptional machinery (referred as heter-
ochromatin), whereas less tight DNA wrapping around histones and lower nucleosome 
density creates a more accessible form of chromatin (referred as euchromatin). “Closed” 
vs “open” chromatin conformation is established through several processes such as post-
translational histone modifications, chromatin remodeling and DNA modifications. 
Histones are modified at special amino acids residues present in histone tails. Histone 
tails are methylated, phosphorylated, acetylated, sumolyated, ubiquitinated and ADP-
ribosylated. There are two characterized mechanisms for the function of these modifi-
cations. The first is the disruption of contacts between nucleosomes in order to unwrap 
chromatin and the second is the recruitment of non-histone proteins. For instance, 
acetylation alters the charge on the histone, which weakens the DNA-histone interaction 
leading to a less compact chromatin structure (Figure 11A).114, 116, 117 In general, active 
chromatin is enriched in acetylated histones H3, H4, H2A and histone H3 methyl-
ated at Lys 4 (H3K4), while histone hypoacetylation and methylation of histone H3 
Lys 9 (H3K9) are a hallmark of inactive chromatin. Next to the histone modifications, 
multiprotein complexes such as chromatin (nucleosome) remodelers have the ability to 
slide or (dis) assemble histone octamers in an ATP-dependent manner which changes the 
chromatin accessibility (Figure 11B).118 Finally, the DNA itself can be modified. CpG 
methylation is generally associated with the gene silencing.119
Ig genes poised for V(D)J recombination are extensively acetylated at histones H3 and 
H4, as well as methylated at H3K4.120-122 First methyl and acetyl groups are added to the 
histones within Dh-Jh region and only after DJh assembly, these are incorporated within 
Vh genes (Figure 11C).123 Within Ig light chain loci, chromatin marks are present only 
after pre-BCR signaling. Importantly, stage-specific trimethylation of H3K4 (H3K4me3) 
in Ig genes can directly recruit RAG2.124-126 Incorporation of histone code within Ig loci is 
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shown to be driven by intron enhancers: germline deletion of iEµ greatly reduces histone 
acetylation on Dh and Jh genes and H3K4me3 levels on Jh genes.127 Consequently, 
iEµ deletion reduces the IGH gene rearrangements.77, 104 iEµ may also initiate chromatin 
remodeling by recruiting the chromatin remodeling SWI/SNF complex to the Dh-Jh 
region.128
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Figure 11. Histone modifications and chromatin remodeling. “Closed” vs “open” chromatin state is estab-
lished through posttranslational histone modifications and chromatin remodeling. (A) Histone marks such 
as acetyl and methyl groups are added to specific amino acids residues within histone tails. (B) Chromatin 
(nucleosome) remodelers have the ability to slide or (dis) assemble histone octamers in an ATP-dependent 
manner. TF, transcription factor. (C) Stepwise addition of histone marks to the IGH locus facilitates the ordered 
rearrangement process. The Figure was adapted from Kouzarides, 2007, Cell117, Saha et al., 2006, Nat Rev Mol 
Cell Biol118 and Feeney, 2011, Curr Opin Immunol.129
3D chromatin structure and long-range genomic interactions
Activation or suppression of genes depends on multiple regulatory elements such as 
enhancers, silencers or locus regulatory elements which often act from a distance (Figure 
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12A).130 Ig loci create large genetic complexes (Figure 8) and V(D)J recombination also 
requires interactions between Ig regulatory elements and Ig genes over the genomic dis-
tance. These long-range genomic interactions are established through chromatin folding. 
Mammalian genomes fold into clusters of loops that assemble into topologically asso-
ciated domains (TADs).131-133 These chromatin loops are established through interactions 
between ubiquitously expressed global chromatin architecture proteins such as CCCTC-
binding factor (CTCF), cohesin and Yin-Yang 1 (YY1).134, 135 CTCF recognizes specific 
bindings sites across the whole genome to mediate the long-range looping,136 whereas 
cohesin interacts with CTCF and forms a ring-like structure around the chromatin loops 
to maintain them (Figure 12B).137 The murine IGH locus is organized into three major 
multi-loop domains of rosettes-like shape (Figure 12C).138 Recent analysis of the pro-B 
cell genome indicates that the long-range interactions within multi-loop chromatin 
domains of IGH are associated with CTCF and YY1 binding.106, 131, 139-141 CTCF and 
YY1 binding sites are disseminated within the Vh region, they are present in intergenic 
control region (IGCR1) and 3’CTCF-binding element (3’ CBE). YY1 can also bind to 
iEµ. Thus, the long-range interactions between these regulatory elements establish the 
chromatin loops within IGH.107, 142
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Figure 12. Long-range interactions between genes and gene regulatory elements. Interactions between 
distal gene regulatory elements and genes are enabled through chromatin folding. (A) Enhancers , silencers 
and other locus regulatory elements can activate a gene from a distance, while insulators inhibit the long-range 
interactions. (B) Speculative model of chromatin looping which brings genes and gene regulatory elements in 
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close spatial proximity. Various global and lineage-specific transcription factors and regulatory proteins cluster 
together around gene and regulatory elements which facilitates looping. Cohesin likely maintains the chromatin 
loop. (C) Schematic representation of IGH locus organization into three multi-loop domains which contract 
upon B-cell differentiation from pre-pro-B cells to pro-B cells. Locus contraction brings Vh genes in close 
proximity of the DJh region and provides equal gene usage during recombination. The Figure was adapted from 
Maston et al., 2006, Annu Rev Genomics Hum Genet130 and Feeney, 2011, Curr Opin Immunol.129
However, global genome folding seems to be insufficient to mediate the gene expres-
sion. Ig loci must further contract at the stage of rearrangement to bring all genes in close 
proximity and provide equal opportunities for rearrangement (Figure 12C).43, 143-145 After 
complete Ig gene rearrangement, the loci decontract to prevent the rearrangement event 
at the second allele.143 Further locus contraction is likely driven by lineage-specific factors 
(Figure 12B). Recent analysis of the pro-B cell genome indicates that long-range inter-
actions between multi-loop chromatin domains of IGH were associated with the binding 
of B-cell specific transcription factors such as E2A, EBF1, Pax5, Ikaros and PU.1.106, 131, 
139-141, 146-150 Likely, these factors contract the three multi-loop domains of IGH locus upon 
progenitor-B cell commitment to pro-B cells.138, 143, 144 So far the role in locus contraction 
was proven for E2A, Pax5 and Ikaros which mediate the efficient rearrangements of Vh 
genes.139, 141, 142, 147, 149 
Looping of IGK locus yields similar picture to that of IGH. First, ubiquitously 
expressed proteins such as CTCF provide the global chromatin folding and subsequently 
the multi-loop domains are contracted by B-cell specific factors such as E2A. CTCF-
binding sites were located across the Vκ region, within SiS and downstream of the 3’Eκ, 
while E2A binds to the Vκ region and iEκ.113, 140, 151, 152 IGK locus also contracts specifi-
cally at the stage of rearrangements in pre-B cells,143 however, the locus contraction was 
also reported in pro-B cells.153
Nuclear positioning of genes
Nuclear positioning of Ig loci is involved in transcriptional control of Ig loci accessibil-
ity for recombination. In general, regions with euchromatin are associated with increased 
transcriptional accessibility, while heterochromatin is transcriptionally repressive. The 
nuclear periphery also represents a repressive region, whereas the nuclear center is enriched 
with transcription factories. The nuclear lamins, which line the inner membrane of the 
nucleus, acts as a repository for transcriptionally inactive chromatin domains, known as 
lamina-associated domains (LADs).154, 155 
In the interphase nucleus, chromatin fibers occupy spatially distinct regions, i.e. 
chromosome territories (Figure 13A).156 Genes can change their nuclear ‘neighborhoods’ 
from repressive sites towards transcription factories through extruding of decondensed 
chromatin loops into interchromosomal space and intermingling with neighboring 
27
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chromosome territories (Figure 13B).116, 157, 158 Many of the genes positioned in LADs are 
recruited at specific stages of cellular differentiation.116, 154, 157, 158 The Ig loci are positioned 
at the nuclear periphery in non-B cells, while they are centrally located in committed 
B-cell progenitors.155, 159, 160 The molecular mechanisms underlying the changes of gene 
localization are still obscure, but seem to correlate with histone acetylation.116
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Figure 13. Nuclear positioning of genes. (A) In interphase nucleus, the more “free” chromatin fibers are not 
positioned randomly but occupy spatially distinct regions named chromosome territories. The nuclear periph-
ery (nuclear lamins which lines the inner nuclear membrane) represents a repressive region, while the nuclear 
center is enriched with transcription factories, therefore genes change their nuclear localization during cellular 
maturation. (B) Genes can change their nuclear ‘neighborhoods’ from repressive sites towards transcription 
factories through extruding of decondensed chromatin loops into interchromosomal space and intermingling 
with neighboring chromosome territories. The Figure was adapted from Schneider and Grosschedl, 2007, 
Genes Dev.116
AIMS OF THE THESIS 
Ig loci recombine in a ordered manner: the IGH locus rearranges before the Ig light 
chain loci, functional Ig rearrangements rarely occur on both Ig alleles, and complete Ig 
assembly is exclusive for B cells. Still, the exact mechanisms controlling the stage-specific 
V(D)J recombination remain unknown. In Chapters II and III, we aimed to decipher 
which epigenetic processes control the stepwise Ig loci assembly in mouse models. In 
Chapter II, we studied how pre-BCR signaling influences the IGK locus recombination, 
while Chapter III elucidates the role of locus contraction and nuclear positioning in 
stepwise V(D)J recombination. 
B-cell differentiation occurs primarily in BM and starts already before birth in fetal 
liver and fetal BM. It is also suggested that B cells may develop in postnatal thymus. The 
ultimate goal of precursor-B-cell differentiation is to generate a diverse Ig repertoire. Still, 
the mechanisms controlling the generation of a diverse Ig repertoire are poorly under-
stood. In Chapters IV, V and VI, we studied the Ig repertoire formation in different 
niches of B-cell development, other than human postnatal BM, and to what extent this 
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influences the Ig reactivity. Chapter IV contains the analysis of Ig repertoire formation in 
human postnatal BM during aging. Chapter V outlines the mechanism underlying the 
skewed Ig repertoire formation during prenatal life. Whereas, Chapter VI describes the 
reactivity of fetal B cells and the Ig gene repertoire and reactivity of thymic B cells.
Finally, the General Discussion summarizes the basic research results and considers 
implications of these results for our understanding of precursor-B-cell biology.  
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ABSTRACT
During B-cell development the precursor B-cell receptor (pre-BCR) checkpoint is 
thought to increase immunoglobulin κ light chain (Igκ) locus accessibility to the V(D)
J recombinase. Accordingly, pre-B cells lacking the pre-BCR signaling molecules Btk 
or Slp65 showed reduced germline Vκ transcription. To investigate whether pre-BCR 
signaling modulates Vκ accessibility through enhancer-mediated Igκ locus topology, 
we performed chromosome conformation capture and sequencing analyses. These 
revealed that already in pro-B cells the κ enhancers robustly interact with the ~3.2 Mb 
Vκ region and its flanking sequences. Analyses in wild-type, Btk and Slp65 single and 
double-deficient pre-B cells demonstrated that pre-BCR signaling reduces interactions 
of both enhancers with Igκ locus flanking sequences and increases interactions of the 
3’κ enhancer with Vκ genes. Remarkably, pre-BCR signaling does not significantly 
affect interactions between the intronic enhancer and Vκ genes, which are already 
robust in pro-B cells. Both enhancers interact most frequently with highly used Vκ 
genes, which are often marked by transcription factor E2A. We conclude that the κ 
enhancers interact with the Vκ region already in pro-B cells and that pre-BCR signaling 
induces accessibility through a functional redistribution of long-range chromatin 
interactions within the Vκ region, whereby the two enhancers play distinct roles. 
INTRODUCTION
B lymphocyte development is characterized by stepwise recombination of 
immunoglobulin (Ig) variable (V), diversity (D) and joining (J) genes, whereby in 
pro-B cells the Ig heavy (H) chain locus rearranges before the Igκ or Igl light (L) chain 
loci.1, 2 Productive IgH chain rearrangement is monitored by deposition of the IgH m 
chain protein on the cell surface, together with the pre-existing surrogate light chain 
(SLC) proteins l5 and VpreB, as the pre-B cell receptor (pre-BCR) complex.3 Pre-BCR 
expression serves as a checkpoint that monitors for functional IgH chain rearrangement, 
triggers proliferative expansion and induces developmental progression of large cycling 
into small resting Ig m+ pre-B cells in which the recombination machinery is reactivated 
for rearrangement of the Igκ or Igl L chain loci.3, 4 
During the V(D)J recombination process, the spatial organization of large antigen 
receptor loci is actively remodeled.5 Overall locus contraction is achieved through 
long-range chromatin interactions between proximal and distal regions within these 
loci. This process brings distal V genes in close proximity to (D)J regions, to which 
Rag (recombination activating gene) protein binding occurs6 and the nearby regulatory 
elements that are required for topological organization and recombination.5, 7, 8 The 
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recombination-associated changes in locus topology thereby provide equal opportunities 
for individual V genes to be recombined to a (D)J segment. Accessibility and recombination 
of antigen receptor loci are controlled by many DNA-binding factors that interact with 
local cis-regulatory elements, such as promoters, enhancers or silencers.7-9 The long-
range chromatin interactions involved in this process are thought to be crucial for the 
regulation of V(D)J recombination and orchestrate changes in subnuclear relocation, 
germline transcription, histone acetylation and/or methylation, DNA demethylation and 
compaction of antigen receptor loci.5, 10
The mouse Igκ locus harbors 101 functional Vκ genes and four functional Jκ elements 
and is spread over >3 Mb of genomic DNA.11 Mechanisms regulating the site-specific 
DNA recombination reactions that create a diverse Igκ repertoire are complex and involve 
local differences in the accessibility of the Vκ and Jκ genes to the recombinase proteins.12 
Developmental-stage specific changes in gene accessibility are reflected by germline 
transcription, which precedes or accompanies gene recombination.13 In the Igκ locus 
germline transcription is initiated from promoters located upstream of Jκ (referred to as 
κ0 transcripts) and from Vκ promoters.
14 Deletion of the intronic enhancer (iEκ), located 
between Jκ and Cκ, or the downstream 3’κ enhancer (3’Eκ), both containing binding 
sites for the E2A and Irf4/Irf8 transcription factors, diminishes Igκ locus germline 
transcription and recombination.15-19 On the other hand, the Sis (silencer in intervening 
sequence) element in the Vκ-Jκ region negatively regulates Igκ rearrangement.20 This Sis 
element was shown to target Igκ alleles to centromeric heterochromatin and to associate 
with the Ikaros repressor protein that also colocalizes with centromeric heterochromatin. 
Sis contains a strong binding site for the zinc-finger transcription regulator CTCC-
binding factor (Ctcf ).21, 22 Interestingly, deletion of the Sis element or conditional deletion 
of the Ctcf gene in the B cell lineage both resulted in reduced κ0 germline transcription 
and enhanced proximal Vκ usage.21, 23 Very recently, a novel Ctcf-binding element located 
directly upstream of the Sis region was shown to be essential for locus contraction and 
recombination to distal Vκ genes.23 In addition, the Igκ repertoire is controlled by the 
polycomb group protein YY1.24 
Induction of Igκ rearrangements requires the expression of the Rag1  and Rag2 
proteins, the attenuation of the cell cycle and transcriptional activation of the Igκ 
locus, all of which are thought to be crucially dependent on pre-BCR signaling.4, 25 
At first, pre-BCR signals synergize with interleukin-7 receptor (IL-7R) signals to drive 
proliferative expansion of IgH m+ large pre-B cells.4 In these cells transcription of the Rag 
genes is low and the Rag2 protein is unstable due to cell-cycle dependent degradation.26 
Subsequently, signaling through the pre-BCR downstream adapter Slp65 (SH2-domain-
containing leukocyte protein of 65 kDa, also known as Blnk or Bash) switches cell fate 
from proliferation to differentiation.4 Importantly, Slp65 (i) induces the transcription 
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factor Aiolos, which downregulates l5 expression,27 (ii) binds Jak3 and thereby interferes 
with IL-7R signaling,28 and (iii) reduces inhibitory phosphorylation of Foxo transcription 
factors.29 All these changes result in attenuation of the cell cycle and thus Rag protein 
stabilization. Moreover, Rag gene transcription is induced by Foxo proteins.30
Although rearrangement and expression of the Igκ locus can occur independently of 
IgH m chain expression,31, 32 several lines of evidence indicate that pre-BCR signaling is 
actively involved in inducing Igκ and Igl locus accessibility and gene rearrangement. First, 
surface IgH m chain expression correlates with germline transcription in the Igκ locus.33 
Second, in the absence of Slp65, κ0 germline transcription is reduced.34 Third, mice 
deficient for Bruton’s tyrosine kinase (Btk), which is a pre-BCR downstream signaling 
molecule interacting with Slp65, show reduced Igl L chain germline transcription and 
reduced Igl usage.35 Fourth, transgenic expression of the constitutively active E41K-
Btk mutant in IgH m chain negative pro-B cells induces premature rearrangement and 
protein expression of Igκ L chain.34 Based on fluorescence in situ hybridization (FISH) 
studies, it has been proposed that in pro-B cells distal Vκ and Cκ genes are separated by 
large distances and that the Igκ locus specifically undergoes contraction in small pre-B 
and immature-B cells actively undergoing Vκ-Jκ recombination.36 However, it remains 
unknown how pre-BCR-induced signals affect the accessibility, contraction and topology 
of the Vκ region, or how they affect the long-range interactions of the κ regulatory 
elements involved in organizing these events. 
In this study, we identified the effects of pre-BCR signaling on germline Vκ 
transcription and on the expression of transcription factors implicated in the regulation 
of Igκ gene rearrangement. We found that the decrease in pre-BCR signaling capacity 
in wild-type, Btk-deficient, Slp65-deficient and Btk/Slp65 double-deficient pre-B 
cells was paralleled by a gradient of decreased expression of many transcription factors 
including Ikaros, Aiolos,  Irf4 and (to a lesser extent) E2A, as well as by a decreased 
Igκ locus accessibility for recombination. Several of these factors can mediate long-range 
chromatin interactions and are known to occupy κ regulatory elements that regulate 
locus accessibility.37-40 We therefore sought to analyze the effect of pre-BCR signaling 
on the higher-order chromatin structure organized by these regulatory sequences at 
the Igκ locus. To this end, we performed chromosome conformation capture and 
sequencing (3C-seq) analyses41 on pro-B cells, and pre-B cells from mice single or 
double deficient for Btk or Slp65 to evaluate the effects of this pre-BCR signaling 
gradient on Igκ locus topology. These 3C-seq experiments demonstrated that already 
in pro-B cells the κ enhancers robustly interact with the ~3.2 Mb Vκ region and its 
flanking sequences, and that pre-BCR signaling induces accessibility by a functional 
redistribution of enhancer-mediated chromatin interactions within the Vκ region. 
45
Formation of the Immunoglobulin Repertoire in Precursor-B-cell Development
RESULTS
Identification of genes regulated by pre-BCR signaling 
Whereas mice deficient for the pre-BCR signaling molecules Btk and Slp65 have a 
partial block at the pre-B cell stage,42, 43 in Btk/Slp65 double-deficient mice only very few 
pre-B cells show progression to the immature-B cell stage characterized by functional 
IgL chain gene recombination.44 To enable analysis of the effects of pre-BCR signaling 
on (i) the expression of genes involved in Igκ gene rearrangement and on (ii) long-
distance chromatin interactions in the Igκ locus in pre-B cells in the absence of Igκ gene 
recombination events, we bred Btk and Slp65 single and double-deficient mice on the 
Rag1-/- background. In these mice, progression of B cell progenitors to the pre-B cell stage 
was conferred by the transgenic, functionally rearranged Vh81X IgH m chain, which 
ensures pre-BCR expression and cellular proliferation. The absence of functional Rag1 
protein precludes IgL chain gene rearrangement and cells are completely arrested at the 
small pre-B cell stage (Figure 1A).
Figure 1. Gene expression profiling strategy for the identification of genes regulated by Btk/Slp65-
mediated pre-BCR signaling. (A). FACS Sorting strategy for purification of pre-B cell fractions from the indi-
cated mice on a Vh81X transgenic Rag1-/- background. Lymphocytes were gated on the basis of forward/side 
scatter and B220+CD19+ pre-B cell fractions were sorted. Virtually all B220+CD19+ cells were cytoplasmic m 
heavy chain positive,34 but showed genotype-dependent levels of expression of the CD2 differentiation marker, 
in agreement with previous findings.34 (B) DNA microarray analysis of total mRNA from FACS-purified 
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B220+CD19+ pre-B/pro-B cell fractions from the indicated mice. One-way ANOVA analysis (p=0.01) identi-
fied 266 significantly different genes. MeV hierarchical clustering of gene expression differences are represented 
in the heatmap. (C) Validation of the expression of transcription factors implicated in Igκ gene rearrangement. 
Total mRNA isolated from FACS-sorted B220+CD19+ pre-B/pro-B cell fractions from the indicated mice, was 
analyzed by quantitative RT-PCR for expression of transcription factors. Expression levels were normalized to 
those of Gapdh, whereby the values in WT pre-B cells were set to one. Bars represent mean values and error bars 
denote standard deviations for 4 independent mice per group. 
We performed genome-wide expression profiling of FACS-purified B220+CD19+ 
pre-B cell fractions from wild-type (WT), Btk and Slp65 single and double deficient 
transgenic Vh81X Rag1-/- mice (Figure 1A). In these experiments non- Vh81X transgenic 
Rag1-/- pro-B cells served as controls. One-way ANOVA analysis using MeV software45 
(p<0.01) revealed that 266 genes were differentially expressed between the five groups 
of pro-B/pre-B cells (Figure 1B). When compared with WT Vh81X transgenic Rag1-/- 
pre-B cells, 174 genes were up regulated, whereby the average values of the fold-increase 
were ~1.70, ~3.28, ~3.36 and ~3.47 for Btk-/-, Slp65-/-, Btk-/-Slp65-/- Vh81X transgenic 
Rag1-/- pre-B cells and non- Vh81X transgenic Rag1-/- pro-B cells, respectively (Table 
S1). A similar gradient of gene expression changes was apparent from the average values 
of the fold-change for the 192 significantly down regulated genes, which were ~1.65, 
~2.29, ~3.79 and ~4.15 in the four groups of pre-B/pro-B cells, respectively (Table S2). 
In a hierarchical clustering analysis of the five groups of B cell precursors, the expression 
profiles of Btk-/-Slp65-/- Vh81X transgenic Rag1-/- pre-B cells and non-Vh81X transgenic 
Rag1-/- pro-B cells were very similar (Figure 1B). This implies that expression of the 
266 genes is not substantially influenced by pre-BCR-mediated proliferation, which is 
still induced in pre-B cells lacking both Btk and Slp6544, 46 but not in Rag1-/- pro-B 
cells. Consistent with these findings, gene distance matrix analysis revealed a clear gene 
expression gradient among the five groups of pre-B/pro-B cells, in which Btk-/-Slp65-/- 
pre-B and Rag1-/- pro-B cells again showed highly comparably expression signatures 
(Figure S1).    
In agreement with previous findings,34, 43, 46 pre-BCR signaling-defective pre-B cells 
manifested increased expression of Dntt, encoding terminal deoxynucleotidyl transferase 
and the SLC components Vpre (Vpreb1) and l5 (Igll1), as well as decreased expression 
of the cell surface markers CD2, CD22, CD25(IL-2R) and MHC class II (Table 1). Btk 
and Slp65 single deficient and particularly double deficient pre-B cells failed to upregulate 
various genes known to be involved in IgL chain recombination, such as Ikzf3 (Aiolos), 
Ikzf1 (Ikaros), Irf4, Spib, Pou2f2 (Oct2), polymerase-m,47 as well as Hivep1 encoding 
the Mbp-1 protein, which has been shown to bind to the κ enhancers.48 In addition, 
pre-BCR signaling influenced the expression levels of many other DNA-binding or 
modifying factors that were not previously associated with IgL chain recombination, 
including Lmo4, Zfp710, Arid1a/3a/3b, the lysine-specific demethylases Aof1 and Phf2, 
Prdm2 (a H3K9 methyltransferase), the sik1 gene encoding a histon deacetylase (HDAC) 
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kinase, Hdac5, Hdac8 and the DNA repair protein gene Rev1 (Table S2). We did not find 
significant differences in the expression of several other transcription factors  implicated 
in Ig gene recombination, e.g. Obf1/Oca-B, Pax5, E2A and Irf8 (Table 1). In addition, in 
signaling-deficient pre-B cells we found reduced transcription of genes encoding several 
signaling molecules, (e.g. Rasgrp1, Rapgefl1, Ralgps2, Blk, Traf5, Hck, Nfkbia (IκBa), Syk, 
Csk), cell surface markers (CD38, CD72, CD74, CD55 and Notch2) or genes regulating 
cell survival (Bmf and Bcl2l1 encoding BclXL) (Table S2). Interestingly, we observed 
concomitant upregulation of signaling molecules that are also associated with the T cell 
receptor (Lat, Zap70 and Prkcq (PKCq); Table S1). 
Next, we used quantitative RT-PCR to confirm the observed differential expression 
of several transcription factors. Expression levels of these genes were indeed significantly 
reduced in a pre-BCR signaling dependent manner, especially for Aiolos, Ikaros and 
Irf4, with residual expression levels in Btk-/-Slp65-/- Vh81X transgenic Rag1-/- pre-B 
cells that were ~1%, ~20% and ~9% of those observed in WT Vh81X Rag1-/- mice, 
respectively (Figure 1C). In addition, we found moderate effects on Obf1 (Oca-B) and 
E2A with residual expression levels of ~28% and ~44%, respectively. In chromatin 
immunoprecipitation (ChIP) assays we observed in pre-B cells substantial binding of E2A 
protein to the intronic and 3’ κ enhancer regions and to the three Vκ regions analyzed. 
Under conditions of reduced pre-BCR signaling activity E2A binding to the enhancers 
was essentially maintained (3’Eκ) or reduced (iEκ), but E2A binding to the Vκ regions 
was lost (Table S3). Consistent with the significant reduction of Ikaros expression in 
Slp65-/- pre-B cells, Ikaros binding both κ enhancers and to Vκ regions was undetectable 
in these cells (Table S3). 
Taken together, from these findings we conclude that the five groups of pro-B/
pre-B cells, representing a gradient of progressively diminished pre-BCR signaling, show 
in parallel a gradient of diminished modulation of many genes that signify pre-B cell 
differentiation, including key genes implicated in Igκ gene recombination.
Progressively diminished Vκ and Jκ GLTs in Btk-/-, Slp65-/-, and Btk-/-Slp65-/- 
pre-B cells
In these expression profiling studies we only detected limited differences in germline 
transcription (GLT) over unrearranged Jκ and Vκ gene segments, which is thought to 
reflect locus accessibility.12 However, we previously showed by serial-dilution RT-PCR 
that the levels of κ0 0.8 and κ0 1.1. germline transcripts, which are initiated in different 
regions 5’of Jκ and spliced to the Cκ region49 are apparently normal in Btk-/- pre-B cells, 
modestly reduced in Slp65-/- pre-B cells and severely reduced in Btk-/-Slp65-/- pre-B cells.34 
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Figure 2. Reduction of Btk/Slp65-mediated pre-BCR signaling is associated with progressive loss of Igκ 
GLT. Quantitative RT-PCR analysis for κ0 (A), l0 (B) and Vκ GLT (C) of FACS-sorted B220+CD19+ pre-B/
pro-B cell fractions from the indicated mice on a Vh81X transgenic Rag1-/- background. Expression levels were 
normalized to those of Gapdh, whereby the values in WT pre-B cells were set to one. Bars represent mean values 
and error bars denote standard deviations for 4 independent mice per group. 
We could confirm these findings for κ0 GLT by quantitative RT-PCR assays on 
FACS-purified B220+CD19+ pro-B/pre-B cell fractions (Figure 2A). In agreement with 
our reported findings,34 we also found that Btk-/-and Slp65-/- pre-B cells have defective 
l0 transcription, which is initiated 5’ of the Jl segments (Figure 2B).49 GLT across 
the Vκ region showed a similar pattern of sensitivity to pre-BCR signaling: decreased 
transcription of six individual Vκ regions tested (Vκ3-7, Vκ8-24, Vκ4-55, Vκ10-96, 
Vκ1-35 and Vκ2-137) correlated with decreased pre-BCR signaling activity (Figure 
2C) in the pre-B cells of the four groups of mice.  GLT over unrearranged Vl1 and 
Vl2 segments was strongly reduced in the absence of Btk or Slp65, as detected by the 
expression arrays (Table 1).These observations indicate that Igκ locus accessibility, a 
Figure 3. 3C-Seq analysis of long-range chromatin interactions within the Igκ locus and flanking regions. 
(A) Overview of long-range interactions revealed by 3C-Seq experiments performed on the indicated cell frac-
tions, representing a gradient of pre-BCR signaling, whereby the iEκ element (top), the 3’Eκ element (centre) or 
the Sis element (bottom) was used as a viewpoint. Shown are the relative interaction frequencies (average of two 
replicate experiments) for the indicated genomic locations. The ~8.4 Mb region containing the Igκ locus (yellow 
shading) and flanking regions (cyan shading) is shown and genes and genomic coordinates are given (bottom). 
The location of the two BAC probes used for 3D DNA-FISH are indicated by a green (distal Vκ probe) and red 
(proximal Cκ/enhancer probe) rectangle (bottom). Pre-B cell fractions were FACS-purified from the indicated 
mice on a Vh81X transgenic Rag1-/- background (see Figure 1 for gating strategy). Erythroid progenitor cells 
were used as a non-lymphoid control. (B) 3D DNA-FISH analysis comparing locus contraction in cultured 
bone marrow-derived E2A-/- pre-pro-B, Rag1-/- pro-B and Vh81X Rag1-/- pre-B cells (see  Figure S6 for pheno-
type of IL-7 cultured B-lineage cells). Location of the BAC probes used are indicated at the bottom of panel A. 
Representative images for all three cell types are shown on the left, quantifications (>100 nuclei counted per cell 
type) on the right. The red lines indicate the median distance between the two probes.  Statistical significance 
was determined using a Mann-Whitney U test (***p<0.001; n.s. = not significant, p≥0.05). 
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Figure 3. (Legend at the bottom of the previous page)
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hallmark of recombination-competent antigen receptor loci, is progressively reduced 
under conditions of diminishing pre-BCR signaling.  
Pre-BCR signaling induces modulation of long-range chromatin interactions 
at the Igκ locus 
Accessibility of antigen receptor loci for V(D)J recombination is thought to be initiated 
by enhancers, in part through long-range chromatin interactions with promoters of non-
coding transcription, resulting in the activation of germline transcription.8 Because pre-
BCR signaling affects the expression of GLT and various nuclear proteins that mediate 
long-range chromatin interactions and bind the κ enhancers, it is conceivable that 
pre-BCR signaling induces changes in the enhancer-mediated higher-order chromatin 
structure of the Igκ locus that facilitates Vκ gene accessibility. 
We therefore performed 3C-Seq analyses on FACS-purified B220+CD19+ fractions 
from the same five groups of mice (WT, Btk-/-, Slp65-/- and Btk-/-Slp65-/- Vh81X transgenic 
Rag1-/- pre-B cells, as well as Rag1-/- pro-B cells). Erythroid progenitors were analyzed in 
parallel as a non-lymphoid control, in which the Igκ locus was not contracted. Genome-
wide chromatin interactions were measured for three regulatory elements involved in the 
control of Igκ locus accessibility and recombination: the iEκ and 3’Eκ enhancers50-52 and 
the Sis element,20 which contain binding sites for Ikaros/Aiolos, E2A and Irf4.16, 17, 20, 38, 53 
In WT pre-B cells, all three regulatory elements showed extensive long-range 
chromatin interactions within the Vκ region and substantially less interactions with 
regions up- or downstream of the ~3.2 Mb Igκ domain (Figure 3A; see Figure S2, Figure 
S3, Figure S4 for line graphs) confirming previous observations.21 Under conditions of 
reduced pre-BCR signaling activity, the three Igκ regulatory elements still showed strong 
interactions with the Vκ region. Surprisingly, even in the complete absence of pre-BCR 
signaling in Rag1-/- pro-B cells, long-range interactions were still observed at frequencies 
well above those seen in non-lymphoid cells, suggesting that a contracted Igκ locus 
topology is not strictly dependent on pre-BCR signaling (Figure 3A and Figures S2, 
S3, S4). Next, we used 3D DNA FISH analyses using BAC probes hybridizing to the 
distal Vκ and Cκ/enhancer regions to confirm that Igκ locus contraction was similar in 
Rag-1-/- pro-B cells and Vh81X transgenic Rag-1-/- pre-B cells (both showing a contracted 
topology, compared with non-contracted pre-pro-B cells deficient for the transcription 
factor E2A (Figure 3B).    
Nevertheless, we did observe that pre-BCR signaling induced clear differences in 
interaction frequencies. Whereas an increase in pre-BCR signaling was associated with a 
decrease in the interaction frequencies between the two κ enhancers and regions flanking 
the Igκ locus (as also revealed by more detailed images of selected regions upstream and 
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downstream of the Igκ domain, Figure S5), the overall interaction frequency within the 
Igκ domain appeared unchanged (Figures S3, S4, S5). Remarkably, interactions with 
the Sis element showed quite an opposite pattern: pre-BCR signaling correlated with 
increased overall interactions within the Igκ domain and did not substantially affect 
interaction frequencies in the Igκ flanking regions (Figures S2, S5).  
Taken together, these analyses show that (i) the Igκ locus is already contracted at the 
pro-B cell stage and that (ii) pre-BCR signaling induces changes in long-range chromatin 
interactions, both within the Igκ locus and in the flanking regions. 
Pre-BCR signaling enhances interactions of 3’Eκ and Sis, but not iEκ, with 
Vκ+ fragments
The differential effects of pre-BCR signaling on long-range chromatin interactions 
of the iEκ, 3’Eκ and Sis elements clearly emerged in a quantitative analysis of the 
3C-Seq datasets (Figure 4A, see Materials and Methods for a detailed description of the 
quantification methods used). When pre-BCR signaling was absent (Rag1-/- pro-B cells) 
or very low (Btk-/-Slp65-/- pre-B cells), the average interaction frequencies were similar 
within the ~3.2 Mb Vκ region and the ~3.2 Mb downstream flanking region, for all three 
regulatory elements. Interaction frequencies with the upstream flanking region were lower, 
consistent with the larger chromosomal distance to the three viewpoints. The presence of 
increasing levels of Btk/Slp65-mediated pre-BCR signaling was associated with reduced 
interaction of iEκ and 3’Eκ with the Igκ flanking regions and with increased interaction 
of the Sis element and (to a lesser extent) 3’Eκ with the Vκ region (Figure 4A). As a 
result, for all three regulatory elements pre-BCR signaling resulted in a preference for 
interaction with fragments inside the Vκ region over fragments  outside the Vκ region 
(Figure S7). 
We next focused our analysis on the Vκ region and compared fragments that harbor 
a functional Vκ gene (Vκ+ fragment) and those that do not (Vκ- fragment). When pre-
BCR signaling was absent (Rag1-/- pro-B cells) or very low (Btk-/-Slp65-/- pre-B cells) 
the average interaction frequencies of the Sis or iEκ elements with Vκ+ fragments were 
higher than with Vκ- fragments. The average interaction frequencies of 3’Eκ with Vκ+ 
and Vκ- fragments, however, were similar (Figure 4B). Upon pre-BCR signaling, the Sis 
element showed an increase in interaction frequencies with both Vκ+ and Vκ- fragments, 
with nevertheless an interaction preference for Vκ+ fragments. In contrast, interaction 
frequencies between the iEκ element and Vκ+ or Vκ- fragments were not modulated by 
pre-BCR signaling at all (Figure 4B). The 3’Eκ element exhibited yet another profile: pre-
BCR signaling induced increased interaction frequencies specifically with Vκ+ fragments, 
while interactions with Vκ- fragments were not notably modulated by pre-BCR signaling 
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(Figure 4B). When we separately analyzed non-functional pseudo-Vκ genes, we found 
for the Sis and 3’Eκ elements that the interaction patterns with functional and non-
functional Vκ genes were similar (Figure S8). In contrast, the iEκ enhancer did show 
an overall increased interaction frequency with Vκ functional genes, compared with 
non-functional Vκ  genes, a phenomenon which was again independent from pre-BCR 
signaling (Figure S8).    
The finding that interactions of Vκ genes with the intronic enhancer are already robust 
in pro-B cells, while those with the 3’κ enhancer are dependent on pre-BCR signaling, 
suggested that for individual Vκ genes pre-BCR signaling may result in more similar 
interaction frequencies with the two enhancers. To investigate this, we examined for all 
individual Vκ genes the correlation between their 3C-Seq interaction frequencies with 
the iEκ and 3’κ elements, and found that these were highly correlated in WT pre-B cells 
(R2=0.68; Figure 4C). Correlation was severely reduced when pre-BCR signaling was low 
in Btk-/-Slp65-/- pre-B cells (R2=0.26; Figure 4C). Similar pre-BCR signaling-dependent 
correlations were observed between Vκ-interactions with the Sis element and those with 
the two enhancers (Figure S9). As the Sis element particularly suppresses recombination of 
the proximal Vκ3 family, we investigated interaction correlations specifically for this Vκ 
family. Similar to our findings for all Vκ genes, a sub-analysis showed strong correlations 
for the interactions of Vκ3 family genes with iEκ, 3’κ and Sis in WT pre-B cells, which 
were diminished when pre-BCR signaling was low, except for iEκ-Sis correlations which 
were pre-BCR signaling-independent (Figure S9). 
In summary, we conclude that pre-BCR signaling induces a redistribution of long-
range interactions of the iEκ, 3’Eκ and Sis elements, thereby restricting interactions 
towards the Vκ gene region. Moreover, upon pre-BCR signaling the long-range 
interactions mediated by 3’Eκ and Sis - but not those mediated by iEκ - become enriched 
for fragments harboring a Vκ gene, demonstrating increased proximity of 3’Eκ and 
Sis to Vκ genes. Finally, for individual Vκ genes the interactions with iEκ, 3’Eκ and 
Sis become highly correlated upon pre-BCR signaling, indicating that pre-BCR signals 
Figure 4. Modulation of long-range chromatin interactions within the Igκ locus by pre-BCR signaling. 
Quantitative analysis of 3C-Seq datasets using the three indicated κ regulatory elements as viewpoints. (A) 
Average long-range chromatin interaction frequencies (from 2 replicate 3C-seq experiments) with upstream 
(~2.0 Mb), Vκ (~3.2 Mb) and downstream (~3.2 Mb) regions, as defined in Figure 3A, for the five B cell 
precursor fractions representing a pre-BCR signaling gradient. Average interaction frequencies per region were 
calculated as the average number of 3C-Seq reads per restriction fragment within that region. See Materials and 
Methods section for more details. (B) Average interaction frequencies within the Vκ region were determined 
for fragments that do not (-) containing a functional Vκ  gene and for those that do contain a functional Vκ 
gene (+). (C) Correlation plots of average interaction frequencies of the two enhancer elements with the 101 
functional Vκ  genes for WT pre-B cells (left) versus Btk
-/-Slp65-/- pre-B cells (right). On the log scale frequencies 
<1 were set to 100. Statistical significance was determined using a Mann-Whitney U test (*p<0.05; **p<0.01; 
***p<0.001; n.s. = not significant, p≥0.05).
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result in regulatory coordination between these three elements that govern Igκ locus 
recombination. In contrast, interactions between genes of the proximal Vκ3 family, Sis 
and iEκ - but not 3’κ - appear to be coordinated already in the absence of pre-BCR 
signaling.
Figure 5. Long-range chromatin interactions of k regulatory elements correlate with Vk gene usage. (A) 
Selected examples of genomic regions containing Vκ+ fragments, showing increased (Vκ4-57, Vκ6-25, Vκ8-24, 
Vκ4-79), stable (Vκ8-23-1, Vκ4-78, Vκ13-84) or decreased (Vκ3-9, Vκ14-111) 3C-Seq interaction frequen-
cies with 3’Eκ or  iEκ upon pre-BCR signaling. Averaged 3C-Seq signals are plotted as a line-graph, with the 
individual data points representing the center of the BglII restriction fragments. Yellow shading marks the BglII 
fragment on which the Vκ gene(s) is located. Vκ gene(s) are indicated (top) and chromosomal coordinates and 
scale bars (10 kb) are plotted (bottom). (B) Classification of Vκ+ fragments, based on the effect of pre-BCR sig-
naling on their interactions with the three κ regulatory elements indicated. Increase and decrease were defined 
as >1.5-fold change of interaction frequencies detected in WT pre-B cells versus Btk-/-Slp65-/- pre-B cells. (C) 
Correlation of average interaction frequencies (for the three κ regulatory elements indicated) with four Vκ 
usage categories ranging from low (<0.1%) to high usage (>0.5%, listed in the table on the right). Diamonds 
represent average interaction frequencies for Btk-/-Slp65-/- pre-B cells (yellow) and WT pre-B cells (grey). The 
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dotted line in each graph depicts the average interaction frequency with fragments that do not contain a func-
tional Vκ (Vκ-). Primary Vκ gene usage data were taken from.54
Long-range chromatin interactions of κ regulatory elements correlate with 
Vκ usage
Next, we investigated the effects of pre-BCR signaling on the interaction frequencies 
of individual functional Vκ genes with the three κ regulatory elements (Figures 5A, 5B). 
The 3C-Seq patterns of the majority (~91%) of the 101 individual Vκ+ fragments showed 
evidence for interaction with one or more of the κ regulatory elements (>25 average 
counts). When comparing Btk-/-Slp65-/- with WT pre-B cells, we observed that for a large 
proportion (~38-52%) of Vκ+ fragments interaction frequencies increased upon pre-BCR 
signaling (Figure 5B). Smaller proportions of Vκ+ fragments showed a decrease (~12-
29%) or were not significantly affected by pre-BCR signaling (~17-25% with <1.5 fold 
change). The observed increase or decrease was not related to proximal or distal location 
of the Vκ genes, nor to their sense or antisense orientation (not shown). Distributions of 
the three different classes of Vκ+ fragments showed substantial differences between the κ 
regulatory elements. For the Sis and 3’Eκ elements more Vκ+ fragments showed increased 
than decreased interactions (Figure 5B), in agreement with the signaling-dependent 
increase in average interaction frequencies of all Vκ+ fragments (Figure 4B). In contrast, 
for the iEκ viewpoint, Vκ+ fragments showing increased and decreased interactions were 
more equal in number, consistent with the limited effects of pre-BCR signaling on overall 
iEκ interaction frequencies of all Vκ+ fragments (Figure 4B).  
Although antigen receptor recombination is in principle regarded as a random 
process, a significant skewing of the primary Igκ repertoire of C57BL/6 mice was recently 
reported:  one third of the Vκ genes was shown to account for >85% of the Vκ segments 
used by B-cells.54 To assess whether a correlation exists between usage of Vκ genes and 
their interaction frequencies with κ regulatory elements, we divided the Vκ genes into 
four usage categories (<0.1%, 0.1-0.3%, 0.3-0.5% and >0.5%) and calculated their 
average 3C-Seq interaction frequencies with Sis, iEκ and 3’κ (Figure 5C). In WT pre-B 
cells, Vκ usage showed a strong positive correlation with 3C-Seq interaction frequencies 
for all three regulatory elements (R2= ~0.7-0.9; Figure 5C). These correlations were pre-
BCR signaling-dependent, since in Btk-/-Slp65-/- pre-B cells they were reduced (for iEκ; 
R2 = 0.33) or absent (for Sis and 3’κ; R2<0.10 and R2<0.16, respectively) (Figure 5C). 
Collectively, our results indicate that specifically the most frequently used Vκ genes 
are the main interaction targets of κ regulatory elements, whereby pre-BCR signaling 
completely underlies this specificity for the Sis and 3’Eκ elements, and to a lesser extent 
for iEκ. 
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Figure 6. Long-range chromatin interac-
tions of κ regulatory elements correlate 
with transcription factor binding and 
histone modifications. (A,D) For frag-
ments within the Vκ region, average 3C-Seq 
interaction frequencies were calculated for 
fragments that did (+) or did not (-) contain 
binding sites for transcription factors or 
H3K4 histone modifications (as determined 
by previous ChIP-Seq studies, see Materials 
and Methods for references). Data for the 
three viewpoint and the five B cell precursor 
fractions representing a pre-BCR signaling 
gradient are shown for Ctcf (A), Ikaros 
(B), E2A (C) and H3K4 di- and tri-meth-
ylation (Me2/3). Statistical significance was 
determined using a Mann-Whitney U test 
(*p<0.05; **p<0.01; ***p<0.001; n.s. = not 
significant, p≥0.05).
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Figure 7. Proximity of Vκ genes to E2A-bindings sites correlates with frequencies of long-range interac-
tions. (A) Schematic representation of the Igκ locus, showing the location of all functional Vκ (grey, top), Jκ 
and Cκ gene segments and the κ regulatory elements Sis, iEκ and 3’Eκ. MAR = matrix attachment region. 
Vκ genes within close proximity (as defined by co-localization on the same 3C-Seq restriction fragment) to 
the indicated transcription factors or H3K4 hypermethylation (as detected by previous ChIP-Seq studies, see 
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Materials and Methods for references), are shown. At the bottom, highly-used (>1.0% used) Vκ gene segments 
are depicted (orange), which cluster within two large high-usage domains (yellow shading). Primary Vκ gene 
usage data was taken from.54 (B) Average usage of Vκ genes marked only by an Ikaros-binding site or those 
marked by binding sites of both Ikaros and E2A. (C) Comparison of average interaction frequencies (for the 
three κ regulatory elements indicated) between Vκ-  fragments (no Vκ), Vκ+ fragments containing an Ikaros 
binding site only and Vκ+ fragments containing both an Ikaros and E2A binding site. Bars represent average 
frequencies for Btk-/-Slp65-/- pre-B cells (yellow) and WT pre-B cells (grey). (D) Classification of Vκ+ fragments, 
containing an Ikaros binding-site only (top) or containing both an Ikaros and E2A binding site (bottom), based 
on the effect of pre-BCR signaling on their interactions with the three κ regulatory elements indicated. Increase 
and decrease were defined as >1.5-fold change of interaction frequencies detected in WT pre-B cells versus Btk-/-
Slp65-/- pre-B cells. (E) Proposed model of pre-BCR signaling-mediated changes in κ enhancer action,  In pro-B 
cells (left) the enhancers show minimal coordination and their interactions are not yet (fully) focused on the Vκ 
genes. Upon pre-BCR signaling and differentiation to pre-B cells (right), transcription factors bind the locus 
to coordinate enhancer action and focus their interactions to the Vκ genes, inducing germline transcription 
(GLT) and accessibility to the V(D)J recombinase. See Discussion for more details. Statistical significance was 
determined using a Mann-Whitney U test (*p<0.05; **p<0.01; ***p<0.001; n.s. = not significant, p≥0.05).
Long-range interactions with κ regulatory elements correlate with the pres-
ence of Ctcf, Ikaros, E2A and H3K4 hypermethylation
Next, we investigated whether long-range interactions between κ regulatory elements 
and the Vκ  region correlated with the presence of the transcription factors Ctcf,
21 Ikaros55 
and E2A,56 which have been implicated in Igκ locus recombination.21, 37, 55, 57, 58 Notably, 
Ikaros and E2A both strongly bind all three κ regulatory elements, while the Sis element 
is also occupied by Ctcf (21; data not shown). 
Remarkably, we found similar striking correlations between the presence of in vivo 
binding sites for each of these transcription factors (as determined by ChIP experiments, 
see Materials and Methods for the relevant references) and long-range chromatin 
interactions with the κ regulatory elements (Figure 6A-C), even though Ctcf sites 
are mostly located in between Vκ genes
21 and Ikaros/E2A sites were frequently found 
close to Vκ gene promoter regions (
2; Figure 7A). Even when pre-BCR signaling was 
absent (Rag1-/- pro B cells) or very low (Btk-/-Slp65-/- pre-B cells) the average interaction 
frequencies of the κ regulatory elements with fragments containing Ctcf, Ikaros or E2A 
bindings sites were higher than those without binding sites. Irrespective of the presence 
or absence of bindings sites for these transcription factors, we found that upon pre-BCR 
signaling interaction frequencies with the Sis element increased and those with the iEκ 
did not change. In contrast, for the 3’Eκ we found that pre-BCR signaling specifically 
increased interaction frequencies with fragments occupied by Ctcf, Ikaros or E2A. 
Finally, we found that the presence of di- or trimethylation of histone 3 lysine 4 
(H3K4Me2/3), an epigenetic signature associated with locus accessibility59 and Rag-
binding,60, 61 also correlated with increased interaction frequencies with κ regulatory 
elements, revealing a similar pre-BCR signaling dependency as seen for the transcription 
factors analyzed (Figure 6D).
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We conclude that the presence of essential transcription factors or H3K4Me2/3 in the 
Vκ region strongly correlates with the formation of long-range chromatin interactions 
with the κ regulatory elements, and that for the Sis and 3’Eκ elements this interaction 
preference is further enhanced by pre-BCR signaling.  
Proximity of Vκ  genes to E2A-binding sites correlates with high Vκ usage 
and increased long-range chromatin interactions 
Since the long-range interactions with κ regulatory elements correlated with the 
presence of transcription factors implicated in Igκ recombination, we next asked whether 
the κ regulatory elements preferentially interacted with Vκ genes that are in close 
proximity to binding sites for Ctcf, Ikaros or E2A. 
Strikingly, the majority of functional Vκ genes (95/101) was found to have an Ikaros-
binding site in close proximity, i.e. located on the same 3C-Seq restriction fragment 
(average length of ~3kb, data not shown) (Figure 7A). Proximity of Vκ genes to an E2A-
binding site (37%) or H3K4Me2/3 positive region (~28%) is more selective, while only 
a small fraction of Vκ  genes are close to Ctcf-binding sites (~12%) (
22; Figure 7A). All 
Vκ genes marked by E2A, Ctcf, H3K4Me2/3 or a combination of these also contain an 
Ikaros-binding site. Frequently used Vκ genes (>1.0% usage; 33/101 genes) were located 
into two separate regions, a proximal and a distal region, which also contained virtually 
all E2A and H2K4Me2/3-marked Vκ genes (Figure 7A). 
We found that Vκ genes marked by both Ikaros and E2A were used substantially more 
often than those only bound by Ikaros (Figure 7B), suggesting that these Vκ genes are 
preferentially targeted for Vκ-to-Jκ  gene rearrangement. Our 3C-Seq analyses showed 
that in WT pre-B cells interaction frequencies with the three κ regulatory elements were 
higher for Ikaros/E2A-marked Vκ genes compared to genes marked by Ikaros-binding 
alone (Figure 7C). In fact, Vκ+ restriction fragments containing an Ikaros-binding site 
but not an E2A-binding site showed interaction frequencies similar to Vκ- restriction 
fragments. Under conditions of very low pre-BCR signaling (in Btk-/-Slp65-/- pre-B cells) 
we observed strongly reduced interaction frequencies of Vκ+ E2A-binding restriction 
fragments with the Sis and 3’Eκ elements. These interaction frequencies were in the 
same range as those of Vκ- fragments or Vκ+ fragments that harbored an Ikaros site only 
(Figure 7C). Interaction frequencies with the iEκ enhancer, however, were independent 
of pre-BCR signaling. As shown in Figure 7D, for the majority of Ikaros/E2A-marked 
Vκ+ fragments (65%) pre-BCR signaling was associated with increased interactions 
with the Sis and 3’Eκ elements (comparing wildtype and Btk-/-Slp65-/- pre-B cells). In 
these analyses only ~13.5% and ~5.4% of Ikaros/E2A-marked Vκ+ fragments showed 
a decreased interaction frequency upon pre-BCR signaling. In contrast, almost equal 
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proportions of Ikaros/E2A-marked Vκ+ fragments showed increased (~37%) and 
decreased (~30%) interactions with iEκ upon pre-BCR signaling.  
Taken together, these data reveal strong positive correlations between the presence of 
E2A-binding sites, Vκ usage and long-range chromatin interactions with κ regulatory 
elements in pre-B cells. Remarkably, for the iEκ element these correlations are largely 
independent of Btk/Slp65-mediated pre-BCR signaling, whereas for the 3’Eκ they are 
completely dependent on signaling. 
DISCUSSION
During B-cell development the pre-BCR checkpoint is known to regulate the 
expression of many genes, part of which control the increase in Igκ locus accessibility to 
the V(D)J recombinase complex. However, it remained unknown how pre-BCR signaling 
events affect accessibility in terms of Igκ locus contraction and topology.
Here we identified numerous genes involved in IgL chain recombination, chromatin 
modification, signaling and cell survival to be aberrantly expressed in pre-B cells lacking 
the pre-BCR signaling molecules Btk and/or Slp65. We found that GLT over the Vκ 
region, reflecting Vκ accessibility, is strongly reduced in these cells. We used 3C-Seq 
to show that in pro-B cells both the intronic and the 3’κ enhancers frequently interact 
with the ~3.2 Mb Vκ region, as well as with Igκ flanking sequences, indicating that the 
Igκ locus is already contracted at the pro-B cell stage. 3C-Seq analyses in wild-type and 
Btk/Slp65 single and double-deficient pre-B cells demonstrated that pre-BCR signaling 
significantly affects Igκ locus topology. First, pre-BCR signaling reduces the interactions 
of the intronic and 3’κ enhancers with Igκ flanking regions, effectively focusing enhancer 
action towards the Vκ region to facilitate Vκ-to-Jκ recombination. Second, pre-BCR 
signaling strongly increases nuclear proximity of the 3’κ enhancer to Vκ genes, whereby 
this increase is more substantial for more frequently used Vκ genes and for Vκ genes 
close to a binding-site for the basic helix-loop-helix protein E2A. Third, pre-BCR 
signaling augments interactions between κ regulatory elements and fragments within the 
Vκ region bound by the key B-cell transcription factors (TFs) Ikaros and E2A and the 
architectural protein Ctcf. Fourth, pre-BCR signaling has limited effects on interactions 
of the intronic κ enhancer with fragments within the Igκ locus, as this enhancer already 
displays interaction specificity for functional Vκ genes and TF-bound regions in pro-B 
cells. Fifth, pre-BCR signaling has limited effects on the interactions between the intronic 
or 3’κ enhancers and fragments that do not contain a Vκ gene or an Ikaros, E2A or 
Ctcf binding site, emphasizing the specificity of pre-BCR signaling-induced changes 
in Igκ locus topology. Sixth, pre-BCR signaling appears to induce mutual regulatory 
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coordination between the three regulatory elements, since their interaction profiles 
with individual Vκ genes become highly correlated upon signaling. Finally, pre-BCR 
signaling increases interactions of the Sis element with DNA fragments in the Igκ locus, 
irrespective of the presence of a Vκ gene or TF. Collectively, our findings demonstrate 
that pre-BCR signals relayed through Btk and Slp65 are required to create a chromatin 
environment that facilitates proper Igκ locus recombination. This multi-step process is 
initiated by upregulation of key TFs like Aiolos, Ikaros, Irf4 and E2A. These proteins 
are then recruited to, or further accumulate at the Igκ locus and its regulatory elements, 
resulting in a specific fine-tuning of enhancer-mediated locus topology that increases 
locus accessibility to the Rag recombinase proteins. 
Importantly, the presence of strong lineage-specific interaction signals between the 
Cκ/enhancer region and distal Vκ genes in pro-B cells indicates that the Igκ locus is 
already contracted at this stage. In contrast to a previous microscopy study indicating 
that Igκ locus contraction did not occur until the small pre-B cell stage,36 our 3D DNA 
FISH analysis indeed detected similar nuclear distances between distal Vκ and the Cκ/
enhancer region in cultured pro-B and pre-B cells. Recently Hi-C was employed to study 
global early B cell genomic organization whereby substantial interaction frequencies were 
found between the intronic κ enhancer and the Vκ region in pro-B cells.
40 E2A-deficient 
pre-pro-B cells, which are not yet fully committed to the B cell lineage,62 showed very 
few interactions among the iEκ and the distal part of the Vκ region,
40 resembling the 
interactions we observed in non-lymphoid cells (Figure 3A). Accordingly, 3D-FISH 
analysis showed that the Igκ locus adopted a non-contracted topology in these pre-pro-B 
cells (Figure 3B). These data indicate that Igκ locus contraction is already achieved in 
pro-B cells and depends on the presence of E2A. Supporting this notion, active histone 
modifications and E2A were already detected at the κ enhancers and Vκ genes at the pro-B 
cell stage,56, 63 whereby E2A was frequently found at the base of long-range chromatin 
interactions together with Ctcf and Pu.1, possibly acting as ‘anchors’ to organize genome 
topology.40 The observed correlation between E2A binding, Vκ gene usage and iEκ 
proximity in pro-B cells (Figures 5C, 7C), further strengthens an early critical role for 
E2A in regulating Igκ locus topology, Vκ gene accessibility and recombination.  
Our 3C-Seq experiments revealed that pre-BCR signaling is not required to induce 
long-range interactions between the κ regulatory elements and distal parts of the Vκ 
locus, indicating that TFs strongly induced by signaling, i.e. Aiolos, Ikaros and Irf4, are 
not strictly necessary to form a contracted Igκ locus. Prime candidates for achieving Igκ 
locus contraction at the pro-B cell stage are E2A and Ctcf, as they have been implicated 
in regulating Ig locus topology21, 40, 64, 65 and E2A already marks frequently used Vκ genes 
at the pro-B cell stage (Figure 7), although we did observe reduced E2A expression and 
binding to the iEκ enhancer and Vκ genes when pre-B cell signaling was low (Figure 
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1 and Table S3), suggesting that pre-BCR signaling is required for high level E2A 
occupancy of the Vκ genes. We previously reported that Igκ gene recombination can 
occur in the absence of Ctcf and that Ctcf mainly functions to limit interactions of the κ 
enhancers with proximal Vκ regions and to prevent prevents inappropriate interactions 
between these strong enhancers and elements outside the Igκ locus.21 Because at the pro-
to-pre B cell transition Aiolos, Ikaros and Irf4 are recruited to the Igκ locus and histone 
acetylation and H3K4 methylation increases,17, 38, 63, 66 we hypothesize that pre-BCR 
induced TFs act upon an E2A/Ctcf-mediated topological scaffold to further refine the 
long-range chromatin interactions of the κ regulatory elements. Hereby, these TFs mainly 
act to focus and to coordinate the interactions of the two κ enhancers to the Vκ gene 
segments, in particular to frequently used Vκ genes, thereby increasing their accessibility 
for recombination (See Figure 7E for a model for pre-BCR signaling-induced changes in 
Igκ  locus accessibility). 
In this context, our 3C-Seq data show that the two κ enhancer elements have distinct 
roles. Both 3’Eκ and iEκ elements manifest interaction-specificity for highly used, E2A-
marked, Vκ genes. However, whereas iEκ already shows this specificity in pro-B cells 
(although pre-BCR signaling does augment this specificity), 3’Eκ only does so in pre-B 
cells upon pre-BCR signaling. These observations indicate that iEκ is already ‘pre-focused’ 
at the pro-B cell stage and that pre-BCR signals are required to fully activate and focus the 
3’Eκ to allow synergistic promotion of Igκ recombination by both enhancers (See Figure 
7E).52 In agreement with such distinct sequential roles, iEκ and not the 3’Eκ was found 
to be required for the initial increase in Igκ locus accessibility, which occurred upon 
binding of E2A only.37, 38, 67 The 3’Eκ on the other hand requires binding of pre-BCR 
signaling-induced Irf4 to promote locus accessibility,19, 38 followed by further recruitment 
of E2A to both κ enhancers and highly-used Vκ genes (Table S3 and 
38, 57). 
The Sis regulatory element was shown to dampen proximal Vκ-Jκ rearrangements and 
to specify the targeting of Igκ transgenes to centromeric heterochromatin in pre-B cells.20 
As Sis is extensively occupied by the architectural Ctcf protein and deletion of Sis or Ctcf 
both resulted in increased proximal Vκ usage,
21, 23 it was postulated that Sis functions 
as a barrier element to prevent the κ enhancers from too frequently targeting proximal 
Vκ genes for recombination. In this context, we now provide evidence that interactions 
between the proximal Vκ genes, Sis and iEκ - but not 3’κ - are already coordinated 
before pre-BCR signaling occurs (Figure S9). Perhaps not surprisingly, Sis-mediated long-
range chromatin interactions displayed a pattern and pre-BCR signaling response that 
was different from the κ enhancers. Unlike for the enhancers, upon pre-BCR signaling 
Sis–mediated interactions with regions outside the Igκ locus were maintained and 
interaction within the Vκ region increased, irrespective of the presence of Vκ genes or 
TF binding sites. Because Sis is involved in targeting the non-recombining Igκ allele to 
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heterochromatin,20 the observed interaction pattern of the Sis element might reflect its 
action in pre-B cells to sequester the non-recombining Igκ locus and target it towards 
heterochromatin. This might also explain the increased interaction frequencies of Sis with 
highly used Vκ genes upon pre-BCR signaling (Figure 5C, 7C), as such highly accessible 
genes likely require an even tighter association with Sis and heterochromatin to prevent 
undue recombination. 
Surprisingly, we observed a striking correlation between Ikaros binding and Vκ gene 
location (94% of Vκ genes were in close proximity to an Ikaros binding site, Figure 
7A). Although Ikaros and Aiolos have a positive role in regulating gene expression 
during B cell development55, 58 and Ikaros is required for IgH and IgL recombination,39, 
58 Ikaros has also been reported to silence gene expression through its association with 
pericentromeric heterochromatin68 or through recruitment of repressive co-factor 
complexes.69, 70 Recruitment of Ikaros to the Igκ locus was found increased in pre-B 
cells as compared to pro-B cells,63 in agreement with its upregulation in pre-B cells 
(Figure 1). Furthermore, Ikaros binds the Sis element, where it was suggested to mediate 
heterochromatin-targeting of Igκ alleles by the Sis region.20 Aiolos, although not essential 
for B cell development like Ikaros,58, 71 is strongly induced by pre-B cell signaling and has 
been reported to co-operate with Ikaros in regulation gene expression.27 Although their 
synergistic role during IgL chain recombination has not been extensively studied, the 
Ikaros/Aiolos ratio changes upon pre-BCR signaling (Figure 1). Increased recruitment 
of Ikaros/Aiolos to Vκ genes and the κ enhancers likely increases Igκ locus accessibility 
and contraction (Figure 6), as Ikaros was very recently shown to be essential for IgL 
recombination.58 On the other hand, it is conceivable that on the non-recombining allele 
increased recruitment of Ikaros/Aiolos to Vκ genes and the Sis region could facilitate 
silencing of this allele. Further investigations using allele-specific approaches72 will be 
required to clarify the allele-specific action of the Sis element during Igκ recombination.
In summary, by investigating the effects of a pre-BCR signaling gradient - rather than 
deleting individual transcription factors - we have taken a more integrative approach 
to study the regulation of Igκ locus topology. Our 3C-Seq analyses in wild-type, Btk 
and Slp65 single and double-deficient pre-B cells show that interaction frequencies 
between Sis, iEκ or 3’ Eκ and the Vκ region are already high in pro-B cells and that 
pre-BCR signaling induces accessibility through a functional redistribution of long-
range chromatin interactions within the Vκ region, whereby the iEκ and 3’Eκ enhancer 
elements play distinct roles. 
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MATERIALS AND METHODS
Mice
Vh81X transgenic mice73 on the Rag-1-/- background 74 that were either wildtype, 
Btk-/-,75 Slp65-/-42 or Btk-/-Slp65-/- have been previously described.34 Mice were crossed on 
the C57BL/6 background for >8 generations, bred and maintained in the Erasmus MC 
animal care facility under specific pathogen-free conditions and were used at 6-13 wks 
of age. Experimental procedures were reviewed and approved by the Erasmus University 
committee of animal experiments.
Flow cytometry
Preparation of single-cell suspensions and incubations with monoclonal antibodies 
(mAbs) were performed using standard procedures. Bone marrow B-lineage cells were 
purified using fluorescein isothiocyanate (FITC)-conjugated anti-B220(RA3-6B2) and 
peridinin chlorophyll protein (PCP)-conjugated anti-CD19, together with biotinylated 
mAbs specific for lineage markers Gr-1, Ter119, and CD11b and APC-conjugated 
streptavidin as a second step to further exclude non-B cells. Cells were sorted with a 
FACSARia (BD Biosciences). The following mAbs were used for flow cytometry: 
FITC-, PerCP-anti-B220 (RA3-6B2), phycoerythrin (PE)-anti-CD2 (LFA-2), PCP-, 
allophycocyanin (APC)- or APC-Cy7-anti-CD19 (ID3), PE- or APC anti-CD43 (S7). 
All these antibodies were purchased from BD Biosciences or eBiosciences.  Samples were 
acquired on an LSRII flow cytometer (BD Biosciences) and analyzed with FlowJo (Tree 
Star) and FACSDiva (BD Biosciences) software.
Quantitative RT-PCR and DNA microarray analysis
Extraction of total RNA, reverse-transcription procedures, design of primers and 
cDNA amplification have been described previously.21 Gene expression was analyzed 
using an ABI Prism 7300 Sequence Detector and ABI Prism Sequence Detection Software 
version 1.4 (Applied Biosystems). All PCR primers used for quantitative RT-PCR of 
transcription factors or κ0, l0 and Vκ GLT are described in 
21, except for Obf1 (forward: 
5’-CCTGGCCACCTACAGCAC-3’, reverse 5’-GTGGAAGCAGAAA CCTCCAT-3’, 
obtained from the Roche Universal Probe Library). 
Biotin-labeled cRNA was hybridized to the Mouse Gene 1.0 ST Array according to 
the manufacturer’s instructions (Affymetrix); data were analyzed with BRB-ArrayTools 
(version 3.7.0, National Cancer Institute) using Affymetrix CEL files obtained from 
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GCOS (Affymetrix). The RMA approach was used for normalization. The TIGR 
MultiExperiment Viewer software package (MeV version 4.8.1) was used to perform 
data analysis and visualize results.45 One-way ANOVA analysis of the five experimental 
groups of B-cells was used to identify genes significantly different from wildtype Vh81X 
Tg Rag1-/- pre-B cells (p<0.01).   
Chromatin Immunoprecipitation (ChIP)
ChIP experiments were performed as previously described76 using FACS sorted bone 
marrow pre-B cell fractions (0.3-2.0 million cells per ChIP). Antibodies against E2A (sc-
349, Santa Cruz Biotechnology) and Ikaros (sc-9861, Santa Cruz Biotechnology) were 
used for immunoprecipitation. Purified DNA was analyzed by quantitative RT-PCR as 
described above. Primer sequences are available on request.
Chromosome conformation capture coupled to high-throughput sequencing 
(3C-Seq)
3C-Seq experiments were essentially carried out as described previously.21, 41 For 
3C-Seq library preparation BglII was used as the primary restriction enzyme; NlaIII as a 
secondary restriction enzyme. 3C-Seq template was prepared from WT E13.5 fetal liver 
erythroid progenitors and FACS-sorted bone marrow pro-B cell or pre-B cell fractions 
(see above) from pools of 4-6 mice. In total, between 1-8 million cells were used for 
3C-Seq analysis. Primers for the Sis, iEκ and 3’Eκ viewpoint-specific inverse PCR were 
described previously.21 3C-Seq libraries were sequenced on an Illumina Hi-Seq 2000 
platform. 3C-Seq data processing was performed as described elsewhere.41, 77 Two replicate 
experiments were sequenced for each genotype and viewpoint and normalized interaction 
frequencies per BglII restriction fragment were averaged between the two experiments.
For quantitative analysis, the Igκ locus and surrounding sequences were divided into 
three parts (mm9 genome build): a ~2 Mb upstream region (chr6:65,441,978-67,443,029; 
759 fragments), a ~3.2 Mb Vκ region (chr6:67,443,034-70,801,754; 1290 fragments) 
and a downstream ~3.2 Mb region (chr6:70,801,759-73,993,074; 1143 fragments). For 
each cell type (as described above) sequence read counts within individual BglII restriction 
fragments were normalized for differences in library size (expressed as ‘reads per million’, 
see 78) and averaged between the 2 replicates before further use in the various calculations. 
Very small BglII fragments (<100 bp) were excluded from the analysis. Fragments in 
the immediate vicinity of the regulatory elements (chr6:70,659,392-70,693,183; 10 
fragments) were also excluded because of high levels of noise around the viewpoint, a 
characteristic of all 3C-based experiments. Vκ  gene coordinates (both functional genes 
II.  Pre-B Cell Receptor Signaling Induces Immunoglobulin Κ Locus Accessibility By Functional    
Redistribution Of Enhancer-Mediated Chromatin Interactions
68
and pseudogenes) were obtained from IMGT11 and NCBI (Gene ID: 243469) databases. 
Vκ  gene usage data (C57BL/6 strain, bone marrow) were obtained from ref. 
54. ChIP-Seq 
datasets were obtained from (Ctcf ),21 (Ikaros)55 and (E2A, H3K4Me2 and H3K4Me3).56 
Vκ  genes were scored positive for transcription factor binding sites or for a histone 
modification, if they were located on the same BglII restriction fragment (corresponding 
to the 3C-Seq analysis).
3D DNA immunofluorescence in situ hybridization (FISH)
Rag-1-/- pro-B and Rag-1-/-;Vh81X pre-B cells were isolated from femoral bone 
marrow suspensions by positive enrichment of CD19+ cells using magnetic separation 
(Miltenyi Biotec). Cells were cultured for 2 weeks in Iscove’s Modified Dulbecco’s medium 
containing 10% fetal calf serum, 200 U/ml penicillin, 200 mg/ml streptomycin, 4 nM 
L-glutamine, and 50 µM β-mercaptoethanol, supplemented with IL-7 and stem cell 
factor at 2 ng/ml. E2A−/− hematopoietic progenitors were grown as described previously.79 
Prior to 3D-FISH analysis, cells were characterized by flow cytometric analysis of CD43, 
CD19 and CD2 surface marker expression to verify their phenotype (Figure S6).  
3D DNA FISH was performed as described previously80 with BAC clones RP23-
234A12 and RP23-435I4 (located at the distal end of the Vκ region and at the Cκ/
enhancer region, respectively, Figure 3A) obtained from BACPAC Resources, Oakland, 
CA. Probes were directly labeled with Chromatide Alexa Fluor 488-5 dUTP and 
Chromatide Alexa Fluor 568-5 dUTP (Invitrogen) using Nick Translation Mix (Roche 
Diagnostics GmbH). 
Cultured primary cells were fixed in 4% paraformaldehyde, and permeabilized in 
a PBS/0.1% Triton X-100/0.1% saponin solution and subjected to liquid nitrogen 
immersion following incubation in PBS wih 20% glycerol. The nuclear membranes were 
permeabilized in PBS/0.5% Triton X-100/0.5% saponin prior to hybridization with the 
DNA probe cocktail. Coverslips were sealed and incubated for 48hr at 37°C, washed and 
mounted on slides with 10 µl of Prolong gold anti-fade reagent (Invitrogen).
Pictures were captured with a Leica SP5 confocal microscope (Leica Microsystems). 
Using a 63× lens (NA 1.4), we acquired images of ~70 serial optical sections spaced 
by 0.15 µm. The data sets were deconvolved and analyzed with Huygens Professional 
software (Scientific Volume Imaging, Hilversum, the Netherlands). The 3D coordinates 
of the center of mass of each probe were transferred to Microsoft Excel, and the distances 
separating each probe were calculated using the equation: √(Xa−Xb)2+(Ya−Yb)2+(Za−
Zb)2, where X, Y, Z are the coordinates of object a or b. 
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Statistical analysis
Statistical significance was analyzed using a nonparametric Mann-Whitney U test 
(IBM SPSS Statistics 20). P values <0.05 were considered significant. 
Accession Numbers
3C-Seq datasets have been submitted to Sequence Read Archive (SRA, accession 
number SRP032509).
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ABSTRACT
Progenitor-B cells recombine their immunoglobulin (Ig) loci to create unique antigen 
receptors. Despite a common recombination machinery, the Ig heavy and Ig light chain 
loci rearrange in a stepwise manner. We studied pre-pro-B cells and Rag-/- progenitor-B 
cells to determine whether Ig locus contraction or nuclear positioning is decisive for 
stepwise rearrangements. We found that both Ig loci were contracted in pro-B and pre-B 
cells. Igh relocated from the nuclear lamina to central domains only at the pro-B cell 
stage, whereas, Igκ remained sequestered at the lamina, and only at the pre-B cell stage 
located to central nuclear domains. Finally, in vitro induced re-positioning of Ig alleles 
away from the nuclear periphery increased germline transcription of Ig loci in pre-pro-B 
cells. Thus, Ig locus contraction juxtaposes genomically distant elements to mediate effi-
cient recombination, however, sequential positioning of Ig loci away from the nuclear 
periphery determines stage-specific accessibility of Ig loci.
INTRODUCTION
During differentiation in bone marrow, each progenitor-B cell assembles a unique 
immunoglobulin molecule (Ig) through genetic recombination of V, D and J genes in 
their Ig heavy chain (Igh) and Ig light chain loci (Igκ or Igλ).1, 2 The lymphoid-specific 
recombination activating gene proteins 1 and 2 (Rag1 and Rag2) are crucial in this pro-
cess through induction of double strand DNA breaks at recombination signal sequences 
(RSS) flanking each V, D and J gene.3, 4 The V(D)J recombination of Ig is initiated in 
uncommitted pre-pro-B cells by formation of incomplete Dh-Jh rearrangements fol-
lowed  by rearrangement of Vh to DJh junction in pro-B cells. Subsequently, V to J gene 
rearrangements in the Ig light chain loci are induced in pre-B cells with expression of 
functional Ig µ molecules on the cell surface.1, 2
Although the core machinery for V(D)J recombination is identical for the different 
loci, each locus undergoes recombination in a developmental stage-specific manner. This 
stage-specific accessibility of the Ig loci for the V(D)J recombination machinery has been 
extensively addressed and is thought to involve 3 epigenetic processes: DNA and chroma-
tin modifications, nuclear positioning, and locus contraction.1, 5, 6 
It is well-established that non-coding RNA transcription,6, 7 and epigenetic modifi-
cations of histones and/or DNA8, 9 modulate gene accessibility. Ig genes poised for V(D)
J recombination are wrapped around histones that are extensively acetylated and meth-
ylated.10, 11 Importantly, stage-specific trimethylation of lysine 4 in H3 (H3K4me3) in Ig 
genes can directly recruit Rag2.12-14
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During cellular maturation, genes can change their nuclear ‘neighborhoods’ by re-po-
sitioning from repressive sites to transcriptionally active compartments, and vice versa.9, 
15-17 Relocation of genes in the nucleus towards transcription factories occurs through 
extruding of decondensed chromatin loops into interchromosomal space and intermin-
gling with neighboring chromosome territories.9, 15, 18 The nuclear periphery represents a 
repressive region through tethering of chromosomal domains to nuclear lamins, thereby 
creating lamina associated domains (LADs).16, 17 The nuclear positioning of Ig loci also 
seems tightly regulated, as they are positioned centrally in committed B-cell progenitors, 
while in non-B cells they are located at the nuclear periphery.17, 19, 20 
Committed B-cell progenitors show large-scale Ig locus contraction to provide a 
diverse antigen receptor repertoire.7, 21-27 Initially, Ig locus contraction was thought to 
only occur at the stage in which the locus undergoes recombination.26, 27 However, recent 
observations indicate that the Igκ locus is contracted in both pro-B and pre-B cells28, 29 
with similar levels of long-range interactions.29-31 Since Igκ gene rearrangements rarely 
occur prior to the pre-B-cell stage, 32 the question arises whether Ig locus contraction is 
decisive for V(D)J recombination. 
Here we have examined how Ig locus contraction and nuclear positioning are associ-
ated with the stepwise control of V(D)J recombination. We found that nuclear localiza-
tion rather than Ig locus topology is closely linked with the developmental regulation of 
Igh and Igκ locus assembly. 
RESULTS
Igh locus contraction in pro-B and pre-B cells
To study the role of 3D organization of the Igh locus in the stepwise Igh and Igκ 
gene rearrangement processes, we employed 3D DNA FISH in uncommitted pre-pro-B 
cells, and in committed pro-B cells and pre-B cells. Each of these subsets was obtained 
from specific mouse models to enable studies on the Igh and Igκ loci in their germline 
configuration. Uncommitted pre-pro-B cells (B220+CD19-CD43+; Figure 1A) were 
cultured from E2A-/- mice and did not contain complete Vh to DJh, nor incomplete 
Dh to Jh rearrangements.33 Pro-B cells were derived from Rag1 or Rag2-deficient mice 
and expressed CD19 and CD43 in absence of Ig gene rearrangements.34 Pre-B cells were 
derived from transgenic mice expressing a functional murine (Vh81X) or human Igh µ 
chain on a Rag-deficient background or from Rag-deficient pro-B cells transduced with 
human Igh µ chain. These cells express a pre-BCR, while their endogenous Ig loci are 
preserved in germline configuration and remain non-functional.35, 36 
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Figure 1. The Igh locus is contracted in pro-B and pre-B cells. (A) Flow cytometric analysis of cultured 
precursor-B cells from E2A-/-, Rag1-/-, and Rag1-/- Vh81X mice confirmed their differentiation block at the pre-
pro-B, pro-B and pre-B cells stage, respectively.63 (B) Schematic representation of the murine Igh locus. Bacterial 
artificial chromosome clones used as 3D FISH probes are indicated.27 The distal Vh probe was conjugated with 
Alexa488, the proximal Vh probe with Cy5 and the Ch probe with Alexa568. The indicated distance separating 
each of the 3 probes and their positions within the Igh locus were determined from the Ensembl mouse genome 
database. (C) Representative FISH images of Igh loci in the different populations. (D) Scatter plots show the 
spatial distances separating the FISH probes with red lines representing median distances. 2-4 mice were used 
for each condition and at least 200 alleles were analyzed per population. The non-parametric Mann-Whitney 
test was used to calculate significance levels: **, P<.01; ****, P< .0001. (E) Cumulative frequency plots showing 
the distribution of spatial distances between the distal Vh, proximal Vh, and Ch probes in the 3 B-cell subsets. 
To determine Igh locus contraction during B-cell development, we measured spatial 
distances between 3 BAC probes hybridized to distal Vh, proximal Vh and Ch regions 
of the Igh locus (Figure 1B-C). Spatial distances between each of these three regions 
were significantly shorter in pro-B cells than in pre-pro-B cells, in line with previous 
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findings.25-27 More interestingly, we found that the spatial distances measured in pre-B 
cells were also significantly shorter than in pre-pro-B cells, and were similar to the spatial 
distances in pro-B cells (Figure 1D-E). The contraction was not affected by the choice of 
model, because the distances were similar between Rag1-/- and Rag2-/- progenitor-B cells, 
and between Vh81X and hIgM transgenics (Figure S1A-B). Furthermore, transduction 
of hIgM into cultured Rag2-/- pro-B cells also did not affect contraction (Figure S1C). The 
Igh locus was also contracted in freshly isolated pro-B cells, excluding effects of culture in 
the spatial organization of Igh (Figure S1A). 
Thus, in line with previous observations, the Igh locus is contracted in pro-B cells, 
but, contrary to previous observations,26 it was not decontracted in pre-B cells. The 3D 
chromatin organization might therefore facilitate locus accessibility for recombination, 
however, it does not seem decisive for closure of Igh in pro-B cells. 
Igκ locus contraction in pro-B and pre-B cells is independent of the intronic 
κ enhancer (iEκ) 
We next evaluated in our model system with germline Ig genes whether the Igκ locus 
was contracted in pre-B cells only,26 or already in pro-B cells.28, 29 3D DNA FISH was 
performed with 3 BAC probes detecting distal Vκ, proximal Vκ and Cκ regions (Figure 
2A-B). The spatial distances between the Igκ probes were similar between pro-B cells 
and pre-B cells as previously published,37 and significantly shorter than in pre-pro-B cells 
(Figure 2C-D). Igκ contraction was similar between Rag1-/-, Rag2-/-, Vh81X, hIgM trans-
genic and hIgM transduced progenitor-B cells, and freshly isolated pro-B cells, excluding 
effects of genetic background or cell culture (Figure S1D-E). 
The intron enhancers in Igh (iEµ) and Igκ (iEκ) are known to contribute to stage-spe-
cific Ig gene rearrangements. Mice carrying homozygous mutations in E-box motifs in 
the iEκ element (κE1/E2mut mice) show reduced efficiencies of Igκ rearrangements,38 
while Igκ alleles with targeted replacement of iEκ by iEµ (EµR mice) already rearrange 
at the pro-B-cell stage.39 To study whether Igκ locus contraction can take place in the 
absence of a functional iEκ, we crossed κE1/E2mut mice on the Rag2-/- Igµ background, 
and performed 3D DNA FISH with the three Igκ BAC probes. The spatial distances 
measured between Igκ BAC probes in κE1/E2mut pre-B cells were similar to pre-B cells 
with a wildtype iEκ and were significantly shorter than in pre-pro-B cells (Figure 2C-D). 
Additional analysis of κE1/E2mut pro-B and EµR pro-B cells also revealed full contraction 
of these Igκ loci (Figure S2). These results suggest that contraction of the Igκ locus in 
pro-B and pre-B cells does not critically depend on a functional iEκ. Thus, the Igκ locus 
undergoes locus contraction in pro-B cells and remained contracted in pre-B cells, inde-
pendent of iEκ functionality. 
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Figure 2. Igκ locus contraction in pro-B and pre-B cells is independent of iEκ. (A) Schematic representation 
of the murine Igκ locus including the bacterial artificial chromosome clones used as 3D FISH probes: distal 
Vκ – Alexa488, proximal Vκ – Cy5, Cκ –Alexa568. The indicated distances separating each of the 3 probes 
and their positions within the Igκ locus were determined from the Ensembl mouse genome database. (B) 
Representative images of the Igκ locus in the 3 B-cell subsets. (C) Scatter plots show the distances between 
distal Vκ, proximal Vκ, and Cκ regions in cultured E2A-/- pre-pro-B, Rag1-/- pro-B, Rag1-/- Igµ pre-B and 
Rag2-/- κE1/E2mut pre-B cells. For each condition 2-3 mice were used and at least 200 alleles were analyzed 
per population. Red horizontal lines represent median distances. The non-parametric Mann-Whitney test was 
used to calculate significance levels: *, P<.05; ***, P<.001; ****, P< .0001. (D) Cumulative frequency plots 
showing the distribution of spatial distances between the distal Vκ, proximal Vκ, and Cκ region probes in the 
4 progenitor-B cell subsets. 
Long-range interactions within the Igh and Igκ loci 
To further study the nature of the contracted Igh and Igκ loci in pro-B and pre-B cells, 
we analyzed interactions within these Ig loci using Chromosome Conformation Capture 
and sequencing (3C-Seq). Viewpoints in iEµ and iEκ were selected and their long-range 
interactions were studied in non-lymphoid erythroid progenitors, E2A-/- pre-pro-B, Rag1-
/- pro-B and Rag1-/- Vh81X pre-B cells. 
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    The bulk of interactions for iEµ were found with sites on other chromosomes or 
other regions on chromosome 12 outside of Igh (Figure 3A). Still many interactions were 
confined to the 3.5 Mb Igh locus (Figure 3B), creating its own discrete topologically 
associated domain (TAD).40 This confinement of interactions within the Igh locus was 
also found with 3 additional viewpoints located in the distal Vh, proximal Vh and 3’RR 
regions (Figure S3A-B). Still, pro-B and pre-B cells contained clearly more interactions 
between iEµ and Vh regions than pre-pro-B cells and erythroid progenitors (Figure 
3A-B). Moreover, pro-B cells carried specific interactions between iEµ and the distal 
Vh region (Figure 3B), whereas in pre-B cells these were mainly found between iEµ 
and proximal Vh genes (Figure 3B). To study whether these interactions preferentially 
involved Vh genes, we determined the frequencies of interactions with fragments that 
contained a Vh gene (+Vh gene) or not (–Vh gene; Figure 3C). Of the 869 BglII frag-
ments within the Vh region, only a minority contained one or more of the 110 Vh 
genes. B-lineage cells showed more interactions between iEµ and the entire Vh region 
than erythroid progenitors. Erythroid progenitors displayed low amounts of interactions 
to the Vh region (Figure 3C). These numbers were significantly higher in pre-pro-B-cells 
and the highest numbers were found in pro-B and pre-B cells. Moreover, the commit-
ted pro-B and pre-B cells showed relatively more interactions with +Vh fragments than 
uncommitted pre-pro-B cells. Thus, committed B-cell precursors showed frequent inter-
actions between iEµ and Vh genes, with distal Vh interactions being more frequent in 
pro-B than in pre-B cells. 
     Similar to Igh, the iEκ viewpoint showed many interactions with sites on other 
chromosomes or other regions on chromosome 6 outside Igκ (Figures 3D and S3C-D). 
Interactions within Igκ increased with more mature subsets and were most frequent in 
pre-B cells (Figure 3D). 
Figure 3. Long-range interactions within the Igh and Igκ loci. (A) Bar graphs showing the relative distri-
bution of 3C-Seq reads in the Igh locus, the rest of chromosome 12 (chr12 except Igh) and rest of the genome 
(genome except chr12). Read distributions across the genome were analyzed for iEµ enhancer viewpoint in 
erythroid progenitors (EP), cultured E2A-/- pre-pro-B, Rag1-/- pro-B and Rag1-/- Vh81X pre-B cells. Indicated 
cell fractions were obtained from 4 mice. Data represent average of 2 biological replicates. (B) 3C-Seq long-
range interactions of the iEµ viewpoint along ~10 Mb range of chromosome 12 were plotted as reads per 
million for erythroid progenitors (EP), E2A-/- pre-pro-B, Rag1-/- pro-B and Rag1-/- Vh81X pre-B cells. The 
frequency of reads within proximal Vh and distal Vh regions are presented for Rag1-/- pro-B and Rag1-/- Vh81X 
pre-B cells as % of total interactions within the entire Vh region. The χ2 test was used to calculate significance 
level. ****, P< .0001. (C) Bar graphs showing total amount of 3C-Seq interactions within the Vh region of Igh 
analyzed for BglII fragments that contain Vh genes (+Vh gene) or not (–Vh gene). Bars represent sum of inter-
actions. The χ2 test was used to calculate significance levels between +Vh gene and -Vh gene fragments of two 
cell types. ****, P< .0001. (D) Bar graphs showing the relative distribution of 3C-Seq reads in the Igκ locus, the 
rest of chromosome 6 (chr6 except Igκ) and rest of the genome (genome except chr6). Read distributions across 
the genome were analyzed for iEκ enhancer viewpoint in erythroid progenitors (EP), cultured E2A-/- pre-pro-B, 
Rag1-/- pro-B and Rag1-/- Vh81X pre-B cells. Indicated cell fractions were obtained from 4 mice. Data represent 
average of 2 biological replicates. (E) 3C-Seq long-range interactions of the iEκ enhancer viewpoint along ~10 
Mb range of chromosome 6 were plotted as reads per million for erythroid progenitors (EP), E2A-/- pre-pro-B, 
Rag1-/- pro-B and Rag1-/- Vh81X pre-B cells. (F) Bar graphs showing total amount of 3C-Seq interactions 
within the Vκ region of Igκ analyzed for BglII fragments that contain Vκ genes (+Vκ gene) or not (–Vκ gene). 
Bars represent sum of interactions. The χ2 test was used to calculate significance levels between +Vκ gene and 
-Vκ gene fragments of two cell types. ****, P< .0001
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Figure 4. Stage-specific positioning of Ig loci away from the nuclear lamina. (A) Bar graphs showing the 
frequencies of Igh alleles positioned within a distance range from the nuclear lamina in cultured E2A-/- pre-
pro-B, Rag1-/- pro-B and Rag1-/- hIgM pre-B cells. (B) Bar graphs depicting frequencies of Igκ alleles positioned 
within a distance range from the nuclear lamina in cultured E2A-/- pre-pro-B, Rag1-/- pro-B and Rag1-/-hIgM 
pre-B cells. In A and B, X-axis represents the distance ranges from the nuclear lamina and y-axis represents the 
% of alleles positioned with a certain distance range. Distances were measured with 3D DNA FISH of >100 
alleles, obtained from 2 mice. Statistical significance was calculated with the χ2 test between Rag1-/- pro-B and 
E2A-/- pre-pro-B and Rag1-/-hIgM pre-B cells in A or between Rag1-/- hIgM pre-B and E2A-/- pre-pro-B and 
Rag1-/- pro-B cells in B based on the sum of alleles located <0.4 µm from the lamina and the sum of alleles 
located >0.4 µm of the lamina. Significant changes in distribution of distances were calculated with the χ2 
test; ***, P<.001; ****, P< .0001. Representative microscope images on the left indicate differential nuclear 
positioning of Ig loci in the 3 precursor-B-cell populations.  
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Long-range interactions within Igκ were found in pre-pro-B, pro-B and pre-B cells. In 
contrast to pre-pro-B and pro-B cells, these interactions were more dispersed in pre-B 
cells, showing fewer hotspots with high interaction frequencies (Figure 3E-F) Taken 
together, both Igh and Igκ loci were associated with locus contraction in committed 
B-lineage cells indicating that locus contraction as such does not correlate with the devel-
opmental regulation of Ig locus assembly. 
Nuclear positioning is associated with stage-specific induction of Ig gene 
rearrangements
To study whether the nuclear positioning of Ig loci orchestrates the stepwise Ig gene 
rearrangements, we analyzed spatial distances between the Igh and Igκ loci and the nuclear 
lamina using 3D DNA FISH. The Igh locus was preferentially positioned at the nuclear 
periphery in uncommitted E2A-/- pre-pro-B cells, and became more centrally positioned 
in Rag1-/- pro-B cells (Figure 4A). Importantly, the Igh alleles were positioned back to 
the nuclear lamina compartments in Rag1-/- Igµ pre-B cells. On the other hand, Igκ was 
located at the nuclear periphery in both pre-pro-B and pro-B cells, and only in pre-B cells 
Igκ was located in the center (Figure 4B). The re-positioning involved both Ig loci in each 
cell as shown by independent analysis of the most lamina-proximal and lamina-distal loci 
(Figure S4A-B). The stage-specific positioning did not appear to involve the iEκ: the Igκ 
allele with the iEµR knock-in was also located at the nuclear lamina in pro-B cells, and 
the Igκ alleles with κE1/E2mut were not fully retained at the nuclear periphery in pre-B 
cells (Figures S5 and S6). Thus, the Ig locus positioning in the nucleus, rather than the 
large-scale contractions, is directly associated with the sequential rearrangement of the Ig 
loci. 
Positioning away from the nuclear lamina increases germline Ig loci 
transcription  
To study whether the nuclear re-positioning was related to the changes in transcrip-
tional activity, we investigated the nuclear localization of Igh and Igκ in E2A-/- pre-pro-B 
cells treated with histone deacetylase inhibitor trichostatin A (TSA). TSA was previously 
shown to modulate gene localization at the nuclear periphery by disturbing the interac-
tions of LAD-derived sequences with the nuclear lamina.41, 42 As a read out for locus acces-
sibility, germline transcription from the Ig loci was assessed. From previously generated 
microarray studies29, 30 and with RQ-PCR, we analyzed Igh and Igκ germline transcripts. 
In line with established concepts, we found high expression of Igh germline transcripts in 
Rag1-/- pro-B cells, while Igκ germline transcripts were high in Rag1-/-Vh81X pre-B cells 
(Figure 5A-C and Table S2). 
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Figure 5. Developmentally regulated germline transcription of Ig loci. (A) Schematic representation of 
Igh (top panel) and Igκ (bottom panel) loci with indicated positions of certain V (grey rectangles), D (blue 
rectangles), J (green rectangles) and C genes (purple rectangles). In addition, the positions of microarray probes 
(grey horizontal lines) for detection of germline transcripts, and 3C-Seq viewpoints (red arrows) are depicted. 
(B) Graphs represent germline transcripts in Igh and Igκ paired between Rag1-/- pro-B and Rag1-/- Vh81X pre-B 
cells. Data was derived from previously generated expression profiles (Table S2 and 29, 30) and significance was 
calculated with the Mann-Whitney U test; *, P<0.05. (C) Germline transcript levels of iEµ and iEκ as assessed 
in E2A-/- pre-pro-B, Rag1-/- pro-B and Rag1-/- Vh81X pre-B with RQ-PCR in 2 independent cultures. Bars 
represent average with SD. Gene expression levels were normalized to the levels of GAPDH, and the values in 
E2A-/- pre-pro-B cells were set to 1. 
Following 10hr incubation of E2A-/- pre-pro-B cells with TSA, spatial distances 
between the Ch and Cκ probes, and the nuclear lamina were measured by 3D DNA 
FISH. Indeed, incubation with TSA resulted in positioning of both Igh and Igκ away 
from the nuclear lamina in these uncommitted early precursor cells (Figure 6A-C). This 
movement was associated directly with increased expression of germline transcription of 
both the Igh and Igκ loci (Figure 6D-E). 
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Figure 6. Positioning away from the nuclear lamina increases germline transcription of Igh and Igκ. (A) 
Representative microscope images indicate differential nuclear positioning of Igh (red) and Igκ (green) loci in 
E2A-/- pre-pro-B-cells cultured with (+) or without (-) TSA. Bar graphs showing the frequencies of (B) Ch 
regions and (C) Cκ regions positioned within a distance range from the nuclear lamina in E2A-/- pre-pro-B 
cultured with (+) or without (-) TSA. >100 alleles were acquired for each condition. Germline transcript levels 
of (D) iEµ and (E) iEκ as assessed with RQ-PCR in 2 independent cultures. Bars represent average with SD. 
ND, not detectable. Dashed lines indicate the detection limit at cycle-threshold 40.
Taken together, these data indicate that large-scale contraction of Ig loci facilitates 
equal utilization of V genes during Ig gene rearrangements. However, it is the spatial 
positioning in the nucleus that orchestrates the Ig loci accessibility for V(D)J recombi-
nation machinery and thereby directs the sequential nature of Ig gene rearrangements in 
precursor-B cells (model in Figure 7). 
DISCUSSION
We studied locus contraction, long-range chromatin interactions and nuclear posi-
tioning of the germline Igh and Igκ alleles in three consecutive progenitor-B-cell sub-
sets with 3D DNA FISH and 3C-Seq. This integrated approach enabled us to identify 
that both Ig loci were already contracted in the earliest committed pro-B-cell stage and 
retained this configuration in pre-B cells. In contrast, positioning away from the nuclear 
lamina was tightly regulated for Igh in pro-B cells and for Igκ in pre-B cells, and correlated 
with germline transcription. Thus, nuclear localization rather than Ig locus topology is 
closely linked with the developmental regulation of Igh and Igκ locus assembly.
In line with previous observations, we observed contraction of Igh in pro-B cells as 
compared to pre-pro-B cells.25-27 However, contrasting a previous study using wild type 
precursor-B-cells,26 our Rag-deficient cells kept the Igh locus contracted in pre-B cells. The 
absence of functional Rag in our system creates an artificial situation, because no DNA 
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breaks are induced that could affect gene expression programs in the progenitor-B cells.43 
Still, the immunophenotypes of our Rag-deficient pro-B and pre-B cells were normal, 
as was the stage-specific upregulation of Igh and Igκ germline transcripts. Rag-proficient 
pre-B cells will carry rearranged Ig genes with unknown spans of excised DNA. Moreover, 
FISH signals could be derived from excision products. Therefore, a model with Igh and 
Igκ in germline configuration is best-suited to study their 3D structural organization. 
pre-pro-B cell pro-B cell pre-B cell
Igh Igκ
pre-BCR
CD19B220
Figure 7. A model for nuclear positioning of Igh and Igκ loci during B-cell development. Nuclei in pre-
pro-B, pro-B and pre-B cells are indicated with schematic drawing of differentially positioned Igh (red) and Igκ 
(green) loci. Both Ig loci were already contracted in the earliest committed pro-B-cell stage and retained this 
configuration in pre-B cells. In contrast, positioning away from the nuclear lamina was tightly regulated for Igh 
in pro-B cells and for Igκ in pre-B cells. Thus, nuclear localization rather than Ig locus topology is closely linked 
with the developmental regulation of Igh and Igκ locus assembly.
Similar to Igh, we observed that Igκ was already contracted in pro-B cells.28, 29 This 
contraction, as well as abundant intra-locus interactions have been described before.7, 21-23, 
29-31, 44 The germline Ig loci on our studies retained cis-regulatory elements that poten-
tially drive locus contraction. These include the intergenic control region 1 (IGCR1) 
downstream of the Vh region,22, 23 and the contracting element for recombination (Cer) 
located within the Vκ-Jκ intervening region.45 These elements likely function similarly 
as the newly described regulatory elements between V and DJ region of the TCRβ locus 
to mediate locus topology.46, 47 Thus, by choosing Rag-deficient models we did not study 
a heterogeneous pool of cells with and without deletion of these intergenic elements. 
The main limitation is the retained presence of IGCR1 in Igh that might affect Igh locus 
contraction resulting in differences between rearranged and non-rearranged alleles.
The consistent Ig locus contraction is potentially mediated by the ubiquitously 
expressed CTCF and YY1, which mediate the global DNA folding,21, 31, 48-50 and the B-cell 
specific transcription factors E2A, EBF1, Pax5, Ikaros and PU.1, which likely further 
facilitate contraction.24, 31, 49, 51-53 This is supported by observations in CTCF-/- pro-B cells 
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where the Igh locus was more compacted than in E2A-/- pre-pro-B cells and only slightly 
decontracted as compared to wild type pro-B cells.21 Because these factors are highly 
expressed in both pro-B and pre-B cells (Table S3 and 29), it is well-possible that they 
function similarly in both developmental stages to maintain the contracted conformation 
of the chromatin fiber. Importantly, our refined model for Ig locus organization supports 
a role for Ig locus contraction in efficient V(D)J recombination, but excludes a role in 
developmental regulation of Ig gene rearrangements. 
We found that the E2A-binding sites in iEκ were unimportant for Igκ locus contrac-
tion, despite their role in Igκ gene rearrangements.38, 39 Previously, deletion of the iEµ 
and 3’RR enhancers in Igh were found to be redundant for contraction or long-range 
interactions in Igh.44, 54 This could imply that the enhancers in Ig loci are not involved in 
3D structural organization, and mediate efficient V(D)J recombination through different 
means. Multiple DNA-binding proteins have been implicated in Ig locus contraction and 
they can bind to regulatory elements disseminated along the loci, such as PAIR elements 
within the Vh region.49 CTCF binding to the Cer region within Igκ mediated the locus 
contraction.45 Likely CTCF binding to IGCR1 also established the Igh folding. Thus, 
the enhancers could be involved in contraction of wild type alleles, but the disruption of 
a single transcription factor binding site would only have a minor impact on large-scale 
chromatin contraction.
Although the decontracted Igκ locus in E2A-/- pre-pro-B cells is not yet a target for 
V(D)J recombination,31 we found a large number of intra-locus interactions. Further 
analysis showed that these mostly involved fragments that did not contain Vκ genes. 
Thus, the extent of spatial decontraction in pre-pro-B cells still allowed physical contacts 
between chromatin domains within the Ig loci, and in fact enabled freedom for random 
interactions. Rather, spatial contraction in pro-B and pre-B cells restricted these interac-
tions with a preference for DNA regions containing V genes, specifically for Igκ following 
pre-BCR signaling.29 
Stage-specific accessibility of Igh and Igκ, as measured by increased germline tran-
scription, was associated with positioning of the loci away from the nuclear periphery 
specifically at the stage of increased germline transcription. Movement of Igh away from 
the nuclear lamina in pro-B cells has been observed before,19 but we are the first to show 
re-location towards the nuclear lamina in pre-B cells. Unexpectedly, our finding of Igκ 
positioning at the nuclear lamina in pro-B cells contradicts previous observations.19 This 
is potentially due to the fact that in these studies 2D FISH was performed and the nuclear 
lamina were not stained. Goldmit et al. found that of the centrally-located Igκ alleles in 
pre-B cells, one was silenced by association with heterochromatin, forming the basis of 
allelic exclusion.55 In their studies, Igκ alleles in pro-B cells hardly associated with heter-
ochromatin, most likely because they are associated with the nuclear lamina as observed 
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here. Thus, in pro-B cells Igκ is inaccessible at the nuclear lamina, and this is a different 
process from heterochromatic recruitment necessary for allelic exclusion. 
The nuclear lamina were previously shown to act as a repository for transcriptionally 
inactive chromatin domains,16, 17 and repositioning of genes can occur at specific stages of 
cellular differentiation.9, 15, 16, 18 Increased acetylation of Ig loci due to histone deacetylase 
inhibitor TSA resulted in movement of Ig loci towards the nuclear interior in E2A-/- pre-
pro-B cells and increase of germline Ig transcription. This suggests that locus mobility and 
gene transcription stay in relation and are controlled by histone modifications. Recently, 
histone modifications were shown to direct V(D)J recombination.10 Specifically, Rag2 is 
recruited through binding to H3K4me3 histone marks.13, 14 These histone modifications 
were detected within the Igh locus in pro-B cells, and in Igκ in the pre-B cell stage.12 It is 
conceivable that nuclear positioning towards the nuclear center enables the induction of 
H3K4me3 histone modifications. Alternatively, H3K4me3 histone modifications poise 
the Ig loci to migrate away from the nuclear lamina. A potential signal guiding histone 
modifications could be induced by IL-7. Recently, Mandal et al. showed that IL-7 sig-
naling inhibited Igκ rearrangements in pro-B cells by recruiting STAT5 heterodimers to 
iEκ, which further induced Ezh2 methyltransferase and thereby silenced the Igκ locus 
through H3K27me3 modifications.56 These modifications could keep Igκ positioned at 
the nuclear lamina, while subsequent attenuation of IL-7R signaling by Ikaros would 
then induce re-positioning of Igκ and enable induction of gene rearrangements.57, 58  
It still remains puzzling, however, which mechanisms control allelic exclusion of the 
second non-rearranged Igh locus in pre-B cells. We here used a model system with an 
Ig heavy chain transgene to study the locus organization and positioning of Igh alleles 
in the germline. As a result, all of our observations in pre-B cells concerned the reloca-
tion of non-functional Igh alleles towards the nuclear periphery and the down regulation 
of germline transcripts (Figure 4B, Figure E4A-B). Thus, repositioning of Igh towards 
nuclear lamina and away from transcription factories could be a potential mechanism 
to decrease the locus accessibility and mediate allelic exclusion. However, the question 
remains whether a functionally rearranged Igh locus with a genomically proximal Vh pro-
motor and iEµ will also move towards the nuclear periphery or remain transcriptionally 
active in the nuclear center.59 Addressing this issue would require a more complex model 
system with a functional Igh rearrangement on one allele and sufficient genomic markers 
to distinguish it from the other germline allele with DNA probes. 
Taken together, our studies confirm that murine Igh and Igκ loci undergo contraction 
prior to gene rearrangement to allow juxtaposing of genomically distant gene segments 
in order to create equal opportunities for recombination. However, we here show that 
nuclear positioning is associated with germline transcription and the developmental reg-
ulation of Igh and Igk locus assembly. These combined new insights are important for 
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future studies on the factors that regulate stepwise control of Ig gene rearrangements and 
indicate that these are likely to be controlled via nuclear positioning of Ig loci.
MATERIALS AND METHODS
Mice
Rag1-/-, Rag2-/-, VH81X transgenic, human IgM transgenic, κE1/E2mut  and EµR 
mice were obtained34-36, 38, 39, 60 and kept on a C57BL/6 background under specific patho-
gen-free conditions. Mice were euthanized at 5-13 weeks of age. The experiments were 
performed on pooled cells from 2-4 mice. Experimental procedures were reviewed and 
approved by the Erasmus University committee of animal experiments.
Cell culture and flow cytometry
CD19+ B cells were enriched from femoral bone marrow suspensions by magnetic 
separation (Miltenyi Biotec), and cultured for 2-3 weeks in Iscove’s Modified Dulbecco’s 
medium containing 10% fetal calf serum, 200 U/ml penicillin, 200 mg/ml streptomy-
cin, 4nM L-glutamine, 50 µM β-mercaptoethanol, and 2 ng/mL of both IL-7 and SCF. 
E2A−/− hematopoietic progenitors were grown as described previously.33
Flow cytometric immunophenotyping of bone marrow suspensions and cultured pro-
genitor cells was performed after staining with B220-PerCP-Cy5.5 (RA3-6B2), CD19-
APC-Cy7 (1D3), CD43-APC (S7), CD2-PE (RM2-5; all from BD Biosciences) on an 
LSRII flow cytometer (BD Biosciences) and analyzed with BD FACSDiva Software.
Probe preparation and 3D DNA fluorescence in situ hybridization (FISH) 
BAC clones CT7-526A21, RP23-24I12, CT7-34H6 for detecting regions in the 
murine Igh locus,27 and RP23-234A12, RP24-475M8, RP23-435I4 recognizing regions 
within murine Igκ locus (all from BACPAC Resources) were used as FISH probes. Probe 
labelling and DNA FISH were performed as described previously.27, 61, 62 Images were 
acquired on a Leica SP5 confocal microscope (Leica Microsystems), followed by decon-
volution and analysis with Huygens Professional software (Scientific Volume Imaging).61, 
62 Details of the procedures are available in the supplementary Materials and Methods.  
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Circular chromosome conformation capture with high-throughput sequenc-
ing (3C-Seq)
3C libraries were prepared from cultured E2A-/-, Rag1-/- and Rag1-/-Vh81X B-cell 
progenitors and wild type fetal liver erythroid progenitors,29, 30, 37 and interactions were 
studied with 4 Igh and 4 Igκ viewpoints (primers sequences are available in the Table 
S1). More details about the 3C-Seq procedure and data analysis can be found in the 
supplementary Materials and Methods. The high-throughput sequencing datasets have 
been submitted to the Sequence Read Archive (SRA), accession number: SRP055900.
 
Gene Expression profiling
The expression profiles of Rag1-/- pro-B and Rag1-/-Vh81X pre-B cells were previously 
generated with Affymetrix Mouse Gene 1.0 ST Arrays,29, 30 and obtained from the Gene 
Expression Omnibus (GEO; accession number GSE53896). 
Inhibition of histone deacetylase activity
For inhibition of histone deacetylase activity, E2A-/- pre-pro-B cells were incubated 
at 37°C for 10hr with trichostatin A (TSA, Sigma-Aldrich) or DMSO at 3ng/ml (Igh) 
or 10ng/ml (Igκ) concentration.41, 42 Next, 3D DNA FISH was performed with the 
Alexa-568-labeled CT7-34H6 probe (Ch), Cy5-labeled RP23-435I4 probe (Cκ) and 
MarinaBlue-labeled nuclear lamina. Germline transcripts from the iEµ and iEκ enhancers 
were quantified with a TaqMan-based RQ-PCR. More details are available in the supple-
mentary Materials and Methods.
Statistics
Statistical significance was calculated with the non-parametric Mann-Whitney U 
test or the χ2 test. The Mann-Whitney U test was used to analyze statistical significance 
between two groups of data following unknown (not normal) distribution, whereas χ2 
test was used to compare the distribution of two data sets of two groups. All statistical 
tests were performed using GraphPad Prism version 5.0. P values <0.05 were considered 
as significant.
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ABSTRACT
Precursor-B-cell production from bone marrow (BM) in mice and humans declines 
with age. Because the mechanisms behind are still unknown, we studied 5 precur-
sor-B-cell subsets (pro-B, pre-BI, pre-BII large, pre-BII small, immature-B) and their 
differentiation-stage characteristic gene expression profiles in healthy individual toddlers 
and middle-aged adults. Notably, the composition of the precursor-B-cell compartment 
did not change with age. The expression levels of several transcripts encoding V(D)J 
recombination factors were decreased in adults as compared to children: RAG1 expres-
sion was significantly reduced in pro-B cells, and DNA-PKcs, Ku80 and XRCC4 were 
decreased in pre-BI cells. In contrast, TdT was 3-fold up-regulated in immature-B cells 
of adults. Still, N-nucleotides, P-nucleotides and deletions were similar for IGH and IGK 
junctions between children and adults. Pre-BII large cells in adults, but not in children, 
showed highly up-regulated expression of the differentiation inhibitor ID2, in absence of 
changes in expression of the ID2-binding partner E2A. We here identified impaired Ig 
locus contraction in adult precursor-B cells as a likely mechanism by which ID2-mediated 
blocking of E2A function results in reduced BM B-cell output in adults. The reduced 
B-cell production was not compensated by increased proliferation in adult immature-B 
cells, despite increased Ki67 expression. These findings demonstrate distinct regulatory 
mechanisms in B-cell differentiation between adults and children with a central role for 
transcriptional regulation of ID2.
INTRODUCTION
Commitment and differentiation of early precursor-B cells to immunoglobulin 
(Ig) producing B lymphocytes is a key requirement for a competent adaptive immune 
system. Each differentiation step is tightly controlled by integrated activities of multiple 
transcription factors in a complex gene regulatory network.1  In fact, a handful of key 
transcription factors is used in multiple contexts and distinct combinations to initiate and 
maintain the commitment process throughout the lifespan of the B cell.2
Production of B lymphocytes from bone marrow (BM) continues throughout life. 
Similar to T lymphocytes,3 the precursor-B cell pool is decreasing with age in both man4,5 
and mice,6-8 whereas the production of other hematopoietic lineages seems to continue 
unchanged.9 With advancing age, the capacity to induce protective antibody responses 
decreases, leading to reduced ability to deal with new and previously encountered patho-
gens.10 Some studies in mice suggest that the impact of aging on lymphoid progenitors 
is first manifested in hematopoietic stem cells (HSCs).11,12 Other studies link the waning 
B-cell production in mice to the inability of immature-B cells to replenish the peripheral 
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compartments,6 to decreased transition of pro-B cells into pre-B cells6,13 and/or to micro-
environmental changes causing altered Ig gene rearrangements.14,15 The question has also 
been raised whether specific transcriptionally regulated mechanisms obstruct B-cell gen-
eration with age, such as changes in expression of ID2 (inhibitor of DNA binding 2)16-20 
– a physiological regulator of the essential transcription factor E2A. E2A protein levels 
in mice have been reported to decrease with age,17 but thus far, no age-related changes 
were found for ID2 protein using in vitro expanded pro-B/early pre-B cells from aged 
and young mice.16 
In contrast to mouse studies, the effects of aging on human precursor-B-cell devel-
opment have been scarcely studied so far. Global gene expression has only been studied 
in successive maturation stages of precursor-B cells in children21 and adults,22 separately. 
We have previously reported that the total pool of precursor-B cells in human BM 
decreased rapidly during the first two years of life concomitantly with reduced expression 
of RAG1.5 Still, these studies were unable to address the issue of decreased BM output of 
B cells. Therefore, we analyzed precursor B cell subsets and their gene expression profiles 
in BM from healthy young children and adults. Through differentiation-stage dependent 
analysis of 5 precursor-B-cell subsets and pair wise comparisons between children and 
adults, we identified several mechanisms that suggest tighter checkpoint control in adult 
precursor-B cells.
RESULTS
The relative distribution of precursor-B cells in BM does not change with age
Within the total leukocyte populations in BM from children and adults, we found 
considerable variations in lymphocyte frequencies, but no age-related differences (mean 
± 2SD): adults 49.7% ± 8.9, and children 41.3% ± 16.6, respectively. In contrast, the 
absolute number of isolated BM restricted CD10+ cells (mean ± 2SD) was significantly 
higher (p < 10-5) in children (8.2 x 106/ml ± 1.2 x 106/ml) than in adults (2.7 x 106/ml 
± 2.2 x 106/ml).   
To study whether the decrease in adults was due to impaired B-cell differentiation, we 
analyzed progenitor-B-cell subsets using a panel of 7 membrane markers (Figure 1A-B). 
The relative sizes of the five major subsets,  pro-B, pre-BI, pre-BII large, pre-BII small 
and immature-B cells, varied individually, but was not related to age (Figure 1C). About 
20% of the compartment consisted of the early CD34+ pro-B and pre-BI progenitor 
cells, whereas pre-BII large and small cells were dominating (~70%). Immature-B cells 
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Figure 1. Precursor-B-cell subset definition and distribution in childhood and adult bone marrow. (A) 
Sort strategy to define five precursor-B-cell subsets from CD10+-enriched BM cells according to van Zelm 
et al. 2005.21 (B) Nomenclature and membrane marker definition of the five precursor-B-cell subsets. (C) 
Distribution of precursor-B-cell subsets in bone marrow. Shown are frequencies within the total CD10+ pre-
cursor-B-cell compartment (mean ± SD) obtained from 4 children and 4 adults. 
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constituted about 12%. This indicates a seemingly similar profile of precursor-B-cell dif-
ferentiation with age.  
105
Formation of the Immunoglobulin Repertoire in Precursor-B-cell Development
Stage-dependent global mRNA expression in precursor-B cells from children 
and adults
To study whether transcriptional regulation of precursor-B-cell differentiation was 
affected by age, we analyzed the gene expression profiles of all 5 precursor-B-cell stages in 
4 children and 4 adults. First, differences in gene expression levels were determined per 
cell stage in children and adults separately using cut off p-value < 0.05 and fold change 
> ± 2 (Table S2). Between pro-B and pre-BI, pre-BI and pre-BII large, pre-BII large and 
pre-BII small, and pre-BII small and immature-B, respectively, a total of 141, 279, 31, 
697 transcripts had an ANOVA p-value less than 0.05 in children (Figure 2). These 
0.2-4.4 % of the transcripts describe the differentiation processes from one stage to the 
next. Corresponding numbers in adults were 294, 683, 174, and 525, representing 1.9 
%, 4.3 %, 1.1 % and 3.3 %, of all transcripts present on the array, respectively. Therefore, 
the total number of transcripts changing expression during differentiation from pro-B to 
pre-BI, pre-BI to pre-BII large and further to pre-BII small were about 2-5 fold higher in 
adults than in children. Only in the last passage from pre-BII small to immature-B, about 
25% more transcripts were differentially expressed in children than in adults.  
A striking difference was up-regulation of 529 transcripts in the pre-BI to pre-BII 
large transition in adults versus 111 transcripts in children. Of these, about 1/6 of the 
transcripts in adults and 2/3 of the transcripts in children were shared. The other cell 
transitions involved a more equal number of up-regulated transcripts with age (Figure 
2A). The number of down-regulated transcripts also showed marked age-related differ-
ences (Figure 2B). Notably, in the last differentiation step, 36% more transcripts were 
down-regulated in children (Figure 2B). Common transcripts in this step represented 
about 1/2 of the transcripts in children and 3/4 in the adult group.
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ulated and (B) down-regulated in each differentiation step in children (black) and adults (grey), respectively. 
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Differences in transcripts essential in V(D)J recombination and their effects 
on Ig gene rearrangements
We first examined if transcripts reported to be involved in precursor-B-cell commit-
ment and differentiation showed similar expression in children and adults, here allowing 
fold change values less than |2|. Of 164 transcripts previously described to be precursor-B 
cell associated,21 23 transcripts were differentially expressed between children and adults 
(Table 1) (mean fold change 2.14, range 1.22 – 5.81; mean p-value 0.02, range 7 x 
10-6 – 0.04).
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Figure 3. V(D)J gene rearrangement processes in precursor-B cells of children and adults. Expression levels 
of (A) RAG1 and RAG2, causing DNA double strand breaks, (B) the DNA-PKcs/Ku70/Ku80 complex signal-
ing the ”DNA damage”, and (C) the DNA repair machinery DNA ligase4/ XRCC4 and the DNA polymerase 
TdT. Dotted lines represent children, solid lines adults. Significant differences in expression for a specific stage 
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from children are reproduced from Nodland et al. 2011,24 adult IGH (n =70) and IGK (n=82) gene rearrange-
ment data were newly generated.
     Among genes higher expressed in children were multiple genes involved in V(D)
J recombination. The recombination activating gene RAG1 was 1.5 higher expressed (p 
= 0.03) in pediatric pro-B cells, while for the other subsets, we found no age-related 
differences. RAG1 and RAG2 mRNA were specifically up-regulated in pre-BI and small 
pre-BII cells of both children and adults, fitting with their involvement in Ig heavy and 
light chain gene rearrangements (Figure 3A). The non-homologous end-joining factors 
Ku80 and DNA-PKcs28 were both 1.5 fold higher (p = 0.01 and 0.02, respectively) in 
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pediatric pre-BI cells than in adults (Figure 3B). Of transcripts encoding DNA ligation 
components, XRCC4 showed a 1.7 fold higher expression (p = 0.03) in pre-BI cells in 
children while LIG4 (encoding DNA ligase IV) was similarly expressed in all subsets in 
children and adults (Figure 3C). IGKC, representing the Ig kappa constant region, was 
significantly higher expressed in adult pro-B (3.6 fold up, p = 7 x 10-6) and pre-BI (4.2 
fold up, p = 4 x 10-6) cells. The template-independent DNA polymerase TdT, inserting 
random nucleotides during V(D)J recombination, was over 3.2 fold higher expressed (p 
= 0.02) in adult immature-B cells than in children (Figure 3C).
     To study whether the reduced RAG expression and increased TdT and IGKC 
levels affected V(D)J recombination, we analyzed IGH and IGK gene rearrangements. To 
avoid the impact of selection, we analyzed IGH gene rearrangements in pre-BI cells and 
IGK gene rearrangements in small pre-BII cells (Figure 3D).21 Since IGH D-J junctions 
are formed in pro-B cells,21 this analysis allowed us to study the Ig gene rearrangement 
process in three differentiation stages: pro-B, pre-BI and pre-BII small. The analyzed 
rearrangements did not show differences for deletions and P-nucleotides between chil-
dren and adults (not shown). Both D-J and V-D rearrangements showed high numbers 
of N-nucleotides, reflecting the high TdT levels in pro-B and pre-BI stages. N-nucleotide 
additions in IGK gene rearrangements were much lower and did not differ significantly 
between children and adults. Thus, the low levels of TdT in pre-BII small as compared 
to pro-B and pre-BI cells result in fewer TdT insertions, but the difference in TdT levels 
between children and adults in pre-BII small does not affect N-nucleotide insertions in 
pre-BII small.
Transcripts encoding pre-BCR components and downstream signaling 
molecules
Several component of the (pre-)BCR were significantly differentially expressed 
between children and adults. CD79A expression was significantly higher in childhood 
pre-BI and pre-BII small cells than in adults (Table 1). Furthermore, IGLL1 (immuno-
globulin lambda-like polypeptide 1) was slightly higher expressed (fold change 1.3, p < 
0.05) in pro-B cells in children than in adults, but similar during further differentiation. 
VPREB1, however, was 1.7 fold higher expressed (p < 0.002) in adult immature-B cells 
than in children, but otherwise showed no age differences. We also analyzed key tran-
scripts in the pre-BCR-signaling pathway29 and found no age-related differences in the 
proliferation inhibiting transcripts BLNK (B-cell linker) and BTK (Bruton´s tyrosine 
kinase) or other components, except for a sole 1.3 fold higher expression (p < 0.05) 
of SYK (spleen tyrosine kinase) in pre-BII large cells in children. These results strongly 
suggest that pre-BCR-signaling in humans as evaluated through these pathways, are pre-
dominantly unchanged with age.
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Figure 4. (A-D) Expression levels of transcription factors essential in B-cell commitment and differenti-
ation. Dotted lines represent children, solid lines adults. Relative levels of ID2 mRNA were confirmed with 
RT-qPCR using (E) a commercial ID2 assay, and (F) a custom-designed primer/probe set targeted to the 
5´end of the transcript. Significant differences in expression between children and adults for a specific stage are 
indicated with an asterisk.
Differences in transcripts essential in B-cell commitment and differentiation 
and the effects on IGH locus contraction
Multiple transcription factors involved in B-cell commitment and differentiation 
were differentially expressed between children and adults. These included transcription 
factors Helios (IKZF2),30 which was 2 fold up in pro-B (p = 0.01) and 2.2 fold up in 
pre-BI (p = 0.01), and Aiolos (IKZF3), which was 2.1 fold up in pre-BI cells (p = 0.0001; 
Figure 4A). Furthermore, the differentiation inhibitor ID2 was up-regulated in adult 
pro-B (2.5 fold, p = 0.028) and pre-BII large cells (5.8 fold, p < 9 x 10-5). In children, ID2 
was expressed at relatively low levels with no significant change from one stage to another 
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(Figure 4B). In adults, a 3.1-fold increase (p = 0.01) in ID2 expression was seen in the 
transition from pre-BI to pre-BII large and a corresponding 3.0-fold decrease (p = 0.008) 
in the subsequent transition to pre-BII small, followed by a further 2.4 fold decrease (p 
= 0.03) differentiating into immature-B cells (Figure 4B). The ID2 expressional pattern 
was confirmed with RT-qPCR (Figures 4E-F and Table S3). The target of ID2, E2A, was 
similarly expressed during differentiation in children and adults (Figure 4B), although 
with a slightly higher expression, 20% (p = 0.02) in pediatric pro-B cells and a similar, but 
not significant (p = 0.06) increase in large pre-BII cells. Furthermore, other transcription 
factors involved in B cell differentiation showed strikingly similar expression in children 
and adult in all differentiation stages (Figures 4C-D). These included: EBF1 (Early B 
cell factor 1), PAX5 (Paired box 5), IRF4 (Interferon regulatory factor 4), IRF8, and 
POU2AF1 (POU class 2 associating factor 1).  
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Figure 5. 3D Spatial organization of the IGH locus in precursor-B cells of children and adults. (A) 
Schematic representation of the human IGH locus and the combinations of bacterial artificial chromosome 
clones used as 3D FISH probes are shown. The distance separating each of the 3 probes and their positions 
within the IGH locus were determined from the IMGT database.26 Numbers in the rectangles represent the size 
of the regions recognized by the probes and the numbers below the arrows represent genomic distances between 
probe sets. (B) Scatter plots showing the distances in micrometers (y-axis) separating distal Vh, proximal Vh, 
and Ch regions in sorted pediatric and adult pre-BI and pre-BII small cells. For each condition, 2 independent 
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sorts were performed on material from 1-3 donors each and at least 900 alleles were analyzed per population. 
Red horizontal lines represent median distances between indicated probes in each population. The nonparamet-
ric Mann-Whitney test was used to calculate significance levels between paired populations (horizontal bars). *, 
P<.05; **, P<.01; ***P< .001. (C) Representative images of IGH loci in the different populations.
The up-regulation of ID2 in adults, without differences in E2A, PAX5 and EBF1 
expression levels, suggests that of these critical factors, only E2A function is potentially 
reduced. E2A is implicated in regulating Ig gene rearrangements [reviewed in 31]. The 
IGH locus was previously found to contract prior to the initiation of complete V to DJ 
rearrangements in mouse and human pre-BI cells.23,24,32-34 To study whether reduced E2A 
function might be contributing to reduced B-cell production in adults as compared to 
children, we measured the spatial distances between 3 probe sets recognizing distal Vh, 
proximal Vh, and Ch regions (Figure 5A). Spatial distances between distal Vh and Ch 
regions, distal Vh and proximal Vh regions, and proximal Vh and Ch regions were short 
in childhood pre-BI cells and significantly larger in small pre-BII cells (Figures 5B-C), 
confirming previous observations.24 The IGH locus of adult pre-BI cells was also more 
contracted than in adult pre-BII cells. Importantly, in both stages the distances between 
distal Vh and Ch regions were larger than in their childhood counterpart (Figures 
5B-C). The distances between distal Vh and proximal Vh between childhood and adult 
cells were not different, but the distance between proximal Vh and Ch regions in adult 
pre-BII cells was significantly larger than in children. Thus, the IGH locus was more 
contracted in childhood than in adult precursor-B cells. 
ID2 interacting molecules are involved in DNA replication, recombination 
and repair, cell cycle progression and checkpoint control 
We further analyzed functional annotations of other transcripts changing with ID2 
in the pre-BI to pre-BII large transition in adults by building a network starting with 
ID2 and E2A using Ingenuity Pathway Analysis. The resulting network consisted of 36 
transcripts involved in DNA replication, recombination, repair and cell cycle progression 
(Figure 6). Of these transcripts, 28 were up-regulated concomitantly with ID2 and 6 
down-regulated. Eleven of the up-regulated molecules were transcription factors, and 
6 were kinases. The cell cycle regulators CDK1 (cyclin-dependent kinase 1) and CDK2 
were located centrally in the interacting hub. Together with cyclin E (CCNE1), these 
kinases regulate the G1/S phase transition, in collaboration with cyclin A the S/G2 
phase traverse, and with cyclin B (CCNB1 and CCNB2) the G2/M (mitosis) transition. 
Both CDK1 and CDK2 complexes are able to phosphorylate ID2, assumed to relieve 
its inhibitory effects on E2A. Notably, it has been suggested that the E2A protein level 
is modulated by both the abundance and phosphorylation status of ID2.35 The network 
also includes the important regulator CHEK1, which is involved in several check points 
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of the cell cycle (Figure 6). Other transcripts up-regulated in the network are key factors 
in DNA replication, such as DNA polymerase α (POLA1) and δ (POLD3) and the pri-
mases PRIM1 and PRIM2, which add RNA primers to Okazaki fragments on the lagging 
strand during DNA synthesis.36 Down-regulated transcripts included the cell cycle regula-
tor cyclin D (CCND2) – possibly caused by ID2 as previously documented.37 Altogether, 
it seems that with increased ID2 expression in adult pre-BII large cells, a network of tran-
scripts involved in DNA replication and cell cycle regulation is concomitantly activated 
or repressed. This is in contrast to children, where only 5 transcripts in this network were 
significantly up-regulated (LYN, IRF4, TFDP2, PTPN6, HDAC9) and 4 significantly 
down-regulated (SLC22A16, ITPR1, ELK3, DNTT) (Table S2). Thus, the differential 
up-regulation of ID2 in adult pre-BII large cells ties in with an ensemble of other known 
cell cycle checkpoint regulators, supporting the hypothesis of the pre-BII large stage as an 
important restriction step in adults. 
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Figure 6. Functional network of ID2 interacting molecules. Red denotes up-regulated and green down-regu-
lated transcripts in the differentiation step pre-BI to pre-BII large stage in adults. Nodes are displayed using 
various shapes that represent the functional class of gene products.  
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Adult immature-B cells do not show signs of compensatory proliferation
In addition to the up-regulation of cell cycle regulators CDK1 and CDK2 in adult 
pre-BII large cells, Ki67 was up-regulated in adult immature-B cells (Figure 7A). Adults 
and children both showed strong up-regulation in their pre-BII cells of this marker 
for cells that are in cycle.38 However, immature-B cells of adults showed significantly 
higher expression of Ki67 than children (2.6 fold up, p= 3 x 10-4).39 The up-regulation of 
proliferation markers could suggest that adult precursor-B cell undergo proliferation to 
compensate for reduced B-cell production. To study this, we determined the replication 
history of small pre-BII and immature-B cells of children and adults using the KREC 
assay.27 In line with previous observations,27 we did not observe any cell divisions in 
precursor-B cells of children (Figure 7B). Furthermore, pre-BII small and immature-B 
cells of adults did not show signs of proliferation either. Thus, despite the differences in 
gene expression levels of Ki67, adult immature-B cells do not undergo proliferation to 
compensate for the reduced production of B-cell progenitors.
A B
0
100
200
300
400
500
600
700
800
ProB PreBI PreBII L  PreBII s  Immature B
M
ea
n 
si
gn
al
Adult Ki67
Child Ki67
*
-1
0
1
2
3
4
5
ce
ll 
di
vi
si
on
s
 PreBII s  Immature B
Child ChildAdult Adult
Figure 7. Proliferation in precursor-B cells from children and adults. (A) Expression levels of Ki67 mRNA 
in the 5 precursor-B-cell subsets. Significant differences in expression between children and adults for a specific 
stage are indicated with an asterisk. (B) The replication history of pre-BII and immature-B cells from children 
and adults determined with the KREC assay. Each grey dot represents the replication history in a sorted subset 
from a single donor. Red horizontal lines represent median distances.  
DISCUSSION
B-cell precursors are committed to differentiation or apoptosis. Here, we character-
ized the differences in transcriptional activity of precursor-B cells in adults and children, 
and identified differences in V(D)J recombination factors, ID2, and cell cycle genes that 
could underlie the marked reduction in the human precursor-B-cell compartment occur-
ring with age.4,5 Functional analysis of potentially involved mechanisms indicated that 
up-regulation of ID2 in adults inhibited E2A-mediated Ig locus contraction to reduce 
efficient V(D)J recombination and precursor-B-cell differentiation.
IV. Increased ID2 Levels In Adult Precursor-B Cells As Compared With Children Is Associated With 
Impaired Ig Locus Contraction And Decreased Bone Marrow Output
114
Our cellular analysis of precursor-B cells in BM revealed a 67% decrease in their 
absolute number in adults as compared to 2-year-old children. This decrease in BM 
precursor-B-cell numbers corresponded to the decline in the absolute size of the B-cell 
population in peripheral blood of adults.40 Importantly, the relative composition of the 
various subsets was unchanged with age and in accordance with previous reports from 
both humans and mice.5,40,41 Thus, the reduced output from BM seemed the result of 
lower numbers of all B-cell progenitors and not restricted to a specific differentiation 
stage.
The issue whether RAG1 and RAG2 expression decrease with age in precursor-B-cell 
subsets has been explored in several studies in mice,15,41-43 but very few reports exist from 
humans. To our knowledge only one human study44 has reported, based on RT-PCR and 
agarose gel electrophoresis, that there was no change in transcription of RAG1 and RAG2 
in precursor-B cells from fetal and adult BM. This contrasts more recent experimental 
studies in mice,15,42 adopting transgenic and knock-in RAG2 reporter animals showing 
that the frequency of pro-B cells expressing RAG2 was significantly lower in aged mice 
as compared to young. We found a 50% higher (p = 0.03) RAG1 expression in pediatric 
pro-B cells as compared to adults; a result which should be confirmed due to the pres-
ent small cohort size. Of other transcripts involved in the V(D)J rearrangement process: 
DNA-PKcs, Ku80 and XRCC4 showed a 50-70% higher expression (p = 0.01 – 0.03) 
in pre-BI cells in children as compared to adults. TdT, on the other hand, was 3.2-
fold up-regulated (p = 0.02) in adult immature-B cells. Despite these differences in gene 
expression levels, we did not observe differences in IGH and IGK gene rearrangements 
regarding N-nucleotides, P-nucleotides and deletions between children and adults. These 
suggest that processing and repair of RAG-induced dsDNA breaks is not affected by age. 
Still, the reduced RAG1 expression levels in adults could negatively affect the efficiency 
of Ig gene rearrangements. Because reduced RAG function is not apparent from junction 
analysis [reviewed in 45], this may contribute to the lower output of precursor-B cells from 
normal BM with age.
We then analyzed transcriptional activity of genes required for commitment and 
differentiation of precursor-B cells. The most striking finding was the temporal increase 
in ID2 mRNA levels restricted to pre-BII large cells in adults, and only once reported 
previously in mice.46 As an E2A inhibitory protein, ID2 is assumed to have a central role 
in modulating the E2A dependent transcriptional regulatory networks, and hence inhibit 
B-cell lineage commitment and differentiation.47,48 ID2 has been shown to negatively 
regulate B-cell differentiation in  mice spleen,49,50 and knock-down by shRNA in hema-
topoietic progenitor cells promoted B-cell differentiation and induction of B-cell lineage 
specific genes.51 In aged, but not in young murine B-cell precursors, reduced E2A protein 
expression was seen in the presence of maintained E2A mRNA levels.52-54 The reduced 
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E2A protein levels in aged murine precursor-B cells seemed to be due to accelerated 
degradation, since it was effectively blocked by proteasome inhibitors indicating involve-
ment of the ubiquitin/proteasome pathway.55  Frasca et al.16 were unable to detect ID2 
protein using in vitro expanded aged and young precursor-B cells, but found E2A protein 
levels decreased in adults. We found no age-related decrease in E2A mRNA expression 
in any precursor-B subsets in agreement with the situation in mice.16 Notably, the above 
referred study16 analyzed only pro-B/early pre-B cells for ID2 expression and no further 
maturation stages. In our study, a striking age-related difference in ID2 expression was 
seen first in pre-BII large cells – a subpopulation more mature than the subsets analyzed 
in mice. We also found a smaller, but significantly higher expression in adult pro-B cells 
– a difference that probably would have been blurred if pro-B and pre-BI subsets had 
been analyzed together.16 Another difference between the studies by Frasca et al16 and 
our study was that they analyzed ID2 protein levels in cultured precursor-B cells while 
we analyzed ID2 mRNA expression in freshly isolated precursor-B cells. Bordon et al46 
in contrast, demonstrated fluctuations in ID2 mRNA expression during precursor-B-cell 
differentiation in adult wild type and transgenic mice overexpressing POU2AF1 (OBF1), 
concordant with our findings in humans. 
To study whether the high ID2 gene expression levels indeed negatively affected E2A 
function, we analyzed one of the processes in which E2A is involved: Ig locus contraction. 
Indeed, we observed decreased contraction of IGH in pre-BI and small pre-BII cells in 
adults. These subsets were analyzed, because they are poised to undergo complete Ig gene 
rearrangements.21 ID2 transcripts were significantly higher in adults in pro-B and large 
pre-BII cells, the stages that directly precede the subsets analyzed for Ig locus contraction. 
Still, high ID2 transcript levels are likely to affect the subsequent differentiation stage, 
because the resulting protein products function to decrease E2A activity. Because E2A 
transcript levels are not up-regulated with age, the effect of high ID2 transcripts is not 
compensated for. Thus, in addition to reduced RAG activity, the efficiency of V(D)J 
recombination in adult precursor-B cells is further reduced by ID2 inhibition of Ig locus 
contraction.
With increased ID2 mRNA expression in adult pre-BII large cells, we identified a 
concomitant up-regulation of transcripts involved in cell cycle progression and control as 
previously reported.56,57 As pre-BII large cells are characterized by a transient proliferative 
burst,21 we observed a similar transcriptional activity in this subset in children and adults 
by using Ki67 as a proliferation marker. On the other hand, there was a clear up-regula-
tion of cell cycle and checkpoint associated genes in the adult subset, concordant with a 
more stringent cell cycle regulation and control. 
 Only at the immature-B cell stage we found differential expression of the mitotic 
marker Ki67 with a 2.6-fold (p = 3.4 x 10-4) higher expression in adults indicating a 
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higher fraction of cycling cells. In 2005, Cancro8 suggested a decreased turnover rate in 
the immature-B-cell subset in adult mice as a homeostatic mechanism counteracting the 
reduced production rate. Our expression data, however, rather suggest an expansion with 
age of the immature-B-cell subset, possibly to compensate for reduced production rate. 
This was not supported by our studies on the relative composition of the immature-B-cell 
subset and of the replication history of pre-BII small and immature-B cells. Thus, the 
increased levels of Ki67 indicate that more cells are in cell cycle, but these cells do not 
show signs of (extensive) proliferation to compensate for the reduced production of B 
cells in adults.
In conclusion, the human precursor-B-cell pool, although smaller, does not show 
major compositional variations with age, and comprises dynamic subpopulations held at 
steady state to support a lifelong production of B lymphocytes. Elevated mRNA levels of 
the differentiation inhibitory molecule ID2 along with a network of transcripts related 
to cell cycle checkpoint control in adult pre-BII large cells, indicate restriction in pre-
cursor-B-cell differentiation. Moreover, the increased ID2 levels are a likely cause for 
the observed impaired Ig locus contraction due to limited E2A function. These findings 
demonstrate distinct regulatory mechanisms in B-cell differentiation between adults and 
children with a central role for transcriptional regulation of ID2.
MATERIALS AND METHODS
Bone marrow samples
We obtained BM samples from healthy children aged 18 ± 2 months (mean ± range) 
and healthy adults aged 50 ± 5 years (mean ± range). The children were eligible for 
minor surgery, the adults for elective orthopaedic surgery. Both groups were haemato-
logically healthy, and none of the middle-aged adults had active inflammatory disease 
requiring regular anti-inflammatory medication. Written informed consent was obtained 
using protocols approved by the Regional Medical Research Ethics Committee of Eastern 
Norway (REK Øst, Accession no. 473-02132) (https://helseforskning.etikkom.no/). The 
study was performed according to the Norwegian Health Regulations.
Isolation of CD10 positive cells  
BM aspirates (~20 ml from children and 120 ml from adults) were subjected to Ficoll 
density gradient centrifugation (Ficoll-Paque PLUS). CD10+ precursor-B cells were pos-
itively selected using streptavidin coated Dynabeads FlowComp Flexi (Invitrogen Dynal 
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AS, Oslo, Norway) and biotin-labeled CD10 antibody (SN5c, Abcam Inc. Cambridge, 
MA, USA). Subsequently, five precursor-B-cell subsets were purified from single indi-
viduals on a FACSAria cell sorter (BD Biosciences) (Figure 1A) after staining with the 
following antibodies: IgM-FITC (G20-127), CD19-APC (HIB19), CD20-PE (2H7), 
CD22-APC (IS7), CD123-PE (6H6), CD10-PE-Cy7 (HI10a) and CD34-PerCP 
(8G12). The membrane marker CD123 was used in combination with CD22 to distin-
guish precursor-B cells from basophilic progenitor cells (CD123+), which also appear in 
the lymphogate. 
RNA isolation
Total RNA was extracted and purified from each precursor-B-cell subset using the 
miRNeasy Mini Kit (Qiagen) and Phase Lock Gel Heavy (5 PRIME GmbH, Hamburg, 
Germany). RNA was quantified with a NanoDrop ND-1000 Spectrophotometer (Saveen 
Werner, Malmö, Sweden), and in case of concentrations using the RiboGreen method 
(Invitrogen, Eugene, OR, USA). Quality was assessed with Agilent 2100 Bioanalyzer 
using either the Agilent RNA 6000 Nano or Pico Kit (Agilent Technologies, Palo Alto, 
CA, USA) depending on sample concentration. The samples concentrations ranged from 
3.9 to 149.5 ng/µl and from 6.4 to 9.9 (mean 8.4, n = 39) for Bioanalyzer RIN indicating 
high RNA purity and integrity.
 
Microarray analyses and statistical analysis of data
Microarray analyses were performed on subsets from single individuals using the 
GeneChip Human Exon 1.0 (Affymetrix, Santa Clara, CA, USA). 5 ng total RNA 
was used to generate cDNA with the Ovation Pico WTA System protocol (NuGEN). 
MinElute Spin Columns (Qiagen) were used for purification of amplified cDNA. Sense 
strand cDNA was generated from 3 µg cDNA with the WT-Ovation Exon Module 
Version 1.0 (NuGEN) according to the manufacturers’ protocols for whole genome gene 
expression analysis. The resulting sense strand cDNA was fragmented and biotinylated 
using the Encore Biotin Module (NuGEN). The labeled cDNA was hybridized on the 
array, washed, and stained. The arrays were scanned using the Affymetrix Gene Chip 
Scanner 3000 7G. The scanned images were processed using the AGCC (Affymetrix 
GeneChip Command Console) Software and the CEL files were imported into Partek 
Genomics Suite software (Partek, Inc. MO, USA). The Robust Multichip Analysis (RMA) 
algorithm was applied for generation of signal values and normalization. On each array, 
21,989 transcripts could be detected. Transcripts were analyzed in core mode (see www.
affymetrix.com) using signal values of less than 22.6 across arrays as threshold to filter 
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for low and non-expressed genes yielding 15,830 expressed genes. For expression com-
parisons of different groups, profiles were compared using a one-way ANOVA model. 
The results were expressed as fold change. Gene lists were generated with the criteria of 
fold change ≥ 2 and p-values < 0.05. For analysis of genes involved in the V(D)J process 
and in B-cell commitment and differentiation, fold change less than |2| was shown. The 
complete gene expression material is available online at ArrayExpress (http://www.ebi.
ac.uk/arrayexpress/) with accession number E-MTAB-1422.
Ingenuity Pathway Analysis (IPA)
Gene networks and canonical pathways representing key genes were identified using 
Ingenuity Pathways Analysis (IPA) (www.ingenuity.com). Briefly, the data set contain-
ing gene identifiers and corresponding fold changes and p-values was uploaded into the 
web-delivered application and each gene identifier was mapped to its corresponding gene 
object in The Ingenuity Pathway Analysis (IPA) software (www.ingenuity.com). The 
functional analysis identified the biological functions and/or diseases that were most sig-
nificant to the data sets. Fisher’s exact test was performed to calculate a p-value assigning 
probability to each biological function.
DNA probe preparation and 3D immunofluorescence in situ hybridization 
(FISH)
3D DNA FISH was performed as described previously23,24 with fosmid clones 
761A10 and 3777B2 (BACPAC Resources, Oakland, CA), BAC clones 47P23, 101G24 
(BACPAC Resources) and 3087C18 (Open Biosystems, Huntsville, AL) recognizing 
regions within the human IGH locus. Probes were either directly labeled with Chromatide 
Alexa Fluor 488-5 dUTP or Chromatide Alexa Fluor 568-5 dUTP (Invitrogen) using 
Nick Translation Mix (Roche Diagnostics GmbH); or they were indirectly labeled using 
DIG-Nick Translation Mix (Roche Diagnostics GmbH). Just prior to use, the probes 
were precipitated and a hybridization cocktail was prepared containing 600 ng of each 
labeled probe, 4 µg of human Cot-1 DNA (Invitrogen), 5 µg of salmon sperm DNA 
dissolved in 2×SSC, 50% formamide, 10% dextran sulfate. The probes were denatured at 
75°C for 5 min prior to hybridization.
Approximately 100 µl of a 1×106 cells/ml suspension of freshly sorted cells was 
directly attached to poly–L-lysine–coated coverslips. The cells were fixed in 4% parafor-
maldehyde, and permeabilized in a PBS, 0.1% Triton X-100, 0.1% saponin solutions and 
subjected to liquid nitrogen immersion following incubation in PBS wih 20% glycerol. 
The nuclear membranes were permeabilized in PBS, 0.5% Triton X-100, 0.5% saponin 
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prior to hybridization with the DNA probe cocktail for 5 min in a HYBrite machine 
at 75ºC. The coverslips were sealed with nail polish and incubated for 48hr at 37°C. 
Subsequently, the coverslips were washed and incubated with Cy5-conjugated mouse 
anti-DIG antibodies (Jackson Immunoresearch) to detect dig-labeled probes Finally, 
the coverslips were washed and mounted on slides with 10 µl of Prolong gold anti-fade 
reagent (Invitrogen) and sealed with nail polish.
Image acquisition, distance calculations and statistics
Pictures were captured with a Leica SP5 confocal microscope (Leica Microsystems). 
Using a 63× lens (NA 1.4), we acquired images of ~70 serial optical sections spaced by 
0.15 µm. The data sets were deconvolved and analyzed with Huygens Professional soft-
ware (Scientific Volume Imaging, Hilversum, the Netherlands). The 3D coordinates of 
the center of mass of each probe were input into Microsoft Excel, and the distances sep-
arating each probe were calculated using the equation: √(Xa−Xb)2+(Ya−Yb)2+(Za−Zb)2, 
where X, Y, Z are the coordinates of object a or b. Differences in distances between each 
two groups of cells were performed with the non-parametric Mann-Whitney test using 
Graphpad Prism version 5.0.
Quantitative RT-PCR for key differentially expressed transcripts
TaqMan Gene Expression Assays (384-well plates) (Applied Biosystems) were used 
for quantitative PCR for selected differentially expressed genes. The arrays were run on 
the ViiA 7 Real-time PCR System (Applied Biosystems). The relative mRNA expression 
was calculated with the Comparative Ct method (fold change = 2-ΔΔCt) using B2M (Beta 
2 microglobulin) as endogenous control.25 Additional primer/probe sets were used for 
ID2 that covered the 5´ end of the transcript (Table S1); two sets for exon I, and one set 
for exon II, because the custom ID2 assay covered only the exon II and III boundary, 
which was partially outside the protein coding area.
IGH and IGK junctional region analysis
DNA was isolated from sorted pre-BI and small pre-BII cells of healthy children or 
healthy adults using a GenElute genomic DNA extraction kit (Sigma Aldrich, St. Louis, 
MO). Multiplex PCR was performed to amplify complete IGH gene rearrangements 
from pre-BI cells and IGK gene rearrangements from small pre-BII cells with V sub-
group-specific forward primers and a consensus J primer, and cloned into the pGEM-T 
Easy vector (Promega Benelux BV, Leiden, The Netherlands).21 Individual clones were 
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sequenced on an ABI Prism 3031 XL fluorescent sequencer (Applied Biosystems, 
Carlsbad, CA). The size and composition of the junctional region with regards to dele-
tions, P- and N-nucleotdes were analyzed using the international ImMunoGeneTics 
(IMGT) information system (http://imgt.cines.fr/).26 Statistical analyses were performed 
using the Mann-Whitney test.
Replication history analysis using the KREC assay
The replication history of sorted precursor-B-cell subsets was determined with the 
Kappa-deleting Recombination Excision Circles (KREC) assay as described previously.27 
Briefly, the amounts of coding and signal joints of the IGK-deleting rearrangement were 
measured by RQ-PCR in DNA from sorted precursor-B-cell populations on an ABI 
Prism 7000 (Applied Biosystems). Signal joints, but not coding joints are diluted two-
fold with every cell division.27 To measure the number of cell divisions undergone by 
each population, we calculated the ratio between the number of coding joints and signal 
joints. The previously established control cell line U698 DB01 (InVivoScribe) contains 
one coding and one signal joint per genome and was used to correct for minor differences 
in efficiency of both RQ-PCR assays.
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ABSTRACT
B cells with rearranged immunoglobulin (Ig) genes appear already during fetal devel-
opment. Still, newborns are unable to mount antibody responses towards certain antigens, 
potentially caused by a restricted Ig gene repertoire. To study the nature of this restricted 
repertoire, we analyzed precursor-B cells and Ig gene rearrangements in fetal liver, fetal 
bone marrow (BM), and pediatric BM. Fetal liver and BM contained precursor-B cells 
with a relative increase of the early pro-B and pre-BI stages and normal contraction of the 
IGH locus. Complete IGH gene rearrangements showed diverse V, D and J gene usage, 
but the junctional regions were short due to fewer N-nucleotides; this was also observed 
in IGH rearrangements of precursor-B-cell leukemia cells of presumed prenatal origin. 
Fetal pro-B and pre-BI cells expressed less TdT, XRCC4, ATM, IL-7Rα and FLT3, which 
might contribute to the different Ig repertoire. Indeed, progenitor-B cells from IL7Rα-
deficient patients had low TdT expression and fewer N-nucleotides in Dh-Jh junctions 
than controls. Our data indicate that fetal precursor-B cells form a diverse but skewed Ig 
repertoire, likely due to decreased IL-7R signaling and subsequent altered IGH junction 
processing. These new insights provide a better understanding of the build-up of adaptive 
immunity in the developing fetus.
INTRODUCTION
During the second trimester of human fetal development, B cells are generated in the 
liver and bone marrow (BM), providing the neonate with a diverse immunoglobulin (Ig) 
repertoire. Still, antibody responses towards certain antigens (e.g. tetanus or diphtheria 
toxoid) are impaired in neonates, and the ability to respond is only acquired with age.1-3 
Various processes can underlie this initial inability to mount such responses, including a 
“pre-mature” diversity of the Ig repertoire.  
B-cell development has been extensively studied in human postnatal BM, where 5 
distinct stages can be identified. In the early pro-B and pre-BI cell stages, D to J gene rear-
rangements and V to DJ gene rearrangements are induced in the Ig heavy chain (IGH) 
locus.4, 5 Functional IgH proteins are expressed on the membrane together with surrogate 
light chain molecules VpreB and λ14.1 to induce proliferation and further differentiation 
into pre-BII large cells.6-8 Subsequently, the cells induce V to J gene rearrangements in 
their Ig light chain loci (IGK or IGL) as pre-B-II small cells and the complete Ig molecule 
is selected for functionality at the immature-B cell stage prior to migration out of the 
BM.6, 8 The lymphoid-specific recombination activating gene proteins 1 and 2 (Rag1 and 
Rag2) are crucial for V(D)J recombination of both IGH and Ig light chain genes through 
induction of double stranded DNA breaks.9, 10 The Rag-induced double stranded DNA 
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breaks activate cell cycle checkpoint protein ATM and the non-homologous end joining 
(NHEJ) pathway,11-13 which enhances diversity in the junctional region that encodes 
the antigen-binding complementary determining region (CDR)3. A central player is 
the lymphoid-specific deoxynucleotidyl transferase protein (TdT) that randomly adds 
N-nucleotides to the junction.14-16 
Several studies have addressed the Ig gene repertoire in human fetuses, and reported 
restricted repertoires due to shorter CDR3 regions in IGH. This restriction was the 
result of limited N-nucleotides in the junctions and more frequent usage of the rela-
tively short Dh7-27, Jh3 and Jh4 genes.1, 2, 17-24 Furthermore, mouse embryos only used 
Dh-proximal Vh genes, which dramatically narrowed the Ig combinatorial repertoire.17, 
18, 21, 22 Such restricted use was not observed in human fetuses, although the Dh-proximal 
Vh6-1 and Vh1-2 genes seemed more frequently used than in cord blood.1, 25-28 Still, 
studies in human fetuses have been based on limited sequences and mostly in functional 
and thus positively selected rearrangements. Paucity in N-nucleotide additions has also 
been found in incomplete and thus unselected D-J gene junctions,19 suggestive of altered 
junction formation. These observations are supported by analysis of a restricted set of 
B-cell precursor acute lymphoblastic leukemia (BCP-ALL) in children ≤ 3 year old. 
These ALL from presumed fetal origin showed fewer N-nucleotide additions in IGH 
gene rearrangements than those in older children.29 Nowadays, BCP-ALL are classified 
based on chromosomal abnormalities. Subgroups with MLL-rearrangements or with 
TEL-AML1 fusion genes have been reported to originate from fetal B-cell progenitors. 
MLL-rearranged BCP-ALL is generally associated with a poor outcome and typically is 
diagnosed early in infanthood, whereas TEL-AML1 positive BCP-ALL is associated with 
good prognosis and has a peak incidence around 4 years of age. Both BCP-ALL subtypes 
have been proven to originate in utero based on studies in identical twins and analysis of 
Guthrie cards.29-32 Previous studies have shown typical Ig rearrangement patterns in both 
BCP-ALL subtype,33, 34 but it is currently not known how the IGH gene repertoires of 
these subgroups relate to others and to their normal counterparts. Thus, the real extent 
of a restricted Ig gene repertoire in normal and malignant fetal B-cell progenitors, and 
the underlying mechanisms for the reported differences with postnatal B cells remains 
unclear. 
We here studied the differences in formation of the Ig repertoire between fetal and 
pediatric B-cell precursors at 4 levels, i.e. cellular composition of the precursor-B-cell 
compartment in BM, epigenetic organization of the IGH locus, genetic composition of 
Ig gene rearrangements, and expression of factors involved in V(D)J recombination. With 
this approach, we could demonstrate in both normal and malignant fetal B-cell progen-
itors that the skewed V, D, and J gene usage and the paucity of N-nucleotide additions 
in IGH gene rearrangements resulted from altered V(D)J recombination rather that Ig 
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repertoire selection. These rearrangements were formed in a different molecular environ-
ment with reduced expression of XRCC4, TdT and ATM, as well as IL7Rα and FLT3.
RESULTS
Skewed Ig repertoire generation in fetal B-cell precursors 
To study the Ig repertoire formation in fetal development, we purified B-cell sub-
sets from 2nd trimester fetal BM and fetal liver, as well as from neonatal cord blood 
and pediatric BM. In line with previous observations,1, 19, 20, 23-26, 28, 35 mature B cells 
(CD19+CD20+CD10-IgM+IgD+) in fetal BM showed more frequent usage of Vh1-2, 
Dh7-27, Jh2 and Jh3 genes than pediatric B cells (Figure S1). This was typical for 
early development, because the IGH repertoire in B cells from neonatal cord blood was 
more similar to pediatric than to fetal B cells. Moreover, CD19+CD34+CD10+ pre-BI 
cells derived from either fetal liver or fetal BM already contained the same skewed IGH 
repertoire (Figure 1A-C). These pre-BI cells initiate Vh to DJh gene rearrangements, 
but do not yet express cytoplasmic IgM and are not selected for functional IGH genes.36 
This was supported by analysis of only the out-of-frame and thus unproductive IGH gene 
rearrangements (Figure S2A-C). Approximately 1/3rd of the pre-BI cells carried in-frame 
and thereby potentially productive IGH gene rearrangements (31% in fetal liver, 29% in 
fetal BM and 33% in pediatric BM). Thus, fetal B-cell progenitors are generated with a 
skewed IGH gene repertoire, which is similar between fetal liver and fetal BM, and does 
not seem to be affected by selection processes. 
In contrast to IGH, the IGK gene repertoire was not different between fetal and pedi-
atric mature B cells nor small pre-B-II cells (Figures S3, S4). Because the vast majority of 
IGK gene rearrangements are formed in small pre-B-II cells, the formation and selection 
processes for the IGK repertoire do not seem to differ between pediatric and fetal B-cell 
development.
Short Dh genes and fewer N-nucleotides in fetal B cells
In addition to the skewed V, D and J gene usage, IGH gene rearrangements in fetal 
naive mature B cells carried shorter IgH-CDR3 than pediatric B cells (Figure 2A-B).1, 2, 
19, 20, 24, 38 This was mostly the result of fewer N-nucleotide additions in both the Dh-Jh 
and Vh-DJh junctions. The IgH-CDR3 of B cells from neonatal cord blood were inter-
mediate in size between fetal and pediatric B cells with slightly more N-nucleotides in the 
Vh-DJh junction than fetal B cells. Both in fetal and in pediatric tissue, the IgH-CDR3 
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regions in pre-BI cells were larger than in naive mature B cells. Still, fetal pre-BI carried 
shorter IgH-CDR3 with fewer N-nucleotides than their pediatric counterparts (Figure 
2B). 
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Figure 2. Fetal B cells have short IgH-CDR3 regions and few N-nucleotides. (A) Scatter plots showing the 
CDR3 length in nucleotides of IGH and IGK. Red horizontal lines represent median values. (B) Bar graphs 
showing the median numbers of N-nucleotides in Dh-Jh, Vh-DJh and Vκ-Jκ junctions with inter-quartile 
range. Numbers in brackets indicate the amount of analyzed sequences. Both in-frame and out-of-frame rear-
rangements were included in the analysis of precursor-B cells, whereas only in-frame functional rearrangements 
were included for the analysis of naive mature-B cells. The nonparametric Mann-Whitney U test was used to 
calculate significance levels. *, p<.05; **, p<.01; ***, p<.001; ****, p<.0001. 
On top of junctional region processing, the choice of Dh affects the IgH-CDR3 size, 
because Dh genes differ greatly in size. Indeed, the Dh7-27 gene that was abundantly 
found in fetal B cells is the shortest of all D genes. In addition, the large Dh genes were 
less frequently used in fetal than in pediatric B cells (Figure S5A-B). Still, as previously 
suggested,19 N-nucleotide additions seem dependent on Dh gene usage. The incom-
plete Dh-Jh rearrangements involving the short Dh7-27 carried more N-nucleotides 
than rearrangements involving any other Dh gene families (Figure S5C). Finally, the 
shorter IgH-CDR3 in naive mature B cells than in pre-BI cells (Figure 2) was associated 
with selection against long Dh genes. Thus, the IgH-CDR3 size seems tightly regulated 
through N-nucleotide additions and Dh gene usage, which differ between fetal and pedi-
atric B-cell progenitors. 
In contrast to IGH, the IGK locus does not contain D genes, and Vκ-Jκ gene rear-
rangements hardly contain any N-nucleotide, thus rendering small CDR3 regions. 
Indeed, the Igκ-CDR3 regions of the fetal, neonatal and pediatric B-cell subsets were 
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much smaller than IgH-CDR3 and did not show overt differences between any of the 
subsets (Figure 2A). Although the pediatric naive mature B cells tended to have more 
N-nucleotide additions (Figure 2B), there was no indication of a different Igκ-CDR3 
repertoire in fetus. 
B cells in BCP-ALL of presumed fetal origin show fetal Ig repertoire 
characteristics
Our data indicate that normal B-cell precursors from fetal tissue differ from chil-
dren. To study whether these cellular and molecular differences were retained in a disease 
model, we analyzed the IGH gene repertoire in BCP-ALL patients. BCP-ALL can be 
classified based on chromosomal aberrations. Of these subgroups, BCP-ALL with MLL 
rearrangements or with TEL-AML1 fusion genes can originate in utero.29-32 We there-
fore studied the IGH gene repertoire of these presumed fetal BCP-ALL subgroups and 
compared with the rest, i.e., subgroups containing E2A-PBX translocations, BCR-ABL 
translocations, hyperdiploidy or none of these abnormalities. The average age in years 
at diagnosis was 0.65 ± 0.68 for MLL rearranged BCP-ALL and 4.85 ± 2.95 for TEL-
AML1-positive BCP-ALL, while the non-fetal origin group aged 6.39 ± 4.18. 
The BCP-ALL of presumed fetal origin indeed showed increased usage of the 
Dh-proximal Vh6-1 gene, similar to fetal B cells (Figure 3A). In contrast, the usage 
of Dh and Jh genes did not differ between the BCP-ALL patients (Figure 3B-C). Still, 
BCP-ALL of presumed fetal origin showed a trend to less frequently use long Dh genes 
than the other BCP-ALL (Figures S5A, S6A), and the IgH-CDR3 length was shorter 
in BCP-ALL of presumed fetal origin. The latter was mostly due to significantly fewer 
N-nucleotides in Dh-Jh junctions (Figure 3D-E), and equally apparent in BCP-ALL 
with MLL-rearrangements and with TEL-AML1 translocations (Figure S6B-C). 
Concluding, these observations in BCP-ALL confirm and extend our results that the 
IGH gene repertoire differences between fetus and child are the result of altered V(D)J 
recombination processes in early progenitors rather than Ig repertoire selection processes 
in mature B cells. 
Enrichment of early B-cell precursors in fetal liver and BM
To study the nature of the skewed IGH gene repertoire generation in prenatal devel-
opment, we first analyzed the precursor-B cells in fetal liver and BM in more detail by 
flow cytometry. The relative distributions of the five major precursor-B-cell subsets in 
these fetal tissues were determined using a panel of membrane and intracellular markers 
and compared with pediatric BM (Figure 4A).39, 40 The frequencies of the pro-B, pre-BII 
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large and pre-BII small within the total CD22+ B-cell precursors were similar between 
fetal liver and fetal BM. Fetal livers contained on average less pre-BI and more imma-
ture-B cells, but these differences were not significant. Both fetal tissues contained more 
CD34+ precursors than pediatric BM (Figure 4B). This was mostly the result of increased 
pro-B cell frequencies (~12% vs 4%), and was to the expense of reduced pre-BII large 
frequencies (~10% vs 20%). 
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Figure 4. Relative increase of early precursor-B cells in fetus. (A) Gating strategy to define 5 precursor B-cell 
subsets according to previous studies.36, 39, 40 (B) Relative distributions of the 5 precursor-B-cell subsets in fetal 
liver, fetal BM and pediatric BM. The nonparametric Mann-Whitney U test was used to calculate significance 
levels between fetal and pediatric paired populations. *, p<0.05; ****, p<0.0001
IGH locus contraction in fetal precursor-B cells
The skewed Ig repertoire formation and developmental block observed in fetus at 
pro-B/pre-BI stage could potentially result from inefficiently formed IGH gene rear-
rangements. To study whether the IGH topology provided optimal conditions for V(D)J 
recombination, we measured  spatial distances between distal Vh, proximal Vh, and Ch 
regions with 3D DNA FISH in precursor-B cells of fetal and pediatric BM (Figure 5A). 
In line with our previous studies,41, 42 spatial distances between all three DNA regions 
were short in pediatric pre-BI cells and slightly, yet significantly, larger in pediatric pre-
BII small cells (Figure 5B-C). IGH locus contraction did not seem defective in fetal 
pre-BI cells, as all spatial distances between Ch and both Vh regions were similarly small 
and between both Vh regions even smaller than in pediatric pre-BI cells. IGH locus 
contraction is therefore likely to facilitate rearrangement of both proximal and distal Vh 
gene rearrangements similarly between fetal and pediatric B-cell precursors. Still, it does 
not provide further insight into the relative abundance of Vh1-2 in the fetal IGH gene 
repertoire. 
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Figure 5. IGH locus contraction in fetal and pediatric B-cell precursors. (A) Schematic representation of 
the human IGH locus including the combinations of bacterial artificial chromosome clones that were used 
as three-dimensional immunofluorescence in situ hybridization (3D FISH) probes.41, 42 (B) Scatter plots of 
distances separating distal Vh, proximal Vh, and Ch regions in pre-BI and pre-BII small cells purified from 
fetal and pediatric BM. For each condition, at least 200 alleles from 2 donors were analyzed. Red horizontal 
lines represent median distances. The nonparametric Mann–Whitney U test was used to calculate significance 
levels. *, p<0.05; **, p<0.01; ***, p<0.001. (C) Representative fluorescence microscopy images of IGH loci in 
precursor B cell subsets
Mechanisms causing formation of skewed Ig repertoire in fetuses
To delve deeper into the mechanism responsible for generation of the different Ig 
repertoires between fetal and pediatric early B-cell progenitors, we performed genome-
wide gene expression profiling of fetal and childhood B-cell progenitors (Figure S7A). 
The analysis was performed in fetal pro-B and pre-BI cells, which were compared to 
previously published childhood subsets,41 and was focused on genes important for B-cell 
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Figure 6. (A) TdT, (B) IL-7Rα, (C) Ki-67, and (D) FLT3 protein expression levels in B-cell progenitors. Graphs 
represent merged data from 3 fetal BM and 3 pediatric BM samples as determined by flow cytometry analysis. 
Immature-B cells of pediatric BM were included as a negative control. The median fluorescence intensities 
(MFI) for each subset are indicated in each plot.
139
Formation of the Immunoglobulin Repertoire in Precursor-B-cell Development
A pro-B pre-BI pre-BII
TdT
D
en
si
ty
0 103 104 105
B
Ki-67
D
en
si
ty
IL-7Rα
D
en
si
ty
fetus
child
immature-B
C
0 103 104 105 0 103 104 105
MFI:MFI: MFI:
0 103 104 105 0 103 104 105 0 103 104 105
0 103 104 105 0 103 104 105 0 103 104 105
immature-B        113 
fetus         649
child         524
immature-B        389 
fetus         766
child         676
immature-B        389 
MFI:MFI: MFI:
MFI:MFI: MFI:
fetus         608
child         983
immature-B        389 
fetus         320
child         475
immature-B        160 
fetus         345
child         211
immature-B        160 
fetus         476
child         568
immature-B        160 
fetus
child
immature-B
fetus
child
immature-B
fetus        2903
immature-B        113 child      10830immature-B        113 
FLT3
D
en
si
ty
MFI:
0 103 104 105102 0 103 104 105102 0 103 104 105102
D
fetus
child
immature-B
fetus          119
child          220
immature-B           35
fetus         37
child         44
immature-B         35
fetus         24
child         40
immature-B         35
child  64%
fetus  44%
fetus        3055                     child     11077
f etus         125
child         221
Figure 6. (Legend at the bottom of the previous page)
V.  Altered V(D)J Recombination Underlies The Skewed Immunoglobulin Repertoires In Normal And 
Malignant B-Cell Precursors From Fetal Origin
140
development and V(D)J recombination to provide insights into the molecular environ-
ment in which Ig gene rearrangements are formed. 
The expression of RAG1 and RAG2 was similar between fetus and child for both 
pro-B and pre-BI cells. However, gene encoding XRCC4 that is part of the NHEJ path-
way,13 was downregulated in fetus (Table 1 and Figure S7B). XRCC4 forms a protein 
complex with TdT, the enzyme responsible for N-nucleotide additions,  and it was shown 
that XRCC4 promotes N-nucleotides addition by TdT.43 Importantly, we also observed 
decreased expression of DNTT, which encodes TdT (Table 1). Additional intracellu-
lar TdT staining by flow cytometry revealed that these decreased transcripts resulted in 
decreased protein levels in both pro-B and pre-BI in fetuses (Figure 6A). Thus, fetal 
B-cell precursors differ from their pediatric counterparts in the repair of Rag-induced 
DNA breaks, and especially in the levels of XRCC4 and TdT expression.  
The genes encoding key B-cell transcription factors E2A and PAX5 were highly 
expressed in fetal progenitors, as was FOXO1, which regulates RAG gene expression.44, 
45 This is in line with the diverse IGH gene repertoire and normal RAG transcripts in 
fetus. Furthermore, the genes encoding pre-BCR signaling components were normally 
expressed and do not seem rate-limiting for differentiation into pre-BII cells. ATM 
transcripts were downregulated in fetuses (Table 1 and Figure S7B). Because ATM is 
important for cell cycle arrest and recruitment of NHEJ factors to DNA breaks,11, 12, 46, 47 
this could affect Rag-induced break repair and a relative increase of early precursor-B cells 
due to delayed formation of a functional IgH (Figure 4B) 
IL-7R signaling affects IGH gene rearrangements and inhibits IGK gene rearrange-
ments.42, 48, 49 Fetal pro-B cells showed low expression of IL7Rα transcripts and membrane 
protein (Table 1 and Figure 6B). In addition, transcripts encoding the IL-7R signaling 
molecule JAK2 were reduced. Furthermore, transcripts of ID2 and germline IGK, which 
are suppressed by IL-7R signaling,50-52 were upregulated (Table 1). The decreased IL-7Rα 
expression did not seem to affect proliferation as transcripts for nuclear Ki-67 levels were 
not different between fetuses and children (Table 1 and Figure 6C). FLT3, the hemato-
poietic progenitor cell receptor, was also downregulated in fetal pro-B cells likely affecting 
the signals received by the cells at early stages of development (Table 1 and Figure 6D). 
Together, the differences in the IGH gene repertoire and precursor-B-cell subset 
composition between fetal and pediatric BM seem to result from reduced expression of 
transcripts encoding NHEJ, TdT and signaling proteins IL-7R and FLT3 in fetus. 
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Figure 7. IL7Rα-regulated expression of TdT and IGH junctional processing. (A) Functional network of 
molecules interacting with IL-7R, FLT3, ATM, XRCC4 and TdT (DNTT) in pro-B cells. Upregulated (red) 
and downregulated (green) transcripts in fetus vs child as determined by genome-wide expression profiling 
(p<0.05). Dark shades indicate fold change >2 in transcript expression, and light shades fold change between 
1.5 and 2. The 5 transcript of interested are depicted in bold font. Nodes are displayed using various shapes 
that represent the functional class of gene products. The interactions were identified with Ingenuity Pathways 
Analysis (www.ingenuity.com) starting with IL-7R, FLT3, ATM, XRCC4 and TdT (indicated in bold font). 
FC, fold change. (B) TdT protein expression in pro-B cells of IL7Rα-deficient patients and pediatric controls. 
Graphs represent merged data of cyCD79A+CD19- pro-B cells from 3 patients and 3 controls. Naive-B cells of 
pediatric BM were included as a negative control. The median fluorescence intensities (MFI) for each subset 
are indicated. (C) Bar graphs showing the median numbers of N-nucleotides in Dh-Jh and Vh-DJh junctions 
with inter-quartile range. Numbers in brackets indicate the amount of analyzed sequences. Data were obtained 
from out-of-frame rearrangements from pre-BI cells of 3 fetal and 3 pediatric donors, and from naive-B cells of 
2 IL7Rα-deficient patients. The nonparametric Mann-Whitney U test was used to calculate significance levels. 
**, p<.01; ****, p<.0001.
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TdT expression and N-nucleotide additions in IL7Rα-deficient patients 
Ingenuity pathway analysis revealed that IL-7R and FLT3 signaling interact with the 
NHEJ pathway (Figures 7A and S8), indicating that these proteins form a functional 
network in precursor-B cells that determine the molecular environment in which IGH 
gene rearrangements take place. To study whether the altered junction processing in fetal 
B cells resulted from decreased IL-7R signaling, we analyzed TdT protein expression 
and IGH junctions in B cells of IL7Rα-deficient patients. CD79A+CD19- pro-B cells 
of IL7Rα-deficient patients showed lower nuclear TdT protein than healthy children 
(Figure 7B). Out-of-frame IGH gene rearrangements in B cells of these patients con-
tained fewer N-nucleotides in the Dh-Jh junctions (Figure 7C). Since these Dh-Jh 
junctions were generated in pro-B cells,36 and were not subjected to selection processes, 
this confirms that IL-7R signaling affects IGH junction processing.   
DISCUSSION
In the present study, we showed that already during fetal development a diverse Ig 
repertoire is formed. Still, this repertoire is skewed with regards to combinatorial diver-
sity but more importantly to junctional diversity as compared to pediatric-B cells. These 
changes were the result of an altered balance in V(D)J recombination components, as 
they were evident in unselected B-cell progenitors and fetal-derived BCP-ALL. Fetal 
B-cell progenitors showed decreased expression of several NHEJ factors and cytokine 
receptors and analysis of IL7Rα-deficient patients revealed that IL-7R signaling affects 
TdT protein-dependent N-nucleotide additions in the IGH junctions.   
The fetal Ig repertoire has been a subject of study for the past 3 decades.1, 2, 19, 20, 23-28, 35 
Differences with postnatal B cells have been reported regarding V, D, and J gene usage, as 
well as N-nucleotide additions,1, 19, 20, 23, 35 but unfortunately the results were ambiguous 
and included evident differences between studies.1, 25, 35 We acknowledged the apparent 
difficulties in the assessment of the fetal Ig repertoire, and took a two-step approach to 
tackle these. First, we assessed the repertoire in single-sorted naive mature B cells, thereby 
avoiding potentially preferential PCR-based amplification of V genes. Consequently, we 
obtained an unbiased view of the naive B cell-repertoire. Secondly, we amplified IGH 
and IGK gene rearrangements from early precursors that have not yet been selected for 
in-frame rearrangements.36 This approach allowed us to study which of the characteristics 
in the mature repertoire were the result of altered V(D)J recombination processes rather 
than selection. Thus, we confirmed that the fetal naive mature Ig repertoire contained 
more Vh1-2, Dh7-27, Jh2 and Jh3 genes than pediatric B cells.1, 19, 20, 23 Despite the high 
Vh1-2 usage, the Dh-proximal Vh genes were in general not more frequently used in 
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the human fetal repertoire,25-27 in contrast to the mouse.17, 18, 21, 22 Importantly, we now 
established that these changes in the IGH gene repertoire were the result of altered V(D)
J recombination, and not due to changes in Ig repertoire selection.
The skewed IGH gene repertoire in fetus did not seem to result from changes in 
chromatin organization as the IGH locus in fetal B-cell precursors was highly contracted. 
Moreover, critical transcription factors for this process, such as E2A and Pax5 were highly 
expressed. The 3D spatial organization would thus normally support the utilization of 
diverse Vh genes in fetal B-cell precursors independent of genomic proximity to the 
Dh-Jh-Ch region.17, 18, 21, 22 It is possible that the Vh1-2, Dh7-27, Jh3 and Jh4 genes 
were more efficiently recombined due to their optimal RSS sequences (www.imgt.org). 
However, RAG gene expression was equally high in both fetal and pediatric B-cell progen-
itors, making it difficult to understand how these were rate-limiting in fetus. Alternatively, 
the Vh1-2 gene promoter activity could be affected by B-cell intrinsic or extrinsic factors. 
A likely candidate pathway would be IL-7R signaling that is known to affect IGH locus 
activity.42, 53 We were unable to study the production of IL-7 in fetal or pediatric BM, but 
we did find evidence for reduced IL-7Rα expression and lower IL-7R signaling in fetal 
B-cell progenitors, indicating that specific changes in Vh gene usage could be the result 
of altered susceptibility for IL-7.  
We found additional evidence for differences in the generation of IGH gene rear-
rangements in fetal precursors through analysis of BCP-ALL. ALL cases with MLL 
rearrangements or TEL-AML1 translocations can arise already during fetal development. 
Although not all cases will actually have a prenatal origin, our comparison of these cases 
with other BCP-ALL subsets confirmed previously observed paucity of N and P nucle-
otides in IGH junctions in ALL cells in neonatal blood spots54 and low TdT transcript 
levels in MLL-rearranged BCP-ALL.55 Furthermore, we report similar changes in the Vh, 
Dh and Jh gene usage as in normal fetal B-cell precursors. Considering the distinct gene 
expression repertoires between fetal and postnatal B-cell precursors, our observations in 
BCP-ALL indicate that those of in utero origin will be derived from distinct precursors 
than other ALL. Thus, it is possible that the differences between BCP-ALL subsets will 
not only be determined by their genetic abnormalities, but also by their origin from fetal 
or postnatal precursor-B cells. 
The fetal mature IGH gene repertoire has been consistently shown to contain only few 
N-nucleotides.1, 20, 35, 56 We here extended these findings to unselected B-cell precursors, 
thereby showing that these were the result of altered TdT activity. In addition, transcripts 
encoding NHEJ factor XRCC4 were reduced in fetal B-cell precursors. Because TdT 
acts during DNA repair via NHEJ, XRCC4 affects TdT function as well.43 Moreover, 
our analysis of IL7Rα-deficient patients provided the first evidence of cytokine-receptor 
mediated expression of TdT and consequent IGH junction processing. Despite complete 
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absence of a functional IL-7R, IL7Rα-deficient patients showed more N-nucleotide addi-
tions in IGH than fetal progenitor-B cells that still expressed low levels of IL-7Rα. Thus, 
TdT expression and function do not completely depend on IL-7R signaling. In contrast 
to IL7Rα-deficient patients, who only have a defect in IL-7Rα, fetal B-cell progenitors 
had downregulated FLT3 and XRCC4. The combined effects of two cytokine signaling 
pathways might have a stronger impact on TdT and XRCC4 function as it was previously 
shown that the IL-7R acts in synergy with Flt-3 signaling to expand the hematopoietic 
progenitors.57 
What would be advantage of having low TdT activity in fetal B-cell precursors? A 
potential explanation can be derived from studies in TdT deficient mice.58 In a com-
petitive setting with TdT-proficient B-cell precursors, TdT-deficient B cells developed 
quicker and demonstrated an advantage in populating peripheral lymphoid tissues. 
Through low TdT expression, the developing fetus would thus be able to provide a fast 
wave of B cells. Decreased ATM expression likely further enhanced expansion of early 
progenitor-B cells in fetus with less strict processing of IGH junctions. Considering the 
low levels of TdT in fetal thymus,59-62 and the low numbers of N-nucleotides in TRB 
junctions,56 it is likely that similar mechanisms apply for T cells. Importantly, we did not 
find differences in IGK between fetus and child. This is partly due to the already low TdT 
activity in junctional processing and was obvious from the low TdT expression levels in 
pre-BII cells. Considering the absence of differences in Vκ and Jκ gene usage, it appears 
that, in contrast to pre-BI cells that rearrange IGH, pre-BII cells from fetus are more 
similar to pediatric pre-BII cells regarding V(D)J recombination processes. In addition 
to fast formation of IGH gene rearrangements, selection processes could be affected. The 
naive B cell repertoire contains fewer long IgH-CDR3 regions than B-cell precursors, 
indicating that these would be negatively selected. By reducing the number of B cells 
with long IgH-CDR3, more precursors might be included in the mature compartment 
resulting in more efficient B-cell generation during fetal life. 
Taken together, we here showed that the skewed fetal IGH gene repertoire that 
has been postulated to contribute to the poor ability of neonates to mount humoral 
responses, was the result of altered V(D)J recombination, rather than repertoire selection. 
Specifically, fetal pro-B and pre-BI cells expressed reduced levels of a network of com-
ponents that included receptors IL-7Rα and FLT3, as well as DNA repair factors ATM, 
XRCC4 and TdT, thereby containing an altered molecular environment in which the 
skewed IGH gene repertoire is formed. These new insights into precursor-B cell develop-
ment could contribute to a better understanding of the build-up of adaptive immunity 
in the developing fetus.
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MATERIALS AND METHODS
Fetal and postnatal tissue
The use of human fetal and pediatric tissue, and cord blood was approved by the 
Medical Ethical Committees of the Erasmus MC and Eastern Norway, and was con-
tingent on informed consent in accordance with the Declaration of Helsinki. Fetal liver 
(3 donors) and fetal BM (9 donors) were obtained from elective abortions. Gestational 
age was determined by ultrasonic measurement of the diameter of the skull and ranged 
from 15 to 19 weeks. Four blood samples were obtained from the umbilical cord vein 
after birth, and 12 pediatric BM samples from children aged 2-11 years.36, 41 PBMC 
and BM B cells from IL-7Rα-deficient patients were obtained from left-over material of 
the diagnostic work-up. The IL-7RA mutations all resulted in premature stop codons. 
Anonymized data from routine diagnostics of children (aged 1-18 years) diagnosed in the 
Erasmus MC between 2004-2014 with B-cell precursor acute lymphoblastic leukemia 
(BCP-ALL) were retrospectively analysed.
Flow cytometric immunophenotyping and cell sorting
Flow cytometric immunophenotyping for B-cell subsets analysis in pediatric BM aspi-
rates, fetal limb BM suspensions and fetal liver homogenates was performed as described 
previously.39, 40 Additional stainings were performed for expression analysis using: 
CD20-PB (2H7), IgM-BV510 (MHM-88), IgD-PerCP-Cy5.5 (IA6-2), CD127-APC 
(A019D5; all from BioLegend), CD34-FITC (8G12), CD22-PE (S-HCL-1), CD19-
PE-Cy7 (SJ25C1), CD34-APC (8G12, all from BD Biosciences) and CD10-APC-C750 
(HI10A, Cytognos). TdT-FITC (HT-6) and Ki-67-FITC (KI-67; both from Zebra 
Biosciences) were used following fixation and permeabilization (AnDerGrub). Cells were 
acquired on a LSRII flow cytometer (BD Biosciences) and analyzed with FACSDiva (BD 
Biosciences) and Infinicyt software (Cytognos). 
B cell subsets were purified from pediatric BM aspirates, fetal limb BM suspensions 
and fetal liver homogenates as described previously.36, 41 Following Ficoll density gradi-
ent centrifugation (Ficoll-Paque PLUS), mononuclear cells were directly stained with 
monoclonal antibodies: CD20-PB (2H7), IgM-BV510 (MHM-88), IgD-PerCP-Cy5.5 
(IA6-2, all from BioLegend), CD34-FITC (8G12), CD123-PE (9F45), CD19-PE-Cy7 
(SJ25C1), CD22-APC (S-HCL-1; all from BD Biosciences), and CD10-APC-C750 
(HI10A, Cytognos). Five precursor-B-cell subsets (pro-B, pre-BI, pre-BII large, pre-
BII small and immature-B) were bulk sorted.36 Naive mature-B cells can be detected in 
BM samples likely due to blood contamination and these were single-cell sorted on a 
FACSAria cell sorter with FACSDiva software (BD Biosciences). 
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PCR-amplification and sequence analysis of complete IGH and IGK gene 
rearrangements
Complete IGH and IGK gene rearrangements were amplified in multiplex PCR 
reactions using V subgroup-specific forward primers and a consensus J primer36, 63 on 
DNA from bulk-sorted pediatric and fetal pre-BI and pre-BII small cells, from umbilical 
cord blood mononuclear cells and PBMC of IL7Rα-deficient patients (Table S1). PCR 
products from bulk sorted precursor-B cells were subsequently cloned into the pGEM-T 
Easy vector (Promega Benelux BV, Leiden, The Netherlands). From RNA of single-cell 
sorted naive mature-B cells, cDNA was prepared and gene rearrangements were ampli-
fied in nested PCR reactions.64 Single-cell PCR products and individual bacterial clones 
were sequenced on an ABI Prism 3031 XL fluorescent sequencer (Applied Biosystems, 
Carlsbad, CA). IGH gene rearrangements in BCP-ALL samples were determined as part 
of the diagnostic work-up.65 The usage of V, (D), J genes as well as size and composition of 
the junctional region with regards to N-nucleotides were analyzed using the international 
ImMunoGeneTics (IMGT) information system (http://imgt.cines.fr/).37 All sequence 
data have been deposited in GenBank (accession numbers KP771015 - KP771662).
3D immunofluorescence in situ hybridization (FISH)
3D DNA FISH of IGH was performed as described previously41, 42, 66 with fosmid 
clones 761A10 and 3777B2 (BACPAC Resources, Oakland, CA), BAC clones 47P23, 
101G24 (BACPAC Resources) and 3087C18 (Open Biosystems, Huntsville, AL). Probes 
were either directly labeled with Chromatide Alexa Fluor 488-5 dUTP or Chromatide 
Alexa Fluor 568-5 dUTP (Invitrogen) using Nick Translation Mix (Roche Diagnostics 
GmbH); or they were indirectly labeled using DIG-Nick Translation Mix (Roche 
Diagnostics GmbH). Freshly sorted pre-BI and pre-BII small cells were fixed in 4% 
paraformaldehyde, and permeabilized in a PBS/0.1% Triton X-100/0.1% saponin solu-
tion and subjected to liquid nitrogen immersion following incubation in PBS wih 20% 
glycerol. The nuclear membranes were permeabilized in PBS/0.5% Triton X-100/0.5% 
saponin prior to hybridization with the DNA probe cocktail. Coverslips were sealed and 
incubated for 48hr at 37°C, washed and mounted on slides with 10 µl of Prolong gold 
anti-fade reagent (Invitrogen). Pictures were captured with a Leica SP5 confocal micro-
scope (Leica Microsystems). Using a 63× lens (NA 1.4), we acquired images of ~70 serial 
optical sections spaced by 0.15 µm. The data sets were deconvolved and analyzed with 
Huygens Professional software (Scientific Volume Imaging, Hilversum, the Netherlands). 
The 3D coordinates of the center of mass of each probe were transferred to Microsoft 
Excel, and the distances separating each probe were calculated using the equation: √((Xa−
Xb)2+(Ya−Yb)2+(Za−Zb)2), where X, Y, Z are the coordinates of object a or b.
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Microarray analyses 
The microarray analysis was performed as described previously.41 Briefly, total RNA 
was extracted from bulk sorted pro-B and pre-BI subsets using the miRNeasy Mini Kit 
(Qiagen) and used to synthetize cDNA with the Ovation Pico WTA System protocol 
(NuGEN). Sense strand cDNA was generated with the WT-Ovation Exon Module 
Version 1.0 (NuGEN), fragmented and biotinylated using the Encore Biotin Module 
(NuGEN). The labeled cDNA was hybridized on the GeneChip Human Exon 1.0 
(Affymetrix, Santa Clara, CA, USA) for whole genome gene expression analysis. The 
arrays were scanned using the Affymetrix Gene Chip Scanner 3000 7G and images were 
processed using the AGCC (Affymetrix GeneChip Command Console Software) and the 
CEL files were imported into Partek Genomics Suite software (Partek, Inc. MO, USA). 
The Robust Multichip Analysis (RMA) algorithm was applied for generation of signal 
values and normalization. Transcripts were analyzed in core mode (see www.affymetrix.
com) using signal values of less than 22.6 across arrays as threshold to filter for low 
and non-expressed genes. The results were expressed as fold change. One-way ANOVA 
test was calculated on all arrays grouped into 4 categories, i.e. fetus pro-B, fetus pre-BI, 
child pro-B and child pre-BI in Partek Genomics Suite to select transcripts for clustering. 
Non-supervised cluster analysis was then performed on 1,257 transcripts which showed a 
false discovery rate (FDR) <0.05% using the euclidean/average linkage algorithm. Gene 
networks and canonical pathways representing key genes were identified using Ingenuity 
Pathways Analysis (www.ingenuity.com) following criteria of fold change >1.5 and p<0.5 
in differences in gene expression. All microarray data have been deposited in ArrayExpress 
(accession number E-MTAB-1422).
Quantitative RT-PCR Analysis
A TaqMan-based RQ-PCR was used to confirm the expression levels of 5 NHEJ 
genes: ATM, DCLRE1C (Artemis), NBN (NBS), PRKDC (DNA-PKcs) and XRCC4. 
Total RNA was extracted from bulk sorted pre-BI cells using the miRNeasy Mini Kit 
(Qiagen) and reverse-transcribed with SuperScript II reverse transcriptase (Invitrogen). 
For cDNA amplification, 15 µl reaction mix was used with Taq-Man Universal MasterMix 
(Applied Biosystems), 670 nM of each primer and 100 nM of FAM-TAMRA-labeled 
probe.67 Primers were designed with the ProbeFinder software (Roche Applied Science) 
and probes were from the Universal ProbeLibrary (Roche Applied Science) (Table S2). 
Duplicate reactions were performed for each cDNA sample. Gene expression was ana-
lyzed with a StepOnePlus Real-Time PCR system and StepOne Software version 2.3 
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(Applied Biosystems). Cycle-threshold levels were calculated for each gene and normal-
ized to values obtained for the endogenous reference gene ABL.
Statistics
Statistical significance was calculated by a non-parametric Mann-Whitney U test, χ2 
test or one-way ANOVA as indicated in the Figure legends. P values <0.05 were consid-
ered as significant.
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SUPPLEMENTAL MATERIAL 
Table S1. Primer sequences used for analysis of complete IGH and IGK gene rearrangements.
PCR type Locus Target Primer Type Sequence (5’-3’)
Ig gene rear-
rangements in 
precursor  
B-cells
IGH Vh - DJh Vh1-FR263 Forward CTGGGTGCGACAGGCCCCTGGACAA
Vh2-FR236 Forward GATCCGTCAGCCCCCAGGGAAGG
Vh3-FR263 Forward GGTCCGCCAGGCTCCAGGGAA
Vh4-FR236 Forward GATCCGCCAGCCCCCAGGGAAGG
Vh5-FR236 Forward GGTGCGCCAGATGCCCGGGAAAGG
Vh6-FR236 Forward GATCAGGCAGTCCCCATCGAGAG
Vh7-FR236 Forward TTGGGTGCGACAGGCCCCTGGACAA
Jh cons36 Reverse CTTACCTGAGGAGACGGTGACC
Ig gene rear-
rangements in 
naive-B cells
IGH Vh - DJh L-Vh164 Forward ACAGGTGCCCACTCCCAGGTGCAG
L-Vh364 Forward AAGGTGTCCAGTGTGARGTGCAG
L-Vh4/664 Forward CCCAGATGGGTCCTGTCCCAGGTGCAG
L-Vh564 Forward CAAGGAGTCTGTTCCGAGGTGCAG
Cµ Ch164 Reverse GGGAATTCTCACAGGAGACGA
Ig gene rear-
rangements in 
BCP-ALL
IGH Vh - DJh Vh1/7-F1-CLB65 Forward TCTGGGGCTGAGGTGAAGAA
Vh2-F1-CLB65 Forward ACCTTGAAGGAGTCTGGTCCT
Vh3-F1-CLB65 Forward GGGGGTCCCTGAGACTCTC
Vh4/6-F1-
CLB65 Forward GCCCAGGACTGGTGAAGC
Vh5-F1-CLB65 Forward CTGGTGCAGTCTGGAGCAG
Jh-R1-CLB65 Reverse ACCTGAGGAGACGGTGACC
Ig gene rear-
rangements in 
precursor 
B-cells
IGK Vκ - Jκ Vκ136 Forward AGGAGACAGAGTCACCATCACT
Vκ236 Forward CTCCATCTCCTGCAGGTCTAGTC
Vκ336 Forward GGAAAGAGCCACCCTCTCCTG
Vκ436 Forward CAACTGCAAGTCCAGCCAGAGTGTTTT
Jκ1-463 Reverse CTTACGTTTGATCTCCACCTTGGTCCC
Jκ563 Reverse CTTACGTTTAATCTCCAGTCGTGTCCC
Ig gene rear-
rangements in 
naive-B cells
IGK Vκ - Jκ L-Vκ1/264 Forward ATGAGGSTCCCYGCTCAGCTCCTGG
L-Vκ364 Forward CTCTTCCTCCTGCTACTCTGGCTCCCAG
L-Vκ464 Forward ATTTCTCTGTTGCTCTGGATCTCTG
Cκ164 Reverse CCAGATTTCAACTGCTCATCAGA
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Table S4. IGK junction characteristics.
sequence 
no
CDR3 
length (nt) del, Vκ P, Vκ N,Vκ-Jκ P, Jκ del, Jκ
fetus liver pre-BII 
small out-of-frame 61 28.15 3.13 0.16 3.02 0.10 2.33
fetus BM pre-BII 
small out-of-frame 182 26.87 3.07 0.13 2.28 0.13 2.63
child BM pre-BII 
small out-of-frame 105 27.05 3.82 0.11 2.23 0.31 2.01
fetus liver pre-BII 
small total 75 27.53 3.11 0.13 2.64 0.08 2.47
fetus BM pre-BII 
small total 240 27.15 2.98 0.12 2.18 0.13 2.41
child BM pre-BII 
small total 138 27.06 3.75 0.09 2.26 0.30 2.06
fetus BM naive-B 92 27.10 2.48 0.07 0.61 0.09 1.37
CB naive-B 46 26.48 2.63 0.07 0.83 0.09 2.13
child BM naive-B 120 27.63 2.88 0.08 1.44 0.08 1.31
Significant differences in fetal IGH junctions as compared to childhood are indicated in bold font; Mann-
Whitney U test; p<0.05
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Figure S3. IGKV (A) and IGKJ (B) gene usage in transcripts from single-cell naive mature-B cells from fetal 
and pediatric bone marrow (BM). The genes are ordered according to their genomic positions in the locus 
(IMGT).37 The panels include 92 sequences derived from 3 fetal BM samples and 120 sequences from 3 pedi-
atric BM donors. Data from individual samples showed similar patterns of gene usage.
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Figure S4. IGKV (A) and IGKJ (B) gene usage in bulk sorted pre-BII small cells from fetal liver, fetal bone 
marrow (BM) and pediatric BM. IGK gene rearrangements were amplified from DNA, and both in-frame and 
out-of-frame rearrangements were included in the analysis. The genes are ordered according to their genomic 
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positions in the locus (IMGT).37 The panels include 75 sequences derived from 3 fetal liver samples, 240 
sequences from 4 fetal BM samples and 138 sequences from 5 pediatric BM donors. Data from individual 
samples showed similar patterns of gene usage.
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Figure S5. IGHD gene sizes. (A) The length of germline IGHD genes. The majority of IGHD genes is ~20 
nucleotides in size. Dh2-2, Dh3-3, Dh2-8, Dh3-9, Dh3-10, Dh2-15, Dh3-16, Dh2-21, Dh3-22 genes 
are ~30 nucleotides and defined as long, whereas Dh7-27 was short, being smaller than 15 nucleotides. (B) 
Relative usage of long, average and short IGHD genes in fetal and pediatric pre-BI and naive mature-B cells. 
Data include 161 sequences from 4 fetal pre-BI samples, 216 sequences from 5 pediatric pre-BI samples, 148 
sequences from 3 fetal naive mature B-cell samples and 152 sequences from 3 pediatric naive mature B-cell 
samples. (C) N-nucleotides additions in Dh-Jh and Vh-DJh junctions in pre-BI cells from fetal liver and fetal 
BM separated based on Dh gene family usage. Bars represent medians with inter-quartile range, and include 
data from 3 fetal liver and 4 fetal BM donors. Numbers of analyzed sequences are indicated between brackets. 
Statistical significance was determined with the χ2 test (panel B) or the Mann-Whitney U test (panel C). *, 
p<.05; **, p<.01; ***, p<.001; ns, not significant.
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Figure S6. IGH junction characteristics in BCP-ALL. (A) Relative usage of long, average and short IGHD 
genes in BCP-ALL subsets. BCB-ALL of fetal origin included MLL-rearranged (n=19) and TEL-AML1 positive 
(n=102) cases, whereas the E2A-PBX positive (n=8), BCR-ABL positive (n=7), hyperdiploid (n=74) and other 
cases (n=79) constituted group of BCP=ALL from non-fetal origin. (B) Scatter plots showing the IgH-CDR3 
length in nucleotides with red horizontal lines representing median values. (C) Bar graphs showing the number 
of N-nucleotides in Dh-Jh and Vh-DJh junctions. Values represent the medians with inter-quartile range and 
the numbers of sequences are indicated between brackets. Data in all panels include in-frame and out-of-frame 
complete IGH gene rearrangements. Statistical significance was calculated with the χ2 test (panel A) or the 
Mann–Whitney U test; *, p<0.05; **, p<0.01; ****, p<0.0001, ns-not significant.
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Figure S7. Gene expression profiling of fetal and pediatric precursor-B-cells. (A) Non-supervised cluster 
analysis of the gene expression profiles from purified fetal (3 donors) and pediatric (4 donors) pro-B and pre-BI 
cells after one–way ANOVA test. Clustering included 1257 transcripts with a false discovery rate (FDR)<0.05% 
using the euclidean/average linkage algorithm. (B) Confirmation of gene expression levels of 5 transcripts enco-
ding factors involved in NHEJ by real-time quantitative RT-PCR. Data was generated from bulk-sorted pre-BI 
cells from 2 fetal BM and 3 pediatric BM samples. Gene expression levels were normalized to the levels of ABL, 
and the values in pediatric pre-BI cells were set to 1.
B
0
0.5
1
1.5
ATM
fetus BM
child BM
0
0.5
1
1.5
2.5
2
3.5
3
4
DCLRE1C
(Artemis)
0
0.5
1
1.5
2
2.5
NBN
(NBS)
0
0.5
1
1.5
2
2.5
PRKDC
(DNA-PKcs)
0
0.5
1
1.5
XRCC4
A
R
el
at
iv
e 
ex
pr
es
si
on
pro-B 1
pro-B 2
pro-B 3
pre-BI 2
pre-BI 3
pre-BI 1
pro-B 1
pro-B 3
pro-B 4
pro-B 2
pre-BI 1
pre-BI 2
pre-BI 3
pre-BI 4
FDR<0.05%; n=1257
6.43 19.28 32.14 45.00 63.28
0.002.63 -2.63
fetus
BM
child
BM
163
Formation of the Immunoglobulin Repertoire in Precursor-B-cell Development
Fi
gu
re
 S
8.
 F
un
ct
io
na
l n
et
w
or
k 
of
 m
ol
ec
ul
es
 in
te
ra
ct
in
g 
w
ith
 I
L-
7R
, F
LT
3,
 A
T
M
, X
RC
C
4 
an
d 
T
dT
 (D
N
T
T
) i
n 
pr
e-
BI
 c
el
ls.
 U
pr
eg
ul
at
ed
 (r
ed
) a
nd
 d
ow
nr
eg
ul
at
ed
 (g
re
en
) 
tr
an
sc
rip
ts 
in
 fe
tu
s 
vs
 c
hi
ld
 a
s 
de
te
rm
in
ed
 b
y 
ge
no
m
e-
w
id
e 
ex
pr
es
sio
n 
pr
ofi
lin
g 
(p
<0
.0
5)
. D
ar
k 
sh
ad
es
 in
di
ca
te
s 
fo
ld
 c
ha
ng
e 
>2
 in
 tr
an
sc
rip
t e
xp
re
ss
io
n,
 a
nd
 li
gh
te
r 
sh
ad
ed
 
fo
ld
 c
ha
ng
e 
be
tw
ee
n 
1.
5 
an
d 
2.
 Th
e 
in
te
ra
ct
io
ns
 w
er
e 
id
en
tifi
ed
 w
ith
 In
ge
nu
ity
 P
at
hw
ay
 A
na
ly
sis
 (w
w
w.
in
ge
nu
ity
.c
om
) s
ta
rt
in
g 
w
ith
 IL
-7
R
, F
LT
3,
 A
T
M
, X
RC
C
4 
an
d 
T
dT
 
(in
di
ca
te
d 
in
 b
ol
d 
fo
nt
).
P
la
sm
a 
M
em
br
an
e
C
yt
op
la
sm
N
uc
le
us
IL
-7
R
ID
3
p=
0.
01
FC
=1
.5
TC
F1
2
p=
0.
01
FC
=-
1.
4
JU
N p
<0
.0
01
FC
=4
.3
N
FK
B
IA
p=
0.
01
FC
=2
.7
FL
T3
C
B
L
p=
0.
02
FC
=-
2.
5
p=
0.
03
FC
=-
1.
3
R
A
D
21
p=
0.
01
FC
=-
1.
3
P
TM
A
p<
0.
00
1
FC
=2
S
N
R
N
P
70
p=
0.
00
2
FC
=1
.7
S
M
A
R
C
A
4
p<
0.
00
1
FC
=1
.7
C
Y
LD
p=
0.
02
FC
=-
1.
3
LC
K p<
0.
00
1
FC
=1
.7
E
IF
2A
K
2
p=
0.
04
FC
=-
1.
8
p=
0.
02
FC
=-
1.
5
D
N
TT
p<
0.
00
1
FC
=-
1.
6
C
U
L3
P
R
K
D
C
p=
0.
02
FC
=-
1.
9
p<
0.
05
FC
=-
1.
6
p=
0.
02
FC
=-
2.
1
p=
0.
00
3
FC
=-
1.
6
S
U
M
O
2
XR
C
C
4
N
B
N
p=
0.
00
3
FC
=-
1.
8
C
A
LM
1 
(in
cl
ud
es
 o
th
er
s)
R
B
1
p=
0.
01
FC
=-
1.
5
p<
0.
00
1
FC
=-
1.
7
S
IA
H
1
R
A
S
A
1
p=
0.
01
FC
=-
1.
5
tra
ns
cr
ip
t. 
re
gu
la
to
r
ki
na
se
en
zy
m
e
ot
he
r
ph
os
ph
at
as
e
re
ce
pt
or
AT
M
p=
0.
01
FC
=-
1.
9
p=
0.
03
FC
=-
1.
4
D
LR
E
C
1
p=
0.
00
1
FC
=-
2.
2
M
R
E
11
A
p<
0.
05
FC
=-
1.
2
R
A
D
50
ot
he
rs
 (n
ot
 s
ho
w
n)
bi
nd
in
g 
on
ly
ac
ts
 o
n
in
hi
bi
ts
ac
ts
 o
n 
an
d 
in
hi
bi
ts

Formation of the Immunoglobulin Repertoire in Precursor-B-cell Development
Chapter VI
The human thymus is enriched 
for autoreactive B cells
Magdalena B. Rother1, Marco W.J. Schreurs1, Roel Kroek1, Sophinus J.W. Bartol1, 
Jacques J.M. van Dongen1 and Menno C. van Zelm1,2 
 
 
(1) Department of Immunology, Erasmus MC, University Medical Center Rotterdam, 
The Netherlands, (2) present address: Department of Immunology, Central Clinical 
School, Monash University, Melbourne, Victoria, Australia 
Manuscript submitted
VI.  The Human Thymus Is Enriched For Autoreactive B Cells
166
ABSTRACT
The human thymus has been shown to host B cells, which have been implicated in 
presentation of autoantigens for negative selection of T-cell progenitors. Although these 
antigens are thought to be taken up through their surface immunoglobulins (Ig), data 
on thymic Ig gene repertoires are limited and reactivity to autoantigens has not been 
demonstrated. We therefore studied the Ig gene repertoires and reactivity to autoantigens 
of single-sorted B cells from pediatric thymus, and compared these with mature B cells 
from fetal and pediatric bone marrow (BM). Nearly all B cells in thymus were mature 
and displayed an Ig gene repertoire that was similar to pediatric BM. Fetal mature B cells 
predominantly used proximal V, D, and J genes, and their antibodies were highly reactive 
to dsDNA. In contrast, thymic B cells were enriched for autoreactive clones that showed 
increased specificity to peptide autoantigens. Thus, the majority of B cells in the thymus 
are resident rather than developing, and are enriched for autoantigen-binding. These fea-
tures support current models for a role of thymic B cells in presentation of autoantigens 
to developing T-cells during negative selection.
INTRODUCTION
The thymus is a primary lymphoid organ where T cells differentiate from bone 
marrow (BM) derived progenitors.1, 2 Progenitor-T cells enter the thymus at the cor-
tico-medullary junction and migrate into the cortex where they rearrange their T-cell 
receptor (TCR) loci.3 TCR expressing progenitors subsequently undergo two important 
selection events. First, TCRs are selected for capability of binding to the major histo-
compatibility complex (MHC) molecules through positive selection. This selection is 
mediated by cortical thymic epithelial cells (cTECs) that express MHC class I (MHCI) 
and class II (MHCII) molecules. Following positive selection, the remaining thymocytes 
undergo negative selection for recognition of self-antigens. Self-antigens are presented to 
T cells by dendritic cells via MHCII and medullary thymic epithelial cells (mTECs) via 
MHCI and MHCII.4 Expression of tissue-specific self-antigens by mTECs is regulated 
by the transcription factor AIRE.5, 6 High affinity interactions of T cells with MHC-
self antigen complexes result in apoptosis of the T cell, thereby ensuring proper central 
immune tolerance.7-9 
Despite being a specific site for T-cell development, the human thymus also hosts B 
cells. These are located in the medulla and created rosette-like structures surrounded by T 
cells.10, 11 It has been suggested that these B cells are involved in autoantigen presentation 
to T cells.12-15 B cells express high levels of MHCII and can efficiently present antigens 
that they recognize with their surface immunoglobulins.16 
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The major site of human B-cell differentiation is the BM. The majority of develop-
ing B cells generates autoreactive immunoglobulins (Ig), which are selectively removed, 
resulting in only 20% autoreactivity in circulating naive mature B cells.17 Early thymic 
progenitors have been shown to sustain B-cell potential,18, 19 and in some studies progen-
itor B cells have been detected in human thymus.10, 11 Moreover, the Ig gene repertoire of 
thymic B cells was found to be distinct from pediatric B cells from BM, and more similar 
to fetal B cells with regards to usage of Vh1-2 and Vh6-1 genes, although thymic B cells 
contained longer IgH-CDR3 regions than fetal B cells.12, 13 Still, data on the thymic Ig 
gene repertoire is limited, and to date, it remains unclear whether these immunoglobulins 
indeed bind to self-antigens. 
Here, we studied the Ig gene repertoires of single-sorted B cells from fetal BM, 
pediatric BM and pediatric thymus, and cloned these genes to assessed their ability to 
bind self-antigens. Fetal B cells showed a distinctive IGH gene repertoire and many were 
reactive to dsDNA. While the Ig gene repertoires of pediatric BM and thymus were very 
similar, thymic B cells showed increased reactivity towards protein autoantigens.
RESULTS 
Detection of B cells in human thymus
To confirm the previously reported presence of B cells in human thymus,10, 11 we 
depleted CD8+ and CD4+ cells by magnetic separation from single cell suspensions prior 
to multi-color flow cytometric analysis. Within these remaining cells, the CD19+ subset 
hardly contained any IgM-negative progenitor B cells, which predominate in fetal or 
pediatric BM (Figure 1). In contract, the vast majority of B cells in human thymus were 
naive mature, being positive for IgM and IgD, and negative for CD34, CD10 and CD27 
(Figure 1). While this does not exclude the potential of the thymus to support B-cell 
differentiation, it appears that the majority of B cells in the human thymus are resident 
mature cells rather than developing progenitors.
Thymic B cells do not express a fetal Ig gene repertoire
To study the nature of these thymic B cells, we first analyzed their Ig gene repertoire. 
Ig heavy (IGH) and Ig light chain (IGK and IGL) gene rearrangements were amplified 
and sequenced from single-sorted CD19+IgM+IgD+ naive mature B cells from human 
thymus, and compared to previously generated rearrangements from naive mature B cells 
of fetal and pediatric BM (Rother et al., submitted). 
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Figure 1. The majority of B cells in the human thymus has a naive mature phenotype. (A) Flow cytomet-
ric analysis of CD19+ precursor-B and naive-B cells in fetal bone marrow (BM), pediatric BM and pediatric 
thymus. Representative dot plot images were derived from one donor. (B) Frequencies of naive-B cells within 
CD19+ cells determined by flow cytometric analysis in fetal BM (9 donors), pediatric BM (9 donors) and 
pediatric thymus (4 donors). Red lines represent median values. The nonparametric Mann-Whitney U test was 
used to calculate significance levels: *, p<.05; **, p<.01; ****, p<.0001. 
The IGH and Ig light chain gene rearrangements of thymic B cells were highly diverse 
regarding V, D and J gene usage (Figures 2, S1A-B, S2A-B). In contrast to fetal BM B 
cells, the thymic B cells did not show skewed usage of Vh1-2, Dh7-27, Jh2 and Jh3. In 
fact, the IGH and Ig light chain gene repertoires of pediatric thymus and BM B cells were 
remarkably similar with the only exception being significantly increased usage of Vh1-69 
in thymic B cells (Figure 2A-C). 
In addition to gene usage, the rearranged IGH and Ig light chain genes in thymic 
B cells encoded highly diverse CDR3 regions (Figure 3, S1C-D, S2C-D). The size 
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distributions did not significantly differ from B cells of pediatric BM. However, fetal 
BM B cells carried significantly smaller IgH-CDR3 regions than B cells from pediatric 
BM or thymus due to smaller numbers of N-nucleotide additions (Figure 3). Thymic 
IgH-CDR3 regions were slightly, but not significantly, smaller than pediatric BM B cells 
(Figure 3A). This was mostly due to significantly fewer N-nucleotides in their Dh-Jh 
junctions (Figure 3B). 
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Figure 3. IgH-CDR3 regions and N-nucleotides are similar in B cells from pediatric thymus and pediatric 
bone marrow (BM), and are distinct from B cells of fetal BM. (A) Scatter plots showing the CDR3 length in 
nucleotides of IGH in single-sorted naive mature-B cells sorted from 3 fetal BM, 3 pediatric BM and 3 thymic 
donors. Red horizontal lines represent median values. Numbers in brackets indicate the amount of analyzed 
sequences. In-frame rearrangements were included in the analysis. (B) Bar graphs showing the median num-
bers of N-nucleotides in Dh-Jh and Vh-DJh junctions with inter-quartile range. The nonparametric Mann-
Whitney U test was used to calculate significance levels: *, p<.05; ***, p<.001; ****, p<.0001. 
Thus, contrary to previously published data,12, 13 we showed that single-cell sorted 
naive mature B cells from human thymus have a diverse Ig gene repertoire, which does 
not show the typical skewing of V, D and J gene usage nor short IgH-CDR3 regions that 
are typically found in fetal BM. 
Autoreactivity of thymic B cells
Previous studies suggested that the thymic B cells are enriched for autoreactive clones 
that are capable to take up auto-antigens and present these to developing T-cells during 
negative selection.10, 12, 13, 15 To test this hypothesis, we generated recombinant antibodies 
from the Ig genes of single-cell sorted naive mature B cells and tested their reactivity by 
ELISA to various types of autoantigens and compared these with antibodies derived from 
naive mature B cells of fetal and pediatric BM. 
We were able to successfully clone and express antibodies from 2 donors of fetal 
BM (26 antibodies), pediatric BM (36 antibodies) and pediatric thymus (31 antibodies). 
These antibodies showed similar Vh, Dh and Jh gene usage as the overall repertoire 
of all amplified rearrangements (Figure S3A-C). To test reactivity to nuclear antigens, 
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we first performed an ELISA with Hep-2 cell lysate, a procedure to detect the presence 
of anti-nuclear antibodies (ANA) in patients with autoimmune disease.21 Significantly 
more antibodies derived from thymic B cells showed reactivity to Hep-2 cell lysate (45%) 
than those from pediatric BM (17%; Figure 4A). Furthermore, the OD levels of thymic 
antibodies were significantly higher than for pediatric BM. Antibodies derived from fetal 
BM showed intermediate levels of Hep-2 cell lysate reactivity (39%) and were not signifi-
cantly different from pediatric BM or thymus.
A
0
2
4
6
fetal BM
(n=26)
pediatric BM
(n=36)
pediatric thymus
(n=31)
O
D
45
0 f
or
 H
ep
-2
 c
el
l l
ys
at
e
***
% of positive
clones 39% 17% 45%
B
0
0.5
1
2.5
% of positive
clones 0% 6% 19%
1.5
2
**
C
0
0.5
1
2.5
O
D
45
0 f
or
 in
su
lin
% of positive
clones 8% 6% 10%
1.5
2
*
D
0
0.5
1
2.5
O
D
45
0 f
or
 M
D
A
-B
S
A
% of positive
clones 19% 17% 26%
1.5
2
*
fetal BM
(n=26)
pediatric BM
(n=36)
pediatric thymus
(n=31)
fetal BM
(n=26)
pediatric BM
(n=36)
pediatric thymus
(n=31)
fetal BM
(n=26)
pediatric BM
(n=36)
pediatric thymus
(n=31)
FE
0
0.5
1
fetal BM
(n=26)
pediatric BM
(n=36)
pediatric thymus
(n=31)
O
D
45
0 f
or
 B
S
A
1.5
2
2.5
0
0.5
1
2.5
O
D
45
0 f
or
 d
sD
N
A
% of positive
clones 81% 58% 71%
1.5
2
**
fetal BM
(n=26)
pediatric BM
(n=36)
pediatric thymus
(n=31)
O
D
45
0 f
or
 H
ep
-2
 p
ro
te
in
 ly
sa
te
*
*
Figure 4. Thymus contains autoreactive B cells. Reactivity of fetal BM, pediatric BM and pediatric thymic 
recombinant antibodies expressed form single-sorted naive mature-B cells. Reactivity was measured by ELISA 
for Hep-2 cell lysate (A), Hep-2 protein lysate (B), dsDNA (C), insulin (D), MDA-BSA (E) and BSA (F). In 
total, 26 fetal BM, 36 pediatric BM and 31 pediatric thymic recombinant antibodies were analyzed, all derived 
from 2 donors. Each ELISA graph shows OD450 values measured for the antibodies and percentage of positive 
clones. Red lines represent median value. Dashed line depicts cut-off value set at 2.5 (Hep-2 cell lysate), 0.6 
(Hep-2 protein lysate), 0.67 (dsDNA), 0.59 (insulin) or 0.5 (MDA-BSA and BSA), above which antibodies 
were determined as positive. The nonparametric Mann-Whitney U test was used to calculate significance levels 
between the OD values of antibodies, and the χ2 test to analyze significance levels of the fractions of positive 
clones between subsets: *, p<.05; **, p<.0001; ***, p<.001.   
Subsequently, we analyzed which cellular components, i.e. Hep-2 cell proteins or 
dsDNA, were recognized more frequently by the recombinant antibodies from fetal BM, 
pediatric BM and pediatric thymus. Despite the low numbers of positive clones, sig-
nificantly more thymus-derived antibodies were reactive to Hep-2 proteins than fetal or 
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pediatric BM (Figure 4B). The frequencies of antibodies reacting to dsDNA were much 
higher: fetus BM, 81%; child BM, 58%; thymus, 71% (Figure 4C), but did not differ 
between the three tissues. However, the OD value for dsDNA-reactive fetal BM-derived 
antibodies was significantly higher than for thymus-derived antibodies. Furthermore, 
70% of fetal Hep-2 reactive antibodies recognized dsDNA, while this was only 50% for 
thymus-derived Hep-2 reactive antibodies (Table S2).
In contrast to dsDNA, only few of the antibodies showed binding to the insulin 
peptide, and to malondialdehyde (MDA) groups, which are products of stress-related 
enhanced lipid peroxidation and are present on apoptotic cells.22 Although the fractions 
of insulin-binding clones did not differ between fetal BM (8%), pediatric BM (6%) and 
thymus (10%), thymus-derived antibodies showed significantly higher levels of interac-
tion than pediatric BM-derived antibodies (Figure 4D). MDA-binding was measured 
with an ELISA to an MDA-bovine serum albumin (BSA) conjugate, and the frequency 
of reactive clones did not differ significantly between fetal BM, pediatric BM and thymus 
(19%, 17% and 26% respectively; Figure 4E). This reactivity was specific for the MDA-
BSA conjugate, as nearly all antibodies were negative for binding to BSA only (Figure 
4F). 
Taken together, we showed that B cells from pediatric thymus had increased reactiv-
ity to protein autoantigens, while autoreactivity of fetal BM derived clones was mostly 
directed towards dsDNA. 
Polyreactivity of thymic B cells
Subsequently, we analyzed binding of the recombinant antibodies to combinations 
of molecules with distinct chemical properties, i.e. dsDNA, insulin, MDA-BSA and LPS 
(Figures 4C-E and 5A). We considered polyreactivity as regognition of 3 or 4 out of 4 
antigens. While fetal BM and pediatric BM clones showed increased simultaneous rec-
ognition of 2 antigens (double-reactivity: fetus BM, 12%; pediatric BM, 11%; pediatric 
thymus, 3%), thymic antibodies reacted more frequently with 3 or even 4 antigens at the 
same time (triple-reactivity: fetus BM, 4%; pediatric BM, 8%; pediatric thymus, 13%, 
quadruple-reactivity: fetus BM, 0%; pediatric BM, 0%; pediatric thymus, 6%) (Figure 
5B). Thus, thymic B cells showed tendency of increased polyreactivity and binding to 
multiple different antigenic structures.
Ig repertoire properties of autoreactive B cells
To study whether specific DNA properties underlined autoreactivity, we compared the 
rearrangements of ANA positive vs negative and dsDNA positive vs negative antibodies 
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of fetal and pediatric BM and pediatric thymus. HEp-2 cell lysate reactive antibodies 
from pediatric BM and thymus showed slightly longer IgH-CDR3 and Ig light chain 
CDR3 regions (IgL-CDR3), of which only the latter were significant (Figure 6A-B). 
Furthermore, Igλ chain usage was significantly higher in ANA from pediatric BM and 
thymus (Figure 6C). 
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Figure 5. Thymic B cells display increased polyreactivity. (A) Reactivity of fetal BM, pediatric BM and 
pediatric thymic recombinant antibodies expressed form single-sorted naive mature-B cells towards LPS. Red 
lines represent median value. Dashed line depicts cut-off value set at 0.67, above which antibodies were deter-
mined as positive. The χ2 test was used to calculate significance levels of the fractions of positive clones between 
subsets: *, p<.05. (B) Frequencies of polyreactive clones within fetal BM, pediatric BM and pediatric thymic 
recombinant antibodies. Polyreactivity was defined as recognition of 3 or 4 out of 4 antigens with different 
properties: dsDNA, insulin, MDA-BSA and LPS. Antibodies were grouped into 5 categorizes, i.e. negative, 
single-reactive, double-reactive, triple-reactive and quadruple-reactive when recognizing 0, 1, 2, 3 or 4 antigens 
respectively. The numbers of analyzed clones are indicated in-between brackets. The χ2 test was used to calculate 
significance levels of the polyreactive vs non-polyreactive clones between subsets.
dsDNA-binding antibodies had a trend for shorter IgH-CDR3 and IgL-CDR3 
lengths (Figure 6D-E), of which only the IgL-CDR3 for pediatric thymus was signifi-
cant. In contrast to ANA, the dsDNA-binding antibodies carried significantly more often 
an Igκ light chain (Figure 6F). 
Taken together, we showed that the reactivity of B cells in fetal BM and pediatric 
thymus differs from that in pediatric BM. Fetal B cells carried a skewed Ig gene repertoire 
and their antibodies showed increased reactivity towards dsDNA. In contrast, the thymic 
B-cell repertoire was not different from pediatric BM, while the antibodies were more 
reactive to protein autoantigens.
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Figure 6. Ig gene repertoire of recombinant antibodies reactive to HEp-2 cell lysate and to dsDNA. IgH-
CDR3 length, Igλ usage, and IgL-CDR3 length analyzed for recombinant antibodies expressed from single-cell 
sorted naive mature-B cells from fetal BM, pediatric BM and pediatric thymus which were negatively (neg) 
and positively (pos) reactive to HEp-2 lysate (A, B, C) and to dsDNA (D, E, F). In total, 26 clones were 
obtained from 2 fetal BM, 36 clones from 2 pediatric BM and 31 clones from 2 pediatric thymic samples. The 
numbers of analyzed clones are indicated in-between brackets.  Red horizontal lines represent median values. 
The non-parametric Mann-Whitney U test (panels A,B,D,E,) and the χ2 test (panels C,F) were used to calculate 
significance levels: *, p<.05; **, p<0.01; ***, p<.001; ****, p<0.0001. 
DISCUSSION
Our study shows that B cells from human thymus display an Ig gene repertoire that is 
similar to pediatric BM and does not show typical skewing in Vh, Dh and Jh gene usage, 
nor short IgH-CDR3 regions that are typical for fetal BM B cells. Still, thymic B cells 
appeared enriched for autoreactive clones that showed increased specificity to peptide 
autoantigens, and not towards dsDNA as seen for fetal B cells. 
We here detected B cells in the human thymus. The presence of B cells in human 
thymus has been postulated almost 30 years ago, and these cells were mainly found 
in the medulla concentrated around Hassall’s corpuscles.10, 11, 23 These were all mature 
Ig-expressing B cells, and in contrast to Weerkamp et al., we and others did not detect 
IgM-negative B-cell precursors.15, 24-26 Furthermore, the Ig gene repertoire of the naive 
mature thymic B cells was diverse and did not differ from that of pediatric BM-derived B 
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cells. Importantly, it did not resemble the skewed fetal Ig gene repertoire, which is char-
acterized by shorter IgH-CDR3 regions and more frequent usage of the Vh1-2, Dh7-27, 
Jh2 and Jh3 genes (Rother et al., submitted).27 Our observations do not exclude that 
the resident mature B cells in human thymus are derived from local precursors. Still, the 
difficulty in detecting progenitor-B cells and the similarities with the pediatric BM Ig 
gene repertoire, are more in line with migration into the thymus of BM-derived mature 
B cells rather than local B-cell development.
In the 1990s, several studies reported that Ig gene rearrangements in human thymus 
were distinct from peripheral blood B cells, and involved more frequent usage of Vh4-34 
and the presence of Vh1, Vh3, Vh6 and Jh2 families restricted to the fetal Ig repertoire.12, 
13 Our observations contrast these earlier findings, most likely due to recent advances in 
Ig repertoire analyses. We and others have more extensively studied the fetal Ig gene 
repertoire in single-sorted B cells or with next generation sequencing (Rother et al., sub-
mitted).27 Thus, the differences between the fetal and pediatric Ig gene repertoires are now 
better defined. Furthermore, our data set from thymic Ig gene rearrangements is much 
larger than those of previous studies and was derived from single-sorted B cells. Although 
in our hands the thymus B-cell repertoire differs greatly from fetal B-cells and was highly 
similar to BM-derived B cells, we do not exclude that subtle differences exist in V, D or J 
gene usage that will only be detectable with high throughput sequencing analysis. 
We here for the first time were able to study the reactivity of thymic B cells. 
Interestingly, thymic B cells were enriched for binding to insulin and to HEp-2 protein 
antigens. Human thymic B cells were previously suggested to be more autoreactive based 
on the more frequent usage of the inherently autoreactive Vh4-34 gene,12 and other Vh4 
subgroup genes that were commonly found in autoimmune diseases.13 The distinct Ig 
gene rearrangements in thymic B cells were postulated to display another reactivity and 
thereby play distinct functions.10, 12, 13 Indeed, studies using mouse models have shown 
that B cells in the thymus are involved in negative selection of T cells.14, 15, 28-30 Detection 
of ANA is a common diagnostic tool in autoimmune diseases.21 Therefore, the presence of 
ANA in thymus fits with the current hypothesis of thymic B cells being involved in auto-
antigen presentation to T cells and their role in maintenance of the central tolerance. We 
here did not find evidence of skewed V, D and J gene usage in ANA. More importantly, 
both pediatric BM and thymus-derived ANA carried longer IgH-CDR3 and IgL-CDR3. 
Thus, the autoreactivity of B cells in the human thymus does not seem to be based on a 
unique Ig gene repertoire, but rather on enrichment for autoreactive B cells with similar 
sequence properties as BM-derived autoreactive B cells.
In addition to thymic B cells, were here also report for the first time on the reactivity 
of fetal BM-derived B cells. Although the repertoire of fetal B cells has been documented 
extensively,27, 31-35 the suggestion that these genes would encode autoreactive antibodies 
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has not been addressed before.36-38 We here showed that fetal B-cell derived antibodies 
bind stronger to dsDNA than pediatric BM-derived B-cells. These results suggest that 
fetal B cells indeed are more frequently autoreactive, and that their reactivity differs from 
that of thymic B cells. This would fit with a different function of fetal B cells, as opposed 
to thymic B cells, in the clearance of cell debris during extensive tissue formation and 
breakdown in the developing fetus. However, more extensive panels of autoantigens 
would need to be studies to elucidate the role of such autoreactive B cells in tissue (re)
modelling. 
Taken together, we here show that B cells present in distinct niches, i.e. fetal BM, 
pediatric BM and pediatric thymus display different reactivity which underlies their 
apparent functions. Fetal antibodies were more reactive to dsDNA, whereas thymic 
antibodies were highly reactive to protein autoantigens. B cells from thymus displayed 
an Ig gene repertoire that was similar to pediatric BM; thus the majority of B cells in 
the thymus are resident rather than developing and present auto-antigens to developing 
T-cells during negative selection. 
MATERIALS AND METHODS
Fetal and postnatal tissue
The use of human pediatric and fetal tissue was approved by the Medical Ethical 
Committees of the Erasmus MC and was contingent on informed consent in accordance 
with the Declaration of Helsinki and the Dutch Fetal tissue act. Thymus material was 
obtained from 3 children requiring surgery for congenital heart disease. These children 
were between 2 months and 1.5 year of age and did not have hematologic or immuno-
logic diseases. Fetal BM (3 donors) were obtained from elective abortions, and informed 
consent was obtained after the decision to abort was finalized. Inclusion in the study did 
not affect the treatment regime in any way, and did not involve any form of payment. 
Gestational age was determined by ultrasonic measurement of the diameter of the skull 
and ranged from 15 to 18 weeks. 3 pediatric BM samples were obtained previously from 
children aged 2-6 years.39, 40 
Single-cell sorting
B cell subsets were purified from homogenized pediatric thymuses, fetal limb BM 
suspensions and pediatric BM aspirates as described previously.11, 19, 39-41 Following Ficoll 
density gradient centrifugation (Ficoll-Paque PLUS), mononuclear cells from thymuses 
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were depleted for CD8 and CD4 positive cells by magnetic separation (Miltenyi Biotec). 
The obtained cells from thymus, fetal BM and pediatric BM samples were stained with the 
following monoclonal antibodies: CD20-PB (2H7), CD27-BV421 (O323), IgM-BV510 
(MHM-88), IgD-FITC (IA6-2), IgM-PerCP-Cy5.5 (MHM-88), IgD-PerCP-Cy5.5 
(IA6-2, all from BioLegend), CD34-FITC (8G12), CD20-PE (L27), CD123-PE (9F45), 
CD19-PE-Cy7 (SJ25C1), CD22-APC (S-HCL-1), CD34-APC (8G12; all from BD 
Biosciences), CD45-PO (HI30, Invitrogen) and CD10-APC-C750 (HI10A, Cytognos). 
Naive mature B cells defined as CD19+CD20+CD10-IgM+IgD+CD27- were single-cell 
sorted on a FACSAria cell sorter with FACSDiva software (BD Biosciences) into 96-well 
PCR plates containing 4 µl lysis solution (0.5× PBS containing 10mM DTT, 8 U RNAsin 
(Promega), and 0.4 U 5′-3′ RNase Inhibitor (Eppendorf )) and immediately frozen on dry 
ice.
 
cDNA synthesis, Ig genes amplification and antibody production
RNA from single cells was reverse-transcribed in the original 96-well plate in 12.5 
µl reactions containing 100 U Superscript III RT (Life Technologies) for 45 minutes 
at 42°C. PCR reactions and primer sequences (Table S1).17, 42, 43 Ig cloning and anti-
body expression procedures were performed as described previously.15, 17, 42, 43 The usage 
of V, D, J genes as well as the junctional regions were analyzed using the international 
ImMunoGeneTics (IMGT) information system (http://imgt.cines.fr/).20
ELISAs
Antibody reactivity analysis was performed as described previously, and the highly 
polyreactive ED38 antibody was used as positive control.15, 17, 42, 43 Briefly, ELISA assays 
were performed to determine Ig reactivity to HEp-2 cell lysate (Inova Diagnostic), Hep-2 
cell protein lysate (Novus Biologicals), dsDNA, insulin, LPS, BSA (all from Sigma-
Aldrich) and MDA-BSA (Academy Bio-medical) using antibodies concentrations of 10 
µg/ml (Hep-2 cell lysate and Hep-2 cell protein lysate) or 1 µg/ml (dsDNA, insulin, 
LPS, BSA and MDA-BSA). Anti-human Igκ and Igλ horse radish peroxidase (HRP) 
conjugates were used for detection (both from Sigma). ELISAs were visualized with 
3,3’,5,5’-Tetramethylbenzidine (TMB) and the reaction was stopped with 1M H2SO4 
prior to optical density (OD) measurements at 450 nm wavelength. Cut-off values were 
determined independently for each ELISA assay based on the total measurements, with 
values above normal Gaussian distribution defined as being positive. 
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Statistics
Statistical significance was calculated by with the non-parametric Mann-Whitney U 
test, or the χ2 test as indicated in the Figure legends. P values <0.05 were considered as 
significant.
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Table S2. Reactivities of fetal BM-, pediatric BM- and thymus-derived antibodies towards Hep-2 cell lysate, 
Hep-2 protein lysate, dsDNA, insulin, MDA-BSA and LPS.
Sample Hep-2 cell lysate Hep-2 protein lysate dsDNA insulin MDA-BSA LPS
fetal BM_1 - - + - - -
fetal BM_2 - - + - - -
fetal BM_3 - - + - - -
fetal BM_4 - - + - - -
fetal BM_5 - - + - - -
fetal BM_6 - - + - - -
fetal BM_7 - - - - - -
fetal BM_8 - - + - - -
fetal BM_9 - - + - - -
fetal BM_10 + - + - - -
fetal BM_11 + - + - - -
fetal BM_12 - - - - - -
fetal BM_13 - - + - - -
fetal BM_14 - - + + - -
fetal BM_15 - - + - - -
fetal BM_16 + - - - + -
fetal BM_17 - - + - - -
fetal BM_18 - - + - - -
fetal BM_19 + - - - + -
fetal BM_20 + - + - - -
fetal BM_21 - - + + + -
fetal BM_22 + - + - + -
fetal BM_23 + - + - - -
fetal BM_24 + - - - - -
fetal BM_25 + - + - - -
fetal BM_26 + - + - + -
child BM_1 - - + - - -
child BM_2 - - - - - -
child BM_3 - - + - - -
child BM_4 - - - - - -
child BM_5 - - - - - -
child BM_6 - - + - - -
child BM_7 - - + - - -
child BM_8 - - + - + +
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child BM_9 - - + - + -
child BM_10 - - + - - -
child BM_11 - - + - + -
child BM_12 - - + + - +
child BM_13 - - + - + -
child BM_14 - - + - - -
child BM_15 - - + - - -
child BM_16 - - + - - -
child BM_17 - - - - - -
child BM_18 - + + - - -
child BM_19 + - - - - -
child BM_20 + - - - - -
child BM_21 + - + - - -
child BM_22 - - - - - -
child BM_23 - - + - - -
child BM_24 - - + - - -
child BM_25 - - - - - -
child BM_26 - - + - + -
child BM_27 + - - - - -
child BM_28 - + + - - -
child BM_29 - - + - - -
child BM_30 + - - - - -
child BM_31 - - - - - -
child BM_32 + - - - - -
child BM_33 - - - - - -
child BM_34 - - - - - -
child BM_35 - - - - - -
child BM_36 - - + + + -
thymus_1 - - + - - -
thymus_2 - - + - - -
thymus_3 - - + - - -
thymus_4 - - + - - -
thymus_5 - - + - - -
thymus_6 + - - - - -
thymus_7 + - - - - -
thymus_8 - + + - - -
thymus_9 - + + - - -
thymus_10 + - + - - -
VI.  The Human Thymus Is Enriched For Autoreactive B Cells
186
thymus_11 + + - - - -
thymus_12 - - + - - -
thymus_13 - + + - - -
thymus_14 - - + - - -
thymus_15 - - + - - -
thymus_16 - + + - - -
thymus_17 + - + - - -
thymus_18 + - + - + -
thymus_19 + - - - - -
thymus_20 + - - - - -
thymus_21 - - + - - -
thymus_22 + - - - - -
thymus_23 - - - - - -
thymus_24 - - + - - -
thymus_25 - + - + + +
thymus_26 + - - - + -
thymus_27 - - + - + +
thymus_28 + - + - + +
thymus_29 + - + + + +
thymus_30 + - + + + +
thymus_31 + - + - + +
“+”, positive; “-“, negative
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The total pool of B cells and T cells in every vertebrate provides an enormous antigen 
receptor repertoire, which enables the host to cope daily with the invading pathogens. 
Formation of the antigen receptor repertoire occurs through somatic V(D)J recombina-
tion of the antigen receptor loci during early stages of lymphocyte development. Still, not 
all mechanisms underlying the formation of this broad repertoire are fully understood. 
Studies described in this thesis aimed to investigate how the stage-specific recombination 
of Ig loci and the generation of a diverse Ig repertoire is controlled during precursor-B-cell 
development. 
The research described in this thesis focused on two main issues. Firstly, it showed in 
mouse models how spatial organization and long-range interactions within Ig loci and 
positioning of these loci within the nucleus regulate the stepwise V(D)J recombination 
process (Chapters II and III). Analysis of the murine IGK locus showed unexpectedly 
that the locus underwent contraction already in committed precursor-B cells before the 
rearrangement-specific stage of development. Still, despite the locus contraction, only 
pre-B cell receptor signaling induced IGK locus accessibility for recombination through a 
functional redistribution of enhancer-mediated long-range chromatin interactions within 
the Vκ region (Chapter II). In Chapter III, the IGH and IGK were shown to be both 
consistently contracted in pro-B and pre-B cells. While Ig locus contraction mediated 
efficient recombination by juxtaposing genomically distant elements, sequential posi-
tioning of the IGH and IGK loci away from the nuclear periphery determined their 
stage-specific accessibility for recombination.
In Chapters IV and V of this thesis, the diversity of Ig molecules generated at different 
stages of human life, i.e. in fetal, childhood and aging bone marrow (BM) was analyzed. 
Furthermore, the diversity and reactivity of Ig molecules was analyzed for B cells residing 
in the human postnatal thymus (Chapter VI). Aging BM produced fewer B cells with 
a seemingly normal and diverse Ig gene repertoire. The decline in B-cell production was 
associated with transcriptional upregulation of ID2 and impaired IGH locus contraction 
(Chapter IV). Developing B cells in the human fetus produced a diverse Ig gene reper-
toire with skewed V, D and J gene use and short IgH-CDR3 regions related to decreased 
IL-7R signaling and altered IGH junction processing (Chapter V). The skewed fetal Ig 
gene repertoire was reactive to dsDNA. Although, the Ig gene repertoires of pediatric BM 
and thymic B cells were very similar, thymic B cells showed increased reactivity towards 
auto-antigens (Chapter VI).  
Putative factors mediating the 3D structural organization of Ig loci
The IGH and IGK loci were contracted in pro-B cells and both loci remained con-
tracted in pre-B cells (Chapters II and III). The consistent contraction of Ig loci in 
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committed precursor-B cells raises the question how the topology of Ig loci changes during 
B-cell development and which factors organize the loci into specific spatial structures. 
Thus far, the topology of Ig loci was extensively studied for the murine IGH, which 
is organized into three multi-loop domains of rosette-like shapes in E2A-deficient pre-
pro-B cells.1 Based on genetic distance measurements, it was computed that this IGH 
locus structure fits best with the multi-loop subcompartment (MLS) model of chromatin 
organization.1, 2 The chromatin folding into MLS structures is mediated by general chro-
matin architecture proteins. Important candidates are CCCTC-binding factor (CTCF), 
cohesins and Yin-Yang 1 (YY1).3-6 CTCF and YY1 recognize specific binding sites across 
the mammalian genomes and through long-range interactions establish the chromatin 
loops, whereas cohesins interact with CTCF and form a ring-like structure around the 
chromatin loops to maintain them.5 CTCF and YY binding sites have been found within 
the murine IGH locus at regulatory elements such us Pax5-activated intergenic elements 
(PAIRs), intergenic control region (IGCR1), iEµ and 3’RR.7-9 Recent analysis of the 
pro-B cell genome indeed indicates that the interactions between CTCF, cohesins and 
YY1 form the long-range contacts between chromatin loops which belong to one multi-
loop domain of the IGH locus.7, 10-13 Thus, the organization of the IGH locus into MLS 
structures is established by CTCF, cohesins and YY1 and this specific chromatin topology 
is already present in uncommitted precursor-B cells (Figure 1A). 
CTCF, cohesin, YY1
E2A, Pax5
enhancers
IGH in pre-pro-BA
B
IGH in pro-B
IGK in pre-pro-B IGK in pro-B
Figure 1. 3D structure of Ig loci. To form a diverse Ig gene repertoire, precursor-B cells rearrange Ig loci 
in developmentally ordered manner. The stepwise V(D)J recombination is regulated by changes in the 3D 
structure of Ig loci during B-cell development. (A) In uncommitted precursor-B cells, Ig loci are organized into 
multi-loop subcompartments (MLS) by general chromatin architecture proteins, i.e. CTCF, cohesins and YY1. 
(B) Upon B-cell commitment, both Ig loci are further contracted by B-cell specific factors, such as E2A and 
Pax5, to bring all Ig coding elements into spatial proximity and facilitate efficient recombination. 
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The IGK locus topology has not been studied yet in such a precise way as it was done 
for the IGH locus. However, we can hypothesis that the IGK topology in uncommitted 
precursor-B cells also fits with the MLS model as CTCF binding sites are present along 
the IGK locus11, 14 and CTCF is ubiquitously expressed (Figure 1B). Moreover, the IGH 
and IGK loci showed the same order of magnitude for spatial distances measured by 
fluorescence in situ hybridization (FISH) in E2A-/- pre-pro-B cells (Chapter III) which 
further suggests that the IGK locus is organized into MLS structures in early progenitor-B 
cells. Still, to prove this assumption, detailed FISH studies of the IGK locus in B-lineage 
and non-B lineage cells are needed. 
The 3D structural organization of IGH into MLS structures is in line with the current 
conviction of the mammalian genome organization into clusters of loops.12, 15, 16 Still, the 
general chromatin folding is insufficient to provide high interaction frequencies between 
V and DJ genes to efficiently mediate V(D)J recombination.17 We and others indeed 
observed contraction of IGH in pro-B cells as compared to pre-pro-B cells (Chapter 
III).1, 18, 19 Because the IGH locus is decontracted in E2A-/- uncommitted B-cells, T-cells 
and erythroid progenitors (Chapter III),19, 20 this contraction is likely established by 
B-cell specific factors. Thus far, E2A and Pax5 have been shown to be involved in IGH 
locus contraction. These proteins recognize multiple binding sites within the IGH regu-
latory elements7 and mice deficient for E2A and Pax5 were unable to contract the IGH 
locus.19, 21 Other candidate factors are EBF1, Ikaros and PU.1. Although their role in 
IGH locus contraction has not been proven yet, the long-range interactions between 
multi-loop chromatin domains of the IGH locus were attributed to EBF1, Ikaros and 
PU.1 in addition to E2A and Pax5.7-13, 21-25 To precisely address the role of EBF1, Ikaros 
and PU.1 in locus contraction, B cells deficient for these factors should be subjected to 
FISH-based microscopic analysis of the IGH topology. Selective deficiencies for each 
factor can be achieved through generation of knockout mice or silencing of gene expres-
sion via shRNA. Additional evidence for the role of B-cell specific factors in locus con-
traction was shown in FISH studies of the IGH in CTCF-/- pro-B cells.10 Spatial distances 
measured between genetic makers aligned across the IGH locus were only marginally 
larger in CTCF-/- pro-B cells than in wild type pro-B cells.10 This suggests that disruption 
of contacts maintained by CTCF between chromatin lops within multi-loop domain had 
a minor effect on the total IGH contraction established through interactions between 
chromatin loops belonging to distinct multi-loop domains. Thus, IGH locus contraction 
is most likely maintained by B-cell specific transcription factors, such as E2A and Pax5 
(Figure 1A). 
The IGK locus was already contracted in pro-B cells (Chapters II and III). Since 
B-cell specific transcription factors such as E2A, Pax5, EBF1, Ikaros and PU.1 are widely 
expressed from the earliest stages of B-cell development (Chapter III), it is tempting to 
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speculate that upon B-cell commitment, these B-cell specific factors also mediate IGK 
locus contraction. IGK locus contraction in pro-B and pre-B cells was dependent on the 
presence of E2A (Chapters II and III). E2A was already detected at the κ enhancers and 
Vκ genes in pro-B cells,26, 27 where E2A was frequently found at the base of long-range 
chromatin interactions together with CTCF and PU.1, possibly acting as ‘anchors’ to 
organize genome topology.12 The correlation between E2A binding, Vκ gene usage and 
iEκ proximity in pro-B cells (Chapter II) further strengthens an early critical role for 
E2A in regulating IGK locus topology (Figure 1B). Still, to better chart the IGK topology 
during B-cell development and define the locus remodeling mediators, more extensive 
FISH microscopy and chromatin immunoprecipitation (ChIP-Seq) studies of the IGK 
locus in pro-B and pre-B cells are needed.       
Due to their large genomic sizes, Ig loci need to undergo contraction to bring all Ig 
genes in spatial proximity to provide their equal usage during recombination. Still, the 
current model of Ig loci accessibility for recombination postulates that the loci contract 
only at the stage of rearrangement and they decontract after successful rearrangement to 
ensure allelic exclusion.1, 18-20, 28 Our consistent finding of locus contraction of both IGH 
and IGK in pro-B and pre-B cells contrasts with the current model (Chapters II and 
III). In previous studies, purified wild type precursor-B-cell subsets were used,18 whereas 
the studies described in this thesis were performed in cells derived from RAG-deficient 
mice. These precursor-B cells retain the IGH and IGK loci in germline configuration, 
excluding any effects of Ig gene rearrangements on the 3D structural organization. The 
absence of RAG creates a slightly artificial situation, because no DNA breaks are induced 
that could affect gene expression programs in the progenitor-B cells.29 Still, the immuno-
phenotypes of the pro-B and pre-B cells were normal, as was the specific upregulation of 
IGH and IGK germline transcripts (Chapters II and III). Thus, the limitations of using 
RAG-deficient models were marginal and did not outweigh the advantage of having the 
Ig genes in germline configuration to establish contraction of both IGH and IGK loci in 
committed precursor-B cells. By contrast, the wild type pro-B cells and pre-B cells can 
have already rearranged Ig genes that affect the spatial distance measurements and mislead 
the analysis of locus structure. Thus, the current model of Ig loci contraction only at the 
stage of rearrangement was established based on observations in a limited model system.18 
Similarly to murine Ig loci, the human IGH locus undergoes topological changes 
during B-cell differentiation20 which are essential for efficient Ig gene rearrangements 
(Chapters IV and V). Impaired IGH locus contraction in B-cell progenitors developing 
in aging BM decreased the V(D)J recombination efficiency and consequently resulted in 
decline of B-cell output from BM (Chapter IV). Our knowledge about human Ig loci 
organization and factors mediating their 3D structure is still limited. The spatial distances 
measured within the human and murine IGH loci in pro-B cells were very similar and 
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smaller than in uncommitted precursor-B cells or T-cells (Chapter III).19, 20 Thus, the 
human IGH locus is likely also organized into MLS structures by general folding factors, 
and in committed B-cell precursors it is further contracted by B-cell specific proteins. 
This assumption, however, requires further investigation. Future chromosome conforma-
tion capture and microscopy studies of the human Ig loci could extend our knowledge 
about the locus topology and establish the presence of long-range interactions. ChIP-Seq 
studies could provide information about factors involved in the 3D organization of the 
loci. Still, wild type precursor-B cells potentially sorted from human BM constitute het-
erogeneous populations containing partially rearranged  Ig genes. Therefore, it is import-
ant to establish a human system with germline Ig loci, which would allow for unbiased 
studies of 3D locus organization. A possible solution can be the use of precursor-B cells 
from RAG-deficient patients. During the diagnostic work-up BM aspirates are obtained 
from these patients, which could be a source for precursor-B cell. The rate-limiting factor 
is the low number of precursor-B cells in these patients, however, this could be overcome 
by expansion of these cells via in vitro culture or transplantation of hematopoietic stem 
cells into RAG-/-γc-/- mice.20
Repressing genes by tethering to the lamins 
The consistent contraction of both Ig loci (IGH and IGK) in pro-B cells and pre-B 
cells (Chapter III) raises an important question about the mechanisms that mediate 
the developmentally ordered recombination. We here showed induction of changes in 
chromatin mobility during B-cell development. Ig loci changed their nuclear localization 
within chromosome territories in interphase nucleus from the transcriptionally repressive 
nuclear periphery to central active domains only at the developmental stage at which 
these loci would normally undergo V(D)J recombination (Figure 2A-B) (Chapter III).30, 
31 The exact mechanisms by which the loci re-localize are currently not known.
Repression of genes positioned at the nuclear periphery occurs through locus binding 
to the lamina (Figure 2B).32-34 The IGH locus was repressed in fibroblasts by association 
to lamina through specific lamina associated sequences (LASs) which were enriched for a 
GAGA motif.35 This repeated motif was bound by the transcriptional repressor cKrox in 
a complex with histone deacetylase HDAC3 and the nuclear envelope protein and tran-
scriptional repressor LAP2beta.35, 36 Blockage of HDAC3 in pre-pro-B cells resulted in 
disruption of the repressive complex and consequently reduced the Ig loci localization at 
the nuclear periphery and induced transcriptional activation (Chapter III). Interestingly, 
another histone mark, i.e. H3K9 redirects genes back to the nuclear lamina.37 Perhaps the 
repressive H3K27me3 histone mark common within the IGK locus in pro-B cells, could 
also mediate interactions of the IGK with the lamina. This could be determined with 
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experiments in which lamina associated domains (LADs) are determined in the three 
consecutive B-cell developmental stages, i.e. pre-pro-B, pro-B and pre-B cells and these 
data are correlated with the ChIP-Seq results of the H3K27me3 histone mark. 
A B
nuclear lamins
IGH in pro-B IGH in pre-B
active histone mark
repressive histone mark
IGK in pre-BIGK in pro-B
Figure 2. Nuclear re-positioning of Ig loci. Both the IGH and IGK loci are contacted in committed precur-
sor-B cells, although IGH is rearranged in pro-B cells, and IGK in pre-B cells (A) During progenitor B-cell 
development, the stepwise accessibility of consistently contracted Ig loci is established through repositioning of 
the loci at the stage of rearrangement from repressive nuclear periphery (nuclear lamina) closer to transcriptional 
hubs localized in the nuclear center. (B) In pro-B cells, the IGH locus is specifically repositioned from the 
nuclear periphery to the central nuclear domains, while for the IGK locus this movement occurs only in pre-B 
cells.
Another issue that remains unsolved is whether movement of Ig loci away from the 
nuclear lamina is an active process, or occurs passively once the direct interaction is dis-
rupted. Recent evidence indicates that the Ig loci are rather stably positioned within 
the nucleus of pro-B cells.38 Thus, it is more likely that the loci are moved in an active 
manner, for instance by chromatin remodelers. These large ATP-dependent complexes 
can shift nucleosomes or in some cases remove or replace them to create space within 
DNA for transcription factors.39-41 Recently, the chromatin remodeler INO80-complex 
was shown to enhance the long-range chromatin mobility which consequently correlated 
with increased recombination.42 Remodeling complexes can read specific histone marks, 
which allows them to carry out their remodeling tasks.41 Thus, the ordered pattern of 
histone modifications within Ig loci during early B-cell development could act as a trigger 
for deposition of chromatin remodelers, thereby changing the nuclear position of the loci 
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and consequently providing the ordered rearrangement. Future studies on factors medi-
ating the Ig locus mobility within the nucleus during B-cell development could provide 
milestone knowledge in our understanding how the stepwise rearrangement process is 
controlled.
Ig enhancers facilitate the stepwise rearrangements
The iEµ and iEκ enhancers are important for induction of Ig gene rearrangements,43-46 
and E2A-mediated locus contraction increases the interaction levels between IgV genes 
and iEµ and iEκ in pro-B cells and pre-B cells (Chapter II and III). Still, the IGK locus 
was not accessible for rearrangement until the pre-B cells stage (Chapter II). Thus, it 
remains puzzling how the enhancers control induction of the rearrangement event in a 
developmentally ordered manner.
The histones within Ig regulatory elements undergo modifications during B-cell 
development to increase the locus accessibility for RAG proteins.47 RAG2 is recruited to 
Ig loci through binding to H3K4me3 histone marks,48, 49 and these modifications were 
detected within the IGH locus in pro-B cells, but within the IGK locus only in pre-B 
cells.50 Additionally in pro-B cells, IGK was localized at the nuclear periphery, which cor-
relates with transcriptional repression (Chapter III). IL-7R recruited STAT5 tetramers 
to iEκ in pro-B cells, which induced Ezh2 methyltransferase and repressive H3K27me3 
marks within the iEκ enhancer (Figure 3).51 Perhaps the H3K27me3 mark mediates 
attachment of the IGK locus in pro-B cells to the nuclear lamina and thereby makes the 
locus inaccessible for the V(D)J recombinase. Still, incorporation of iEµ into the IGK 
locus and deletion of E-boxes from iEκ did not reposition the IGK locus from the nuclear 
periphery to more centrally located domains (Chapter III). Because E-boxes within iEµ 
and iEκ contain binding sites for E2A, this suggest that E2A does not play a role in 
chromatin mobility. However, it does not rule out the possibility that other transcription 
factors that also bind to iEµ and iEκ, such as NFκB, function as chromatin guiders and 
thereby provide a function for intron enhancers in chromatin mobility, facilitating the 
process of ordered rearrangements. 
The inaccessibility of iEκ for E2A binding in pro-B cells prevents too early rearrange-
ment events,51 although it did not affect locus contraction (Chapter III). Interestingly, 
deletion of iEµ did not affect the IGH topology either.17 Thus, while the intron enhancers 
are crucial for rearrangement,43-46 these seem redundant for locus contraction. Likely, the 
presence of multiple binding sites for general and B-cell specific factors across the Ig loci 
is sufficient to maintain their 3D structure.
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Figure 3. IL-7R signaling and STAT5. IL-7R induced STAT5 activation regulates the accessibility of Ig loci for 
recombination. In pro-B cells, STAT5 homodimers promote IGH locus accessibility to the V(D)J recombinase, 
whereas as a STAT5 tetramers deposited on iEκ suppress Vκ to Jκ gene rearrangements through induction of 
repressive histone marks.
Pre-BCR signaling increases IGK locus accessibility
Although the E2A-mediated IGK locus contraction increased the amount of long-
range interactions between Vκ genes and κ enhancers already in pro-B cells, only 
recruitment or further accumulation of E2A, Ikaros and IRF4 at the IGK enhancers 
following pre-BCR signaling focused the enhancer-mediated interactions on the Vκ 
genes and thereby increased the locus accessibility for RAG proteins (Chapters II and 
III). Still, E2A and Ikaros are also expressed in pro-B cells (Chapters II and III). This 
raises the question how pre-BCR signaling increases IGK locus accessibility for Vκ-Jκ 
recombination. 
Induction of IGK gene rearrangements occurs only after attenuation of IL-7R sig-
naling and is mediated by pre-BCR signaling through SLP65 (BLNK) and BTK. SYK 
phosphorylates BTK and SLP65 which inhibits STAT5 phosphorylation and thereby 
attenuates the cell cycle. This allows the IGK locus to escape from the repressive histone 
marking supported by IL-7R signaling (Figure 3).51 SLP65 also activates the RAS-ERK 
pathway, which together induces E2A and represses the E2A inhibitor ID3.52 The result-
ing greater abundance of free nuclear E2A can now bind to the available E-boxes within 
iEκ and mediate the long range interactions between κ enhancers and Vκ genes. Indeed, 
the BTK and SLP65-deficient pre-B cells showed decreased levels of specific long-range 
interactions at Vκ genes (Chapter II). The pre-BCR signaling increases also chromatin 
accessibility for Ikaros,53-55 and these E2A and Ikaros-mediated interactions induce a 
STAT5TyrP
H3K27me3 
repressive histone mark
STAT5TyrP
active histone mark
IGH in pro-B IGK in pro-B
enhancers
IL-7R IL-7R
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functional redistribution of enhancer-mediated long-range interactions within the Vκ 
region and facilitate Vκ to Jκ gene rearrangements (Chapter II). 
Still, the mechanisms which keep the IGK locus inaccessible for Ikaros binding in 
pro-B cells remain unknown. Perhaps specific chromatin modifications attract Ikaros, or 
Ikaros can only perform this function in concert with E2A. Lack of E2A binding to iEκ 
in pro-B cells prevents Vκ to Jκ gene rearrangements. iEκ release from repressive marking 
in pre-B cells allowed for loading of E2A and Ikaros at the iEκ and thereby facilitates 
the rearrangement. The pre-BCR could potentially release the iEκ from repressive his-
tone marking by disruption of the speculative complex between H3K27me3 and nuclear 
lamina or by induction of IGK locus movement to the nuclear center. It would thus be 
very interesting to study the nuclear positioning of the IGK locus in pre-B cells with 
reduced pre-BCR signaling due to BTK and/or SLP65-deficiency. 
Ig gene repertoire formation in human fetal B-cell progenitors
The Ig gene repertoire in fetal B cells was skewed towards increased usage of Vh1-2, 
Dh7-27, Jh2 and Jh3 genes (Chapter V). It is tempting to speculate that the skewing 
towards proximal gene segments results from impaired Ig locus topology. The Ig locus 
contraction brings all Ig genes into spatial proximity which creates a stochastic environ-
ment for all genes to be recombined, albeit that during V(D)J recombination only one V, 
one (D) and one J genes are chosen for assembly. Impaired locus topology can therefore 
skew the Ig gene usage. However, IGH locus contraction was not altered in fetal progen-
itor B-cells (Chapter V). Thus, the skewed Ig gene usage in fetus does not seem to result 
from an altered global chromatin topology of IGH.
An alternative explanation for the skewed gene usage could be impaired opening of 
the IGH locus. Fetal derived human pro-B cells and pre-BI cells had decreased expression 
of IL-7R (Chapter V). Studies in mouse models have indicated a role for IL-7R induced 
activation of STAT5 in opening of the IGH locus for the transcription machinery.56 
STAT5 binds to the promoters of multiple Vh genes, and STAT5-/- pro-B cells show 
impaired induction of Vh-DJh rearrangements.57, 58 STAT5 did not affect the nuclear 
repositioning or compaction of the IGH locus, but regulated locus opening through ger-
mline transcription and histone acetylation of the distal Vh region in pro-B cells.56 Thus, 
likely in the fetus, the DJh region was more efficiently opened at the proximal site, which 
increased the usage of Dh7-27, Jh2 and Jh3 genes. Subsequently, the Vh region was also 
more accessible at its proximal site, resulting in the increased usage of Vh1-2 in IGH gene 
rearrangements in the fetus. 
How IL-7R expression is regulated in B cells remains unknown. In invariant natural 
killer (NK)T cells, IL-7R expression is under control of the transcription factor lymphoid 
201
Formation of the Immunoglobulin Repertoire in Precursor-B-cell Development
enhancer factor 1 (LEF1).59 Interestingly, LEF1 was highly expressed in progenitor-B 
cells of pediatric BM,60 while in fetal progenitor-B cells the transcript level of LEF1 was 
decreased (Chapter V). Thus, the low expression of LEF1 in fetal precursor-B cells cor-
responds with the lower IL-7R expression and decreased STAT5 activation leading to 
the impaired IGH locus opening (Figure 4). Furthermore, the Ig gene repertoire in fetal 
precursor-B cells was characterized by shorter IgH-CDR3 regions due to less amount of 
N-nucleotides (Chapter V).61-68 The shorter junction formation was caused by altered 
IGH junction processing due to decreased TdT expression which, as suggested by the 
ingenuity pathway analysis, was related to decreased IL-7R expression (Chapter V). Thus, 
the formation of the skewed fetal Ig gene repertoire is very likely controlled by decreased 
IL-7R signaling. It would be interesting to confirm that decreased IL-7R signaling directly 
causes decreased TdT expression and consequently reduced insertion of N-nucleotides in 
the Ig gene repertoire of B cells from IL-7R-deficient patients.  
The expression of LEF1 in fetal derived precursor-B cells could be controlled by exter-
nal factors such as antigens. Fetuses develop in a sterile host with limited amounts of 
pathogens. The skewed fetal Ig repertoire could thus be considered as a basic Ig repertoire. 
This Ig repertoire already changes prior to birth as evidenced from the less skewed IGH 
gene repertoire in neonatal cord blood (Chapter V). It is tempting to speculate that this 
is caused by exposure to external antigens, which can already cross the placenta at low 
concentrations, but will especially affect the neonate upon direct exposure to the environ-
ment. How the presence of antigens within fetuses would result in upregulation of LEF1 
and IL-7R, remains subject of further studies.
Ig gene repertoire formation in postnatal aging BM
Aging BM produced a diverse Ig gene repertoire as compared to B cells of pediat-
ric BM, but fewer B cells were generated with age (Chapter IV). The decline in B-cell 
production was associated with transcriptional upregulation of ID2 (Chapter IV). As 
an E2A-inhibitory protein, ID2 is assumed to have a central role in modulating the 
E2A-dependent transcriptional regulatory networks, and hence inhibits B-cell lineage 
commitment and differentiation.69, 70 We did not observe a block at early stages of B-cell 
development in adults, and the relative composition of the B-cell compartment of adult 
BM was normal (Chapter IV). Thus, ID2 upregulation might result in decreased B-cell 
generation, but not in inhibition of maturation. Likely, the decreased B-cell output from 
adult BM was caused by altered IGH locus contraction. The IGH locus contraction is 
established by general chromatin folding factors and B-cell specific transcription factors, 
including E2A (Chapters II and III).7-13, 21-25 Thus, even in the presence of normal E2A 
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transcript levels (Chapter IV), upregulation of ID2 likely suppresses E2A-mediated Ig 
locus contraction and reduced efficient V(D)J recombination (Figure 4).
Figure 4. Bone marrow delivers different signals to developing B-cells during life. B-cell development in 
BM starts before birth and continues in postnatal BM. Through human life, the environmental milieu in BM 
undergoes physiological changes which results in providing different signals to developing B cells and thereby 
distinct Ig gene repertoires are generated. The fetal Ig gene repertoire is skewed towards proximal IGH gene 
usage and shorter junction formation due to decreased IL-7R signaling. IL-7R expression stays under control of 
the transcription factor lymphoid enhancer factor 1 (LEF1). The decreased IL-7R signaling in fetuses resulted in 
lower STAT5 activation and impaired IGH locus opening. Ig gene repertoire generated in aging BM is diverse 
but fewer B cells are produced due to transcriptional upregulation of ID2. ID2 inhibits E2A, the mediator of 
locus contraction, which causes impaired IGH locus contraction and less efficient V(D)J recombination. 
Which factors induce the expression of ID2 in precursor-B cells is not known. Likely 
the expression of ID2 is regulated by cytokines produced by BM stromal cells. It was 
recently shown that the production of chemokine CCL5 increases with age. CCL5 is 
produced by BM stromal cells and supports myeloid production from HSC and inhibits 
lymphopoiesis.71 It is therefore possible that CCL5 or other soluble factors control ID2 
expression in B-cell progenitor. Moreover, it is tempting to speculate that the cytokine 
levels produced by BM stromal cells are controlled by external factors, such as inflam-
mation status. Adults have difficulties in clearing new infections and the pathways of B 
lymphopoiesis deviate from normal at old age as a consequence of increased inflammation 
locally within the BM.72 Another plausible mechanism could be the increased number 
of plasma cells and memory B-cells with age. It was previously shown that expansion of 
E2A ID2
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STAT5TyrP
distal V genes
IL-7R
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the memory-B cell compartment with age negatively affects B-cell development.73 If the 
presence of large numbers of memory-B-cells and plasma cells affects ID2 expression, 
this would be reversed when these cells are depleted. Thus, it would be interesting to 
unravel whether adults following B-cell depletion therapy show normal ID2 expression 
and normal IGH locus contraction. Such studies could e.g. be performed in adults who 
have replenished their B-cell compartment, but still have reduced memory B cell frequen-
cies following rituximab treatment.  
Distinct hematopoietic stem cells (HSC) within prenatal and postnatal bone 
marrow 
The apparent quantity and diversity of Ig molecules generated from fetal, childhood 
and adult BM (Chapters IV and V) could alternatively result from intrinsic properties of 
HSC. It is suggested based on studies in mouse models that the HSCs in fetuses differen-
tiate mainly into B-1 cells, while in postnatal BM the B-2 cell fate dominates.74 A striking 
distinction between these two B-cell populations is the less diverse Ig gene repertoire of 
B-1 cells as compared to B-2 cells and this, in turn, is reflected in the capacity of these two 
populations to respond to antigens.75, 76 Indeed, antibody responses towards certain anti-
gens are impaired in neonates,64, 65, 77 which is partially related to the pre-mature diversity 
of the fetal Ig repertoire (Chapter V) and thus supports a different origin of fetal B cells. 
However, the presence of B-1 cells in humans is still controversial and has not been 
definitively demonstrated,78-80 and adult-derived precursor-B cells were found to gener-
ate a diverse IGH gene repertoire in NOD-SCID mice.81 In additional, in vivo recip-
rocal adoptive transfers of either young or aged BM cells into irradiated young or aged 
recipients indicated that reconstitution of B lymphopoiesis was influenced by the host 
microenvironment.82 Thus, Ig gene repertoire formation in B-cell progenitors seems more 
dependent on the distinct signals delivered by BM stromal cells during life rather than 
distinct HSC properties. 
Ig gene repertoire and Ig reactivity
B cells in the human thymus were more reactive to protein auto-antigens than 
BM-derived B cells, despite their seemingly similar Ig gene repertoires (Chapter VI). By 
contrast, fetal B cells carried a skewed Ig gene repertoire (Chapter V), and displayed only 
a marginal increase in reactivity to dsDNA (Chapter VI). This raises a question how the 
Ig gene repertoire and accordingly the Ig reactivity is shaped during B-cell development 
in distinct niches.
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B cells that develop in distinct niches have been found to play different functions. 
Fetal B cells are suggested to clear common pathogens and cell debris produced during 
extensive hematopoiesis.83-85 Therefore, the Ig produced by fetal B cells had mostly natural 
antibody properties with a skewed Ig gene repertoire. Still, fetal Ig molecules did not 
recognize more frequently cellular antigens, insulin, dsDNA or epitopes expressed on 
apoptotic cells such as MDA (Chapter VI). Thus, the exact function of fetal B cells 
remains unknown. Due to shorter IGH junctions and thereby smaller antigen-binding 
loops, the fetal antibodies are likely less specific and recognize more general foreign struc-
tures. This would make sense, as in utero infections are rare, and the fetus is also protected 
by maternal IgG antibodies that have crossed the placenta.86, 87 To better elucidate the 
role of fetal antibodies, more extensive panels of antigens with different properties would 
need to be studied. 
By contrast, the thymic B cells were enriched in autoreactive clones that are capable 
to take up auto-antigens and present these to developing T-cells during negative selec-
tion.88-90 This was confirmed by greater amount of anti-nuclear antibodies (ANA) in 
thymus than in pediatric BM (Chapter VI). Still, we did not find evidence of skewed V, 
D and J gene usage in ANA, although we do not exclude that subtle differences may exist 
in gene usage that will only be detectable with next-generation sequencing analysis. More 
importantly, however, both pediatric BM and thymus-derived ANA carried longer IgH-
CDR3 and IgL-CDR3. Thus, the auto-reactivity of B cells in the human thymus does not 
seem to be based on a unique Ig gene repertoire, but rather enrichment for autoreactive B 
cells with similar sequence properties as BM-derived autoreactive B cells.
Concluding remarks    
During life, B-cells differentiate in BM in consecutive stages to rearrange their Ig 
genes and ultimately generate a broad Ig repertoire. Studies described in this thesis pro-
vide better understanding how the Ig gene repertoire formation is regulated. The step-
wise V(D)J recombination process is tightly controlled by transcriptional and epigenetic 
mechanisms which must cooperate to provide the stepwise developmental increase in 
Ig loci accessibility for rearrangement. Furthermore, the formation of a diverse Ig gene 
repertoire is differentially regulated during ontogeny. Through life, the BM milieu is 
modified by external factors. This provides different signals to developing B cells and 
consequently results in formation of Ig gene repertoires with different reactivity. Which 
environmental factors modify the Ig loci accessibility for the V(D)J recombinase and 
thereby control the Ig repertoire formation remains a subject for future studies. This 
knowledge could then potentially be applied to help shape an optimal Ig repertoire in 
patients with inherited immune diseases or patients following B-cell depletion treatment.
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3C-Seq circular chromosome conformation capture with high-through-put sequencing
3D FISH 3-dimensional fluorescence in situ hybridization
ATM ataxia telangiectasia mutated
BCR B cell antigen receptor
bHLH basic helix loop helix
BM bone marrow
C constant
CBE CTCF binding element
ChIP chromatin immunoprecipitation
CDR complementary determining region
CTCF CCCTC binding factor
CyIg cytoplasmic Ig
D diversity gene segment
DNA-PKcs catalytic subunit of DNA dependent protein kinase
DSB double strand break
EBF early B cell factor
FOXO1 forkhead box protein O1
FR framework
HSC hematopoietic stem cell
iE intron enhancer
Ig immunoglobulin
IGCR1 intergenic control region
IgH Ig heavy chain
Igκ Ig kappa light chain
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Igλ Ig lambda light chain
J joining gene segment
LAD lamina associated domain
LAS lamina associated sequence
LIG4 DNA ligase IV
Mb megabases
MLS multi-loop subcompartment
NHEJ nonhomologous end joining
N-nucleotide random nucleotide
PAIR Pax5-activated intergenic elements
P-nucleotide palindromic nucleotide
RAG recombinase activating gene
RQ-PCR real-time quantitative polymerase chain reaction
RSS recombination signal sequence
SiS silencer in the intervening sequence
SmIg surface membrane Ig
STAT5  signal transducer and activator of transcription 5
TAD topologically associated domain
TCR T cell receptor
TdT terminal deoxynucleotidyl transferase
TF transcription factor
CB cord blood
V variable gene segment
YY1 Yin Yang 1
Addendum
216
SUMMARY
Precursor-B cells develop in bone marrow (BM) from hematopoietic stem cells (HSC) 
with the ultimate goal to generate mature B-cells with unique immunoglobulins (Ig), 
whereby all B cells together provide an enormous Ig repertoire diversity. Formation of the 
Ig occurs through somatic V(D)J recombination of the Ig heavy chain (IGH) and the Ig 
light chain (IGK or IGL) loci that contain multiple variable (V), diverse (D) and joining 
(J) coding elements. Random assembly of these elements creates the highly diverse Ig 
repertoire. The Ig loci recombine in a ordered manner. The IGH locus rearranges before 
the Ig light chain loci and functional Ig rearrangements are generally restricted to one 
allele. Although the V(D)J recombination machinery is expressed in both B cells and T 
cells, complete Vh-DJh rearrangements occur in B cells. Thus, the ordered accessibility 
of Ig loci for rearrangements is tightly controlled. Studies described in this thesis aimed 
to better understand the mechanisms underlying the stage-specific regulation of V(D)
J recombination and the generation of a diverse Ig repertoire during precursor-B-cell 
development.
During B-cell development, the precursor-B cell receptor (pre-BCR) signaling is 
thought to increase the IGK locus accessibility to the V(D)J recombinase enzyme system. 
However, it remains unknown how the pre-BCR-induced signals regulate the IGK locus 
accessibility. In Chapter II, we identified the effects of pre-BCR signaling on germline Vκ 
transcription and on the expression of transcription factors implicated in the regulation 
of IGK gene rearrangement. We found that the decrease in pre-BCR signaling capacity 
from wild-type to BTK-deficient, and to SLP65-deficient and BTK/SLP65 double-defi-
cient pre-B cells was paralleled by a progressively decreased expression of many transcrip-
tion factors including Ikaros, Aiolos,  IRF4 and (to a lesser extent) E2A, as well as by a 
decreased IGK locus accessibility for recombination. Several of these factors can mediate 
long-range chromatin interactions and are known to occupy κ regulatory elements that 
regulate locus accessibility. We therefore analyzed the effect of pre-BCR signaling on the 
higher-order chromatin structure organized by these regulatory sequences at the IGK 
locus. To this end, we performed chromosome conformation capture and sequencing 
(3C-seq) analyses on pro-B cells, and pre-B cells from mice single or double deficient for 
BTK or SLP65 to evaluate the effects of different levels of pre-BCR signaling on IGK 
locus topology. These 3C-seq experiments demonstrated that already in pro-B cells the κ 
enhancers robustly interact with the Vκ region and its flanking sequences, and that pre-
BCR signaling induces accessibility by a functional redistribution of enhancer-mediated 
chromatin interactions within the Vκ region.
Committed B-cell progenitors show large-scale Ig locus contraction to provide 
a diverse Ig repertoire. Initially, Ig locus contraction was thought to occur only at the 
stage of locus rearrangement, however, recent observations question whether Ig locus 
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contraction is decisive for V(D)J recombination. In Chapter III, we have examined how 
Ig locus contraction and nuclear positioning are associated with the stepwise control of 
V(D)J recombination. We analyzed locus contraction, long-range chromatin interactions 
and nuclear positioning of the germline IGH and IGK alleles in three consecutive progen-
itor-B-cell subsets with 3D-DNA FISH and 3C-Seq. This integrated approach enabled us 
to identify that both Ig loci were already contracted in the earliest committed pro-B-cell 
stage and retained this configuration in pre-B cells. In contrast, positioning away from 
the nuclear lamins was tightly regulated for IGH in pro-B cells and for IGK in pre-B 
cells, and correlated with germline transcription. Thus, nuclear localization rather than 
Ig locus topology is closely linked with the developmental regulation of IGH and IGK 
locus assembly.
After birth, B cell generation in human BM continues throughout life, although the 
total pool of precursor-B cells decreases with age. The effects of aging on human precur-
sor-B-cell development have been scarcely studied so far. In Chapter IV, we analyzed 
precursor-B-cell subsets and their gene expression profiles in BM from healthy young 
children and adults. We characterized the differences in transcriptional activity of pre-
cursor-B cells in adults and children, and identified differences in V(D)J recombination 
factors, ID2, and cell cycle genes that could underlie the marked age-related reduction 
in the human precursor-B-cell compartment. Functional analysis of potentially involved 
mechanisms indicated that upregulation of ID2 in adults inhibited E2A-mediated Ig 
locus contraction. This caused reduction in efficiency of V(D)J recombination and pre-
cursor-B-cell differentiation leading to decline in B-cell output from BM.
B cell generation starts already before birth in fetal liver and fetal BM providing the 
neonate with a diverse Ig repertoire. Still, antibody responses towards certain antigens 
are impaired in neonates and this initial inability to mount such antibody responses is 
underlined by “pre-mature” diversity of the Ig repertoire. In Chapter V, we studied the 
differences in formation of the Ig repertoire between fetal and pediatric B-cell precursors 
at 4 levels, i.e. cellular composition of the precursor-B-cell compartment in BM, epigen-
etic organization of the IGH locus, genetic composition of Ig gene rearrangements, and 
expression of factors involved in V(D)J recombination. With this approach, we demon-
strated that fetuses generated a diverse Ig gene repertoire. Still, this repertoire showed 
skewed V, D, and J gene usage and was restricted to shorter CDR3 regions in IGH. This 
restriction was the result of limited N-nucleotides in the junctions and more frequent 
usage of the relatively short Dh7-27, Jh3 and Jh4 genes. The paucity of N-nucleotide 
additions in IGH gene rearrangements resulted from altered V(D)J recombination rather 
than Ig repertoire selection. These rearrangements were formed in a different molecular 
environment with reduced XRCC4, TdT and ATM, as well as IL7R and FLT3. 
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The major site of postnatal human B-cell differentiation is the BM. Still, B cells are 
present in the thymus, and these cells were suggested to present self-antigens during nega-
tive selection of T cells. In Chapter VI, we studied the Ig gene repertoires of single-sorted 
B cells from fetal BM, pediatric BM and pediatric thymus, and cloned these genes to 
assessed their ability to bind self-antigens. B cells from human thymus displayed an Ig 
gene repertoire that was similar to pediatric BM and did not show typical skewing in Vh, 
Dh and Jh gene usage, nor short IgH-CDR3 regions that are characteristic for fetal BM 
B cells. Still, thymic B cells were enriched for autoreactive clones that showed increased 
specificity to peptide autoantigens, and not towards dsDNA as seen for fetal B cells. 
Although, the majority of B cell progenitors in BM generate an autoreactive Ig, these 
were previously found to be counterselected resulting in only 20% autoreactive circulat-
ing B cells. Thus, autoreactive thymic B cells might either develop in the thymus or in a 
distinct BM niche with selection mechanisms allowing for formation of self-reactive Ig 
gene repertoire. Alternatively, the autoreactive BM-derived B cells can home specifically 
to the thymus.  
The studies described in this thesis provide better understanding of mechanisms 
controlling the stage-specific regulation of V(D)J recombination and the generation 
of a diverse Ig repertoire during precursor-B-cell development. The stepwise V(D)J 
recombination process is controlled by transcriptional and epigenetic mechanisms which 
must cooperate together to provide the developmental increase in Ig loci accessibility 
for rearrangement. The formation of the broad Ig repertoire is dependent on the B-cell 
developmental niche. The BM niche undergoes physiological changes during life and 
therefore provides different signals to developing B cells, resulting in distinct Ig gene 
repertoires with distinct reactivity. Future studies should reveal which environmental 
factors modify the Ig loci accessibility for the V(D)J recombinase and thereby control 
the Ig repertoire and reactivity. Such knowledge might be applicable for shaping the Ig 
repertoire in immune deficient patients.
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SAMENVATTING
Voorloper B-cellen ontwikkelen in het beenmerg (BM) vanuit hematopoietische 
stamcellen (HSC). Het ultieme doel is het genereren van mature B-cellen die elk een 
unieke immuunglobuline (Ig) tot expressie brengen. Op deze manier zorgen alle B-cellen 
tezamen voor een enorme hoeveelheid verschillende antistoffen; Ig repertoire diversi-
teit. Vorming van deze Ig vindt plaats door herschikking van ‘variable’ (V), ‘diversity’ 
(D) en ‘joining’ (J) gensegmenten op DNA niveau in de genen die coderen voor de Ig 
zware (IGH) en de Ig lichte ketens (IGK of IGL). De willekeurige samenvoeging van 
een van elk van deze elementen, zgn. V(D)J-recombinatie, zorgt voor een zeer divers Ig 
repertoire. De Ig loci worden herschikt in een stapsgewijs proces. Het IGH locus her-
schikt vóór de Ig lichte keten loci en functionele herschikkingen blijven in het algemeen 
beperkt tot één allel. Hoewel alle V(D)J-recombinatie elementen aanwezig zijn in zowel 
B-cellen als T-cellen, vinden complete Vh-DJh herschikkingen alleen plaats in B-cellen. 
De stapsgewijze toegankelijkheid van de Ig loci voor herschikkingen wordt dus strikt 
gereguleerd. De studies beschreven in dit proefschrift hadden als doel het beter begri-
jpen van het mechanisme dat ten grondslag ligt aan de fase-specifieke regulatie van V(D)
J-recombinatie en het genereren van een divers Ig repertoire tijdens de ontwikkeling van 
voorloper B-cellen.
Er wordt verondersteld dat tijdens voorloper-B-cel ontwikkeling signalering door 
de pre-B-cel-receptor (pre-BCR) het IGK locus toegankelijk maakt voor het V(D)
J-recombinase enzym-systeem. Echter, het is nog steeds niet bekend hoe de pre-BCR 
geïnduceerde signalen de toegankelijkheid van het IGK locus reguleren. In Hoofdstuk 
II identificeerden wij de effecten van pre-BCR signalering op transcriptie van nog niet 
herschikte IGK allelen en op de expressie van transcriptiefactoren die IGK genherschik-
kingen reguleren. Wij vonden een stapsgewijze afname in pre-BCR signalering van voor-
loper B-cellen van wild type naar BTK-deficiënte, naar SLP65-deficiënte en tenslotte 
naar BTK/SLP65-dubbel deficiënte muizen. Deze stapsgewijze afname liep parallel met 
een progressief verlaagde expressie van de transcriptiefactoren Ikaros, Aiolos, IRF4 en 
(in mindere mate) E2A, alsmede met een verlaagde IGK locus toegankelijkheid voor 
recombinatie. Deze effecten hadden gevolgen voor de interacties tussen V segmenten en 
enhancers in het IGK locus, zoals bleek uit ‘chromosome conformation capture’ (3C-)
sequencing analyses. Deze 3C-seq experimenten demonstreerden dat reeds in pro-B-cel-
len de IGK enhancers een robuuste interactie vertonen met de Vκ regio en de omliggende 
sequenties, en dat pre-BCR-signalering verdere toegankelijkheid induceert door een 
functionele herverdeling van enhancer-gemedieerde chromatine interactie binnen de Vκ 
regio. 
Voor efficiënte V(D)J-recombinatie ondergaan Ig loci in voorloper-B-cellen contrac-
tie.  Eerder werd gedacht dat Ig locus contractie alleen plaatsvindt in het stadium waarin 
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het betreffende locus herschikt wordt, maar meer recente observaties lijken dit tegen te 
spreken. In Hoofdstuk III hebben wij bestudeerd hoe locuscontractie en positionering 
van de celkern geassocieerd zijn met de stapsgewijze regulatie van V(D)J-recombinatie. 
Hiervoor analyseerden wij IGH en IGK locuscontractie, intra-locus chromatine interac-
ties en positionering binnen de celkern in 3 opeenvolgende stadia van voorloper-B-cellen 
in de muis door middel van 3D-DNA FISH en 3C-Seq. Door middel van deze geïn-
tegreerde aanpak konden wij aantonen dat beide Ig loci al gecontraheerd waren in het 
vroege pro-B-cel stadium waarin normaal gesproken IGH wordt herschikt en deze con-
figuratie behielden als pre-B-cellen waarin IGK herschikt wordt. In de vroegste pre-pro-B 
cellen waren beide loci niet gecontraheerd en gepositioneerd aan de rand van de celkern, 
dichtbij de lamina. In pro-B cellen bevonden de IGH allelen zich in het centrum van 
de celkern, weg van de lamina, en waren IGH transcripten verhoogd. IGK was specifiek 
in het centrum gelokaliseerd in pre-B-cellen, die ook verhoogde IGK transcripten lieten 
zien. Hier kan uit geconcludeerd worden dat niet de topologie, maar specifieke lokalisatie 
binnen de celkern van het Ig locus geassocieerd lijkt te zijn met de regulatie van toegan-
kelijkheid voor V(D)J-recombinatie.
In zowel de muis als de mens worden gedurende het hele leven nieuwe B cellen aange-
maakt vanuit hematopoietische stamcellen in het beenmerg. Met toenemende verouder-
ing nemen de aantallen voorloper-B-cellen in het beenmerg af, maar de oorzaak hiervan 
is tot op heden niet bekend. In Hoofdstuk IV analyseerden wij de voorloper-B-cel stadia 
in het beenmerg van gezonde jonge kinderen en volwassenen. Uit genexpressie analy-
ses bleek dat de voorloper-B-cellen van volwassenen verhoogde aantallen transcripten 
hadden van het ID2 gen ten opzichte van kinderen. Id2 blokkeert de functie van E2A, 
een transcriptiefactor die een rol speelt in Ig locus contractie. Voorloper-B-cellen van vol-
wassenen bleken minder sterke contractie van het IGH locus te hebben dan bij  kinderen 
het geval was. Hieruit concludeerden wij dat de verhoogde ID2 transcripten zorgen voor 
verminderde E2A activiteit en Ig locus contractie. Dit zou een belangrijke rol kunnen 
spelen in de efficiëntie van de V(D)J-recombinatie en voorloper-B-cel differentiatie, lei-
dend tot een afname in de B-cel output vanuit het beenmerg in volwassen.
De aanmaak van B-cellen begint al voor de geboorte in de foetale lever en foetale 
BM waardoor een pasgeborene al een divers Ig repertoire heeft. Toch zijn pasgeborenen 
niet in staat om voldoende sterke antistof responsen te vormen tegen bepaalde antigenen 
en hebben de B-cellen een afwijkend, onderontwikkeld (“pre-mature”) Ig repertoire. In 
Hoofdstuk V hebben wij bestudeerd hoe het komt dat de vorming het Ig repertoire zo 
verschilt tussen foetussen en jonge kinderen. Hiervoor zijn voorloper-B-cellen uit been-
merg geïsoleerd en bestudeerd op 4 niveaus: de cellulaire samenstelling, de 3D vouwing 
van het IGH locus, de gevormde Ig genherschikkingen en expressie van factoren die 
betrokken zijn bij V(D)J-recombinatie. Met deze aanpak hebben wij aangetoond dat 
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foetale voorloper-B-cellen in staat zijn om een divers Ig gen repertoire te vormen. Echter, 
in IGH genherschikkingen werden de proximale V, D en J gensegmenten relatief vaak 
gebruikt en waren de CDR3 regio’s korter dan in jonge kinderen. De kortere CDR3 
regio’s waren het resultaat van verminderde aantallen N-nucleotiden in de juncties, en het 
frequente gebruik van de relatief korte Dh7-27, Jh3 en Jh4 gensegmenten. De vermin-
derde aantallen N-nucleotiden waren niet beïnvloed door Ig repertoire selectie, maar een 
direct gevolg van verminderde expressie van XRCC4 en TdT. Bovendien waren de recep-
toren IL7R en FLT3 verlaagd op foetale voorloper-B-cellen, en leidt een IL7R-deficientie 
tot verminderde TdT expressie en N-nucleotide inserties in D-J juncties. 
De belangrijkste locatie voor postnatale humane B-celdifferentiatie is het beenmerg. 
B-cellen bevinden zich echter ook in de thymus. Tijdens de negatieve selectie van T-cellen 
zouden deze B-cellen in de thymus rol spelen in de presentatie in MHC klasse II van 
autoantigenen, die zijn opgenomen door herkenning via de membraangebonden Ig. In 
Hoofdstuk VI hebben wij het Ig repertoire bestudeerd van B-cellen uit foetaal beenmerg, 
en beenmerg en thymus van kinderen. Wij hebben individuele B-cellen geïsoleerd om het 
Ig genrepertoire te bestuderen en om de Ig genen te kloneren. Van deze gekloneerde genen 
hebben we vervolgens in vitro antistoffen geproduceerd om te testen of ze autoantigenen 
kunnen binden. Wij vonden dat het  Ig repertoire van B-cellen in de thymus vergelijk-
baar was met dat van B-cellen in het beenmerg van kinderen. Er was geen verschuiving 
in Vh, Dh en Jh gengebruik zichtbaar, noch zagen wij de voor foetale BM B-cellen 
karakteristieke korte IgH-CDR3 regio’s. Wel zagen wij dat B-cellen uit de thymus meer 
autoreactieve klonen bevatten. Deze autoreactieve klonen waren veelal specifiek voor pep-
tide autoantigenen en juist niet voor dsDNA, zoals foetale B-cellen. Aangezien we geen 
voorloper-B-cellen konden aantonen in de thymus is het waarschijnlijk dat autoreactieve 
B-cellen die geproduceerd zijn in het beenmerg specifiek migreren naar de thymus, of 
specifiek in de thymus overleven, waardoor deze cellen relatief frequent aanwezig zijn. 
De studies beschreven in dit proefschrift geven inzicht in de controlerende mechanis-
mes voor de strikte regulatie van V(D)J-recombinatie en de ontwikkeling van een divers Ig 
repertoire tijdens de voorloper B-cel ontwikkeling. Het stapsgewijze V(D)J-recombinatie 
proces wordt gecontroleerd door transcriptionele en epigenetische mechanismes. Deze 
mechanismes moeten samenwerken om te zorgen dat de Ig loci beter toegangelijke 
worden voor V(D)J recombinatie tijdens een specifiek stadium van ontwikkeling. De 
vorming van een breed Ig repertoire is afhankelijk van de niche waar deze B-cellen zich 
ontwikkelen. De niche in het beenmerg ondergaat fysiologische veranderingen gedurende 
het leven en verzorgt op die manier verschillende signalen voor ontwikkelende B-cellen. 
Dit resulteert in een karakteristiek Ig repertoire met een specifieke reactiviteit tijdens 
verschillende fases van het leven. Vervolgstudies moeten meer inzicht geven welke omgev-
ingsfactoren de Ig loci toegankelijkheid voor de V(D)J-recombinase beïnvloeden en op 
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die manier het Ig repertoire en reactiviteit bepalen. Deze kennis zou toegepast kunnen 
worden om het beperkte Ig repertoire van immuundeficiëntie patiënten te verbreden 
zonder problemen te krijgen met autoreactiviteit. 
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